<html xmlns:v="urn:schemas-microsoft-com:vml"
xmlns:o="urn:schemas-microsoft-com:office:office"
xmlns:w="urn:schemas-microsoft-com:office:word"
xmlns:m="http://schemas.microsoft.com/office/2004/12/omml"
xmlns="http://www.w3.org/TR/REC-html40">

<head>
<meta http-equiv=Content-Type content="text/html; charset=windows-1252">
<meta name=ProgId content=Word.Document>
<meta name=Generator content="Microsoft Word 15">
<meta name=Originator content="Microsoft Word 15">
<link rel=File-List href="sample_file_files/filelist.xml">
<!--[if gte mso 9]><xml>
 <o:DocumentProperties>
  <o:Author>DELL</o:Author>
  <o:LastAuthor>DELL</o:LastAuthor>
  <o:Revision>2</o:Revision>
  <o:TotalTime>4089</o:TotalTime>
  <o:Created>2024-03-26T11:35:00Z</o:Created>
  <o:LastSaved>2024-03-26T11:35:00Z</o:LastSaved>
  <o:Pages>1</o:Pages>
  <o:Words>22203</o:Words>
  <o:Characters>126561</o:Characters>
  <o:Paragraphs>en-IN</o:Paragraphs>
  <o:Lines>1054</o:Lines>
  <o:Paragraphs>296</o:Paragraphs>
  <o:CharactersWithSpaces>148468</o:CharactersWithSpaces>
  <o:Version>15.00</o:Version>
 </o:DocumentProperties>
</xml><![endif]-->
<link rel=themeData href="sample_file_files/themedata.thmx">
<link rel=colorSchemeMapping href="sample_file_files/colorschememapping.xml">
<!--[if gte mso 9]><xml>
 <w:WordDocument>
  <w:TrackMoves>false</w:TrackMoves>
  <w:TrackFormatting/>
  <w:AutoHyphenation/>
  <w:PunctuationKerning/>
  <w:ValidateAgainstSchemas/>
  <w:SaveIfXMLInvalid>false</w:SaveIfXMLInvalid>
  <w:IgnoreMixedContent>false</w:IgnoreMixedContent>
  <w:AlwaysShowPlaceholderText>false</w:AlwaysShowPlaceholderText>
  <w:DoNotPromoteQF/>
  <w:Compatibility>
   <w:BreakWrappedTables/>
   <w:SnapToGridInCell/>
   <w:WrapTextWithPunct/>
   <w:UseAsianBreakRules/>
   <w:UseWord2010TableStyleRules/>
   <w:DontGrowAutofit/>
   <w:SplitPgBreakAndParaMark/>
  </w:Compatibility>
  <w:DoNotOptimizeForBrowser/>
  <m:mathPr>
   <m:mathFont m:val="Cambria Math"/>
   <m:brkBin m:val="before"/>
   <m:brkBinSub m:val="&#45;-"/>
   <m:smallFrac m:val="off"/>
   <m:dispDef/>
   <m:lMargin m:val="0"/>
   <m:rMargin m:val="0"/>
   <m:defJc m:val="centerGroup"/>
   <m:wrapIndent m:val="1440"/>
   <m:intLim m:val="subSup"/>
   <m:naryLim m:val="undOvr"/>
  </m:mathPr></w:WordDocument>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:LatentStyles DefLockedState="false" DefUnhideWhenUsed="false"
  DefSemiHidden="false" DefQFormat="false" DefPriority="99"
  LatentStyleCount="371">
  <w:LsdException Locked="false" Priority="0" QFormat="true" Name="Normal"/>
  <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 1"/>
  <w:LsdException Locked="false" Priority="9" SemiHidden="true"
   UnhideWhenUsed="true" QFormat="true" Name="heading 2"/>
  <w:LsdException Locked="false" Priority="9" SemiHidden="true"
   UnhideWhenUsed="true" QFormat="true" Name="heading 3"/>
  <w:LsdException Locked="false" Priority="9" SemiHidden="true"
   UnhideWhenUsed="true" QFormat="true" Name="heading 4"/>
  <w:LsdException Locked="false" Priority="9" SemiHidden="true"
   UnhideWhenUsed="true" QFormat="true" Name="heading 5"/>
  <w:LsdException Locked="false" Priority="9" SemiHidden="true"
   UnhideWhenUsed="true" QFormat="true" Name="heading 6"/>
  <w:LsdException Locked="false" Priority="9" SemiHidden="true"
   UnhideWhenUsed="true" QFormat="true" Name="heading 7"/>
  <w:LsdException Locked="false" Priority="9" SemiHidden="true"
   UnhideWhenUsed="true" QFormat="true" Name="heading 8"/>
  <w:LsdException Locked="false" Priority="9" SemiHidden="true"
   UnhideWhenUsed="true" QFormat="true" Name="heading 9"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="index 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="index 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="index 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="index 4"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="index 5"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="index 6"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="index 7"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="index 8"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="index 9"/>
  <w:LsdException Locked="false" Priority="39" SemiHidden="true"
   UnhideWhenUsed="true" Name="toc 1"/>
  <w:LsdException Locked="false" Priority="39" SemiHidden="true"
   UnhideWhenUsed="true" Name="toc 2"/>
  <w:LsdException Locked="false" Priority="39" SemiHidden="true"
   UnhideWhenUsed="true" Name="toc 3"/>
  <w:LsdException Locked="false" Priority="39" SemiHidden="true"
   UnhideWhenUsed="true" Name="toc 4"/>
  <w:LsdException Locked="false" Priority="39" SemiHidden="true"
   UnhideWhenUsed="true" Name="toc 5"/>
  <w:LsdException Locked="false" Priority="39" SemiHidden="true"
   UnhideWhenUsed="true" Name="toc 6"/>
  <w:LsdException Locked="false" Priority="39" SemiHidden="true"
   UnhideWhenUsed="true" Name="toc 7"/>
  <w:LsdException Locked="false" Priority="39" SemiHidden="true"
   UnhideWhenUsed="true" Name="toc 8"/>
  <w:LsdException Locked="false" Priority="39" SemiHidden="true"
   UnhideWhenUsed="true" Name="toc 9"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Normal Indent"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="footnote text"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="annotation text"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="header"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="footer"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="index heading"/>
  <w:LsdException Locked="false" Priority="35" SemiHidden="true"
   UnhideWhenUsed="true" QFormat="true" Name="caption"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="table of figures"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="envelope address"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="envelope return"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="footnote reference"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="annotation reference"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="line number"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="page number"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="endnote reference"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="endnote text"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="table of authorities"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="macro"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="toa heading"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Bullet"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Number"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List 4"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List 5"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Bullet 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Bullet 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Bullet 4"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Bullet 5"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Number 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Number 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Number 4"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Number 5"/>
  <w:LsdException Locked="false" Priority="10" QFormat="true" Name="Title"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Closing"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Signature"/>
  <w:LsdException Locked="false" Priority="1" SemiHidden="true"
   UnhideWhenUsed="true" Name="Default Paragraph Font"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Body Text"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Body Text Indent"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Continue"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Continue 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Continue 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Continue 4"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Continue 5"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Message Header"/>
  <w:LsdException Locked="false" Priority="11" QFormat="true" Name="Subtitle"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Salutation"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Date"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Body Text First Indent"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Body Text First Indent 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Note Heading"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Body Text 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Body Text 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Body Text Indent 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Body Text Indent 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Block Text"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Hyperlink"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="FollowedHyperlink"/>
  <w:LsdException Locked="false" Priority="22" QFormat="true" Name="Strong"/>
  <w:LsdException Locked="false" Priority="20" QFormat="true" Name="Emphasis"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Document Map"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Plain Text"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="E-mail Signature"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Top of Form"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Bottom of Form"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Normal (Web)"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Acronym"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Address"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Cite"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Code"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Definition"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Keyboard"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Preformatted"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Sample"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Typewriter"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Variable"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Normal Table"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="annotation subject"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="No List"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Outline List 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Outline List 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Outline List 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Simple 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Simple 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Simple 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Classic 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Classic 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Classic 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Classic 4"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Colorful 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Colorful 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Colorful 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Columns 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Columns 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Columns 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Columns 4"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Columns 5"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Grid 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Grid 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Grid 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Grid 4"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Grid 5"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Grid 6"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Grid 7"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Grid 8"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table List 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table List 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table List 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table List 4"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table List 5"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table List 6"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table List 7"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table List 8"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table 3D effects 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table 3D effects 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table 3D effects 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Contemporary"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Elegant"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Professional"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Subtle 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Subtle 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Web 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Web 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Web 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Balloon Text"/>
  <w:LsdException Locked="false" Priority="39" Name="Table Grid"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Theme"/>
  <w:LsdException Locked="false" SemiHidden="true" Name="Placeholder Text"/>
  <w:LsdException Locked="false" Priority="1" QFormat="true" Name="No Spacing"/>
  <w:LsdException Locked="false" Priority="60" Name="Light Shading"/>
  <w:LsdException Locked="false" Priority="61" Name="Light List"/>
  <w:LsdException Locked="false" Priority="62" Name="Light Grid"/>
  <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1"/>
  <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2"/>
  <w:LsdException Locked="false" Priority="65" Name="Medium List 1"/>
  <w:LsdException Locked="false" Priority="66" Name="Medium List 2"/>
  <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1"/>
  <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2"/>
  <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3"/>
  <w:LsdException Locked="false" Priority="70" Name="Dark List"/>
  <w:LsdException Locked="false" Priority="71" Name="Colorful Shading"/>
  <w:LsdException Locked="false" Priority="72" Name="Colorful List"/>
  <w:LsdException Locked="false" Priority="73" Name="Colorful Grid"/>
  <w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 1"/>
  <w:LsdException Locked="false" Priority="61" Name="Light List Accent 1"/>
  <w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 1"/>
  <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 1"/>
  <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 1"/>
  <w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 1"/>
  <w:LsdException Locked="false" SemiHidden="true" Name="Revision"/>
  <w:LsdException Locked="false" Priority="34" QFormat="true"
   Name="List Paragraph"/>
  <w:LsdException Locked="false" Priority="29" QFormat="true" Name="Quote"/>
  <w:LsdException Locked="false" Priority="30" QFormat="true"
   Name="Intense Quote"/>
  <w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 1"/>
  <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 1"/>
  <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 1"/>
  <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 1"/>
  <w:LsdException Locked="false" Priority="70" Name="Dark List Accent 1"/>
  <w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 1"/>
  <w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 1"/>
  <w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 1"/>
  <w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 2"/>
  <w:LsdException Locked="false" Priority="61" Name="Light List Accent 2"/>
  <w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 2"/>
  <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 2"/>
  <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 2"/>
  <w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 2"/>
  <w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 2"/>
  <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 2"/>
  <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 2"/>
  <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 2"/>
  <w:LsdException Locked="false" Priority="70" Name="Dark List Accent 2"/>
  <w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 2"/>
  <w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 2"/>
  <w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 2"/>
  <w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 3"/>
  <w:LsdException Locked="false" Priority="61" Name="Light List Accent 3"/>
  <w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 3"/>
  <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 3"/>
  <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 3"/>
  <w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 3"/>
  <w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 3"/>
  <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 3"/>
  <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 3"/>
  <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 3"/>
  <w:LsdException Locked="false" Priority="70" Name="Dark List Accent 3"/>
  <w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 3"/>
  <w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 3"/>
  <w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 3"/>
  <w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 4"/>
  <w:LsdException Locked="false" Priority="61" Name="Light List Accent 4"/>
  <w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 4"/>
  <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 4"/>
  <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 4"/>
  <w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 4"/>
  <w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 4"/>
  <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 4"/>
  <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 4"/>
  <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 4"/>
  <w:LsdException Locked="false" Priority="70" Name="Dark List Accent 4"/>
  <w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 4"/>
  <w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 4"/>
  <w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 4"/>
  <w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 5"/>
  <w:LsdException Locked="false" Priority="61" Name="Light List Accent 5"/>
  <w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 5"/>
  <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 5"/>
  <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 5"/>
  <w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 5"/>
  <w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 5"/>
  <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 5"/>
  <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 5"/>
  <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 5"/>
  <w:LsdException Locked="false" Priority="70" Name="Dark List Accent 5"/>
  <w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 5"/>
  <w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 5"/>
  <w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 5"/>
  <w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 6"/>
  <w:LsdException Locked="false" Priority="61" Name="Light List Accent 6"/>
  <w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 6"/>
  <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 6"/>
  <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 6"/>
  <w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 6"/>
  <w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 6"/>
  <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 6"/>
  <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 6"/>
  <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 6"/>
  <w:LsdException Locked="false" Priority="70" Name="Dark List Accent 6"/>
  <w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 6"/>
  <w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 6"/>
  <w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 6"/>
  <w:LsdException Locked="false" Priority="19" QFormat="true"
   Name="Subtle Emphasis"/>
  <w:LsdException Locked="false" Priority="21" QFormat="true"
   Name="Intense Emphasis"/>
  <w:LsdException Locked="false" Priority="31" QFormat="true"
   Name="Subtle Reference"/>
  <w:LsdException Locked="false" Priority="32" QFormat="true"
   Name="Intense Reference"/>
  <w:LsdException Locked="false" Priority="33" QFormat="true" Name="Book Title"/>
  <w:LsdException Locked="false" Priority="37" SemiHidden="true"
   UnhideWhenUsed="true" Name="Bibliography"/>
  <w:LsdException Locked="false" Priority="39" SemiHidden="true"
   UnhideWhenUsed="true" QFormat="true" Name="TOC Heading"/>
  <w:LsdException Locked="false" Priority="41" Name="Plain Table 1"/>
  <w:LsdException Locked="false" Priority="42" Name="Plain Table 2"/>
  <w:LsdException Locked="false" Priority="43" Name="Plain Table 3"/>
  <w:LsdException Locked="false" Priority="44" Name="Plain Table 4"/>
  <w:LsdException Locked="false" Priority="45" Name="Plain Table 5"/>
  <w:LsdException Locked="false" Priority="40" Name="Grid Table Light"/>
  <w:LsdException Locked="false" Priority="46" Name="Grid Table 1 Light"/>
  <w:LsdException Locked="false" Priority="47" Name="Grid Table 2"/>
  <w:LsdException Locked="false" Priority="48" Name="Grid Table 3"/>
  <w:LsdException Locked="false" Priority="49" Name="Grid Table 4"/>
  <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark"/>
  <w:LsdException Locked="false" Priority="51" Name="Grid Table 6 Colorful"/>
  <w:LsdException Locked="false" Priority="52" Name="Grid Table 7 Colorful"/>
  <w:LsdException Locked="false" Priority="46"
   Name="Grid Table 1 Light Accent 1"/>
  <w:LsdException Locked="false" Priority="47" Name="Grid Table 2 Accent 1"/>
  <w:LsdException Locked="false" Priority="48" Name="Grid Table 3 Accent 1"/>
  <w:LsdException Locked="false" Priority="49" Name="Grid Table 4 Accent 1"/>
  <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark Accent 1"/>
  <w:LsdException Locked="false" Priority="51"
   Name="Grid Table 6 Colorful Accent 1"/>
  <w:LsdException Locked="false" Priority="52"
   Name="Grid Table 7 Colorful Accent 1"/>
  <w:LsdException Locked="false" Priority="46"
   Name="Grid Table 1 Light Accent 2"/>
  <w:LsdException Locked="false" Priority="47" Name="Grid Table 2 Accent 2"/>
  <w:LsdException Locked="false" Priority="48" Name="Grid Table 3 Accent 2"/>
  <w:LsdException Locked="false" Priority="49" Name="Grid Table 4 Accent 2"/>
  <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark Accent 2"/>
  <w:LsdException Locked="false" Priority="51"
   Name="Grid Table 6 Colorful Accent 2"/>
  <w:LsdException Locked="false" Priority="52"
   Name="Grid Table 7 Colorful Accent 2"/>
  <w:LsdException Locked="false" Priority="46"
   Name="Grid Table 1 Light Accent 3"/>
  <w:LsdException Locked="false" Priority="47" Name="Grid Table 2 Accent 3"/>
  <w:LsdException Locked="false" Priority="48" Name="Grid Table 3 Accent 3"/>
  <w:LsdException Locked="false" Priority="49" Name="Grid Table 4 Accent 3"/>
  <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark Accent 3"/>
  <w:LsdException Locked="false" Priority="51"
   Name="Grid Table 6 Colorful Accent 3"/>
  <w:LsdException Locked="false" Priority="52"
   Name="Grid Table 7 Colorful Accent 3"/>
  <w:LsdException Locked="false" Priority="46"
   Name="Grid Table 1 Light Accent 4"/>
  <w:LsdException Locked="false" Priority="47" Name="Grid Table 2 Accent 4"/>
  <w:LsdException Locked="false" Priority="48" Name="Grid Table 3 Accent 4"/>
  <w:LsdException Locked="false" Priority="49" Name="Grid Table 4 Accent 4"/>
  <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark Accent 4"/>
  <w:LsdException Locked="false" Priority="51"
   Name="Grid Table 6 Colorful Accent 4"/>
  <w:LsdException Locked="false" Priority="52"
   Name="Grid Table 7 Colorful Accent 4"/>
  <w:LsdException Locked="false" Priority="46"
   Name="Grid Table 1 Light Accent 5"/>
  <w:LsdException Locked="false" Priority="47" Name="Grid Table 2 Accent 5"/>
  <w:LsdException Locked="false" Priority="48" Name="Grid Table 3 Accent 5"/>
  <w:LsdException Locked="false" Priority="49" Name="Grid Table 4 Accent 5"/>
  <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark Accent 5"/>
  <w:LsdException Locked="false" Priority="51"
   Name="Grid Table 6 Colorful Accent 5"/>
  <w:LsdException Locked="false" Priority="52"
   Name="Grid Table 7 Colorful Accent 5"/>
  <w:LsdException Locked="false" Priority="46"
   Name="Grid Table 1 Light Accent 6"/>
  <w:LsdException Locked="false" Priority="47" Name="Grid Table 2 Accent 6"/>
  <w:LsdException Locked="false" Priority="48" Name="Grid Table 3 Accent 6"/>
  <w:LsdException Locked="false" Priority="49" Name="Grid Table 4 Accent 6"/>
  <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark Accent 6"/>
  <w:LsdException Locked="false" Priority="51"
   Name="Grid Table 6 Colorful Accent 6"/>
  <w:LsdException Locked="false" Priority="52"
   Name="Grid Table 7 Colorful Accent 6"/>
  <w:LsdException Locked="false" Priority="46" Name="List Table 1 Light"/>
  <w:LsdException Locked="false" Priority="47" Name="List Table 2"/>
  <w:LsdException Locked="false" Priority="48" Name="List Table 3"/>
  <w:LsdException Locked="false" Priority="49" Name="List Table 4"/>
  <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark"/>
  <w:LsdException Locked="false" Priority="51" Name="List Table 6 Colorful"/>
  <w:LsdException Locked="false" Priority="52" Name="List Table 7 Colorful"/>
  <w:LsdException Locked="false" Priority="46"
   Name="List Table 1 Light Accent 1"/>
  <w:LsdException Locked="false" Priority="47" Name="List Table 2 Accent 1"/>
  <w:LsdException Locked="false" Priority="48" Name="List Table 3 Accent 1"/>
  <w:LsdException Locked="false" Priority="49" Name="List Table 4 Accent 1"/>
  <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark Accent 1"/>
  <w:LsdException Locked="false" Priority="51"
   Name="List Table 6 Colorful Accent 1"/>
  <w:LsdException Locked="false" Priority="52"
   Name="List Table 7 Colorful Accent 1"/>
  <w:LsdException Locked="false" Priority="46"
   Name="List Table 1 Light Accent 2"/>
  <w:LsdException Locked="false" Priority="47" Name="List Table 2 Accent 2"/>
  <w:LsdException Locked="false" Priority="48" Name="List Table 3 Accent 2"/>
  <w:LsdException Locked="false" Priority="49" Name="List Table 4 Accent 2"/>
  <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark Accent 2"/>
  <w:LsdException Locked="false" Priority="51"
   Name="List Table 6 Colorful Accent 2"/>
  <w:LsdException Locked="false" Priority="52"
   Name="List Table 7 Colorful Accent 2"/>
  <w:LsdException Locked="false" Priority="46"
   Name="List Table 1 Light Accent 3"/>
  <w:LsdException Locked="false" Priority="47" Name="List Table 2 Accent 3"/>
  <w:LsdException Locked="false" Priority="48" Name="List Table 3 Accent 3"/>
  <w:LsdException Locked="false" Priority="49" Name="List Table 4 Accent 3"/>
  <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark Accent 3"/>
  <w:LsdException Locked="false" Priority="51"
   Name="List Table 6 Colorful Accent 3"/>
  <w:LsdException Locked="false" Priority="52"
   Name="List Table 7 Colorful Accent 3"/>
  <w:LsdException Locked="false" Priority="46"
   Name="List Table 1 Light Accent 4"/>
  <w:LsdException Locked="false" Priority="47" Name="List Table 2 Accent 4"/>
  <w:LsdException Locked="false" Priority="48" Name="List Table 3 Accent 4"/>
  <w:LsdException Locked="false" Priority="49" Name="List Table 4 Accent 4"/>
  <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark Accent 4"/>
  <w:LsdException Locked="false" Priority="51"
   Name="List Table 6 Colorful Accent 4"/>
  <w:LsdException Locked="false" Priority="52"
   Name="List Table 7 Colorful Accent 4"/>
  <w:LsdException Locked="false" Priority="46"
   Name="List Table 1 Light Accent 5"/>
  <w:LsdException Locked="false" Priority="47" Name="List Table 2 Accent 5"/>
  <w:LsdException Locked="false" Priority="48" Name="List Table 3 Accent 5"/>
  <w:LsdException Locked="false" Priority="49" Name="List Table 4 Accent 5"/>
  <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark Accent 5"/>
  <w:LsdException Locked="false" Priority="51"
   Name="List Table 6 Colorful Accent 5"/>
  <w:LsdException Locked="false" Priority="52"
   Name="List Table 7 Colorful Accent 5"/>
  <w:LsdException Locked="false" Priority="46"
   Name="List Table 1 Light Accent 6"/>
  <w:LsdException Locked="false" Priority="47" Name="List Table 2 Accent 6"/>
  <w:LsdException Locked="false" Priority="48" Name="List Table 3 Accent 6"/>
  <w:LsdException Locked="false" Priority="49" Name="List Table 4 Accent 6"/>
  <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark Accent 6"/>
  <w:LsdException Locked="false" Priority="51"
   Name="List Table 6 Colorful Accent 6"/>
  <w:LsdException Locked="false" Priority="52"
   Name="List Table 7 Colorful Accent 6"/>
 </w:LatentStyles>
</xml><![endif]-->
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:Helvetica;
	panose-1:2 11 5 4 2 2 2 2 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-format:other;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:Courier;
	panose-1:2 7 4 9 2 2 5 2 4 4;
	mso-font-charset:0;
	mso-generic-font-family:modern;
	mso-font-format:other;
	mso-font-pitch:fixed;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Tms Rmn";
	panose-1:2 2 6 3 4 5 5 2 3 4;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-format:other;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:Helv;
	panose-1:2 11 6 4 2 2 2 3 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-format:other;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"New York";
	panose-1:2 4 5 3 6 5 6 2 3 4;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-format:other;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:System;
	panose-1:0 0 0 0 0 0 0 0 0 0;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-format:other;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:Wingdings;
	panose-1:5 0 0 0 0 0 0 0 0 0;
	mso-font-charset:2;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:0 268435456 0 0 -2147483648 0;}
@font-face
	{font-family:"MS Mincho";
	panose-1:2 2 6 9 4 2 5 8 3 4;
	mso-font-alt:"\FF2D\FF33 \660E\671D";
	mso-font-charset:128;
	mso-generic-font-family:roman;
	mso-font-format:other;
	mso-font-pitch:fixed;
	mso-font-signature:1 134676480 16 0 131072 0;}
@font-face
	{font-family:Batang;
	panose-1:2 3 6 0 0 1 1 1 1 1;
	mso-font-alt:\BC14\D0D5;
	mso-font-charset:129;
	mso-generic-font-family:auto;
	mso-font-format:other;
	mso-font-pitch:fixed;
	mso-font-signature:1 151388160 16 0 524288 0;}
@font-face
	{font-family:SimSun;
	panose-1:2 1 6 0 3 1 1 1 1 1;
	mso-font-alt:\5B8B\4F53;
	mso-font-charset:134;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:515 680460288 22 0 262145 0;}
@font-face
	{font-family:PMingLiU;
	panose-1:2 1 6 1 0 1 1 1 1 1;
	mso-font-alt:\65B0\7D30\660E\9AD4;
	mso-font-charset:136;
	mso-generic-font-family:auto;
	mso-font-format:other;
	mso-font-pitch:variable;
	mso-font-signature:1 134742016 16 0 1048576 0;}
@font-face
	{font-family:"MS Gothic";
	panose-1:2 11 6 9 7 2 5 8 2 4;
	mso-font-alt:"\FF2D\FF33 \30B4\30B7\30C3\30AF";
	mso-font-charset:128;
	mso-generic-font-family:modern;
	mso-font-pitch:fixed;
	mso-font-signature:-536870145 1791491579 134217746 0 131231 0;}
@font-face
	{font-family:Dotum;
	panose-1:2 11 6 0 0 1 1 1 1 1;
	mso-font-alt:\B3CB\C6C0;
	mso-font-charset:129;
	mso-generic-font-family:modern;
	mso-font-format:other;
	mso-font-pitch:fixed;
	mso-font-signature:1 151388160 16 0 524288 0;}
@font-face
	{font-family:SimHei;
	panose-1:2 1 6 0 3 1 1 1 1 1;
	mso-font-alt:\9ED1\4F53;
	mso-font-charset:134;
	mso-generic-font-family:modern;
	mso-font-format:other;
	mso-font-pitch:fixed;
	mso-font-signature:1 135135232 16 0 262144 0;}
@font-face
	{font-family:MingLiU;
	panose-1:2 1 6 9 0 1 1 1 1 1;
	mso-font-alt:\7D30\660E\9AD4;
	mso-font-charset:136;
	mso-generic-font-family:modern;
	mso-font-format:other;
	mso-font-pitch:fixed;
	mso-font-signature:1 134742016 16 0 1048576 0;}
@font-face
	{font-family:Mincho;
	panose-1:2 2 6 9 4 3 5 8 3 5;
	mso-font-alt:\660E\671D;
	mso-font-charset:128;
	mso-generic-font-family:roman;
	mso-font-format:other;
	mso-font-pitch:fixed;
	mso-font-signature:1 134676480 16 0 131072 0;}
@font-face
	{font-family:Gulim;
	panose-1:2 11 6 0 0 1 1 1 1 1;
	mso-font-alt:\AD74\B9BC;
	mso-font-charset:129;
	mso-generic-font-family:roman;
	mso-font-format:other;
	mso-font-pitch:fixed;
	mso-font-signature:1 151388160 16 0 524288 0;}
@font-face
	{font-family:Century;
	panose-1:2 4 6 4 5 5 5 2 3 4;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:647 0 0 0 159 0;}
@font-face
	{font-family:"Angsana New";
	panose-1:2 2 6 3 5 4 5 2 3 4;
	mso-font-charset:222;
	mso-generic-font-family:roman;
	mso-font-format:other;
	mso-font-pitch:variable;
	mso-font-signature:16777217 0 0 0 65536 0;}
@font-face
	{font-family:"Cordia New";
	panose-1:2 11 3 4 2 2 2 2 2 4;
	mso-font-charset:222;
	mso-generic-font-family:roman;
	mso-font-format:other;
	mso-font-pitch:variable;
	mso-font-signature:16777217 0 0 0 65536 0;}
@font-face
	{font-family:Mangal;
	panose-1:0 0 4 0 0 0 0 0 0 0;
	mso-font-alt:"Courier New";
	mso-font-charset:1;
	mso-generic-font-family:roman;
	mso-font-format:other;
	mso-font-pitch:variable;
	mso-font-signature:8192 0 0 0 0 0;}
@font-face
	{font-family:Latha;
	panose-1:2 0 4 0 0 0 0 0 0 0;
	mso-font-charset:1;
	mso-generic-font-family:roman;
	mso-font-format:other;
	mso-font-pitch:variable;
	mso-font-signature:262144 0 0 0 0 0;}
@font-face
	{font-family:Sylfaen;
	panose-1:1 10 5 2 5 3 6 3 3 3;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:67110535 0 0 0 159 0;}
@font-face
	{font-family:Vrinda;
	panose-1:0 0 4 0 0 0 0 0 0 0;
	mso-font-charset:1;
	mso-generic-font-family:roman;
	mso-font-format:other;
	mso-font-pitch:variable;
	mso-font-signature:0 0 0 0 0 0;}
@font-face
	{font-family:Raavi;
	panose-1:2 0 5 0 0 0 0 0 0 0;
	mso-font-charset:1;
	mso-generic-font-family:roman;
	mso-font-format:other;
	mso-font-pitch:variable;
	mso-font-signature:0 0 0 0 0 0;}
@font-face
	{font-family:Shruti;
	panose-1:2 0 5 0 0 0 0 0 0 0;
	mso-font-charset:1;
	mso-generic-font-family:roman;
	mso-font-format:other;
	mso-font-pitch:variable;
	mso-font-signature:0 0 0 0 0 0;}
@font-face
	{font-family:Sendnya;
	panose-1:0 0 4 0 0 0 0 0 0 0;
	mso-font-charset:1;
	mso-generic-font-family:roman;
	mso-font-format:other;
	mso-font-pitch:variable;
	mso-font-signature:0 0 0 0 0 0;}
@font-face
	{font-family:Gautami;
	panose-1:2 0 5 0 0 0 0 0 0 0;
	mso-font-charset:1;
	mso-generic-font-family:roman;
	mso-font-format:other;
	mso-font-pitch:variable;
	mso-font-signature:0 0 0 0 0 0;}
@font-face
	{font-family:Tunga;
	panose-1:0 0 4 0 0 0 0 0 0 0;
	mso-font-charset:1;
	mso-generic-font-family:roman;
	mso-font-format:other;
	mso-font-pitch:variable;
	mso-font-signature:0 0 0 0 0 0;}
@font-face
	{font-family:"Estrangelo Edessa";
	panose-1:0 0 0 0 0 0 0 0 0 0;
	mso-font-charset:1;
	mso-generic-font-family:roman;
	mso-font-format:other;
	mso-font-pitch:variable;
	mso-font-signature:0 0 0 0 0 0;}
@font-face
	{font-family:"Cambria Math";
	panose-1:2 4 5 3 5 4 6 3 2 4;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-536869121 1107305727 33554432 0 415 0;}
@font-face
	{font-family:"Arial Unicode MS";
	panose-1:2 11 6 4 2 2 2 2 2 4;
	mso-font-charset:128;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-134238209 -371195905 63 0 4129279 0;}
@font-face
	{font-family:"Calibri Light";
	panose-1:2 15 3 2 2 2 4 3 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-469750017 -1073732485 9 0 511 0;}
@font-face
	{font-family:Calibri;
	panose-1:2 15 5 2 2 2 4 3 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-469750017 -1073732485 9 0 511 0;}
@font-face
	{font-family:"Segoe UI";
	panose-1:2 11 5 2 4 2 4 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-469750017 -1073683329 9 0 511 0;}
@font-face
	{font-family:"Liberation Serif";
	mso-font-alt:"Times New Roman";
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:0 0 0 0 0 0;}
@font-face
	{font-family:OpenSymbol;
	mso-font-alt:"Arial Unicode MS";
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:0 0 0 0 0 0;}
@font-face
	{font-family:"Liberation Sans";
	mso-font-alt:Arial;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:0 0 0 0 0 0;}
@font-face
	{font-family:"S hne";
	mso-font-alt:ui-sans-serif;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:0 0 0 0 0 0;}
@font-face
	{font-family:0;
	mso-font-charset:1;
	mso-generic-font-family:auto;
	mso-font-pitch:auto;
	mso-font-signature:0 0 0 0 0 0;}
@font-face
	{font-family:Roboto;
	panose-1:0 0 0 0 0 0 0 0 0 0;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-format:other;
	mso-font-pitch:auto;
	mso-font-signature:0 0 0 0 0 0;}
@font-face
	{font-family:"Noto Naskh Arabic";
	panose-1:0 0 0 0 0 0 0 0 0 0;
	mso-font-alt:"Times New Roman";
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-format:other;
	mso-font-pitch:auto;
	mso-font-signature:0 0 0 0 0 0;}
@font-face
	{font-family:NSimSun;
	panose-1:2 1 6 9 3 1 1 1 1 1;
	mso-font-charset:134;
	mso-generic-font-family:modern;
	mso-font-pitch:fixed;
	mso-font-signature:515 680460288 22 0 262145 0;}
@font-face
	{font-family:"Microsoft YaHei";
	panose-1:2 11 5 3 2 2 4 2 2 4;
	mso-font-charset:134;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147483001 718224464 22 0 262175 0;}
@font-face
	{font-family:"S hne\;ui-sans-serif\;system-ui\;a";
	panose-1:0 0 0 0 0 0 0 0 0 0;
	mso-font-alt:"Times New Roman";
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-format:other;
	mso-font-pitch:auto;
	mso-font-signature:0 0 0 0 0 0;}
@font-face
	{font-family:Marlett;
	panose-1:0 0 0 0 0 0 0 0 0 0;
	mso-font-charset:2;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:0 268435456 0 0 -2147483648 0;}
@font-face
	{font-family:"Arial Black";
	panose-1:2 11 10 4 2 1 2 2 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-1610612049 1073772795 0 0 159 0;}
@font-face
	{font-family:"Bahnschrift Light";
	panose-1:2 11 5 2 4 2 4 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-1610612025 2 0 0 415 0;}
@font-face
	{font-family:"Bahnschrift SemiLight";
	panose-1:2 11 5 2 4 2 4 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-1610612025 2 0 0 415 0;}
@font-face
	{font-family:Bahnschrift;
	panose-1:2 11 5 2 4 2 4 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-1610612025 2 0 0 415 0;}
@font-face
	{font-family:"Bahnschrift SemiBold";
	panose-1:2 11 5 2 4 2 4 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-1610612025 2 0 0 415 0;}
@font-face
	{font-family:"Bahnschrift Light SemiCondensed";
	panose-1:2 11 5 2 4 2 4 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-1610612025 2 0 0 415 0;}
@font-face
	{font-family:"Bahnschrift SemiLight SemiConde";
	panose-1:2 11 5 2 4 2 4 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-1610612025 2 0 0 415 0;}
@font-face
	{font-family:"Bahnschrift SemiCondensed";
	panose-1:2 11 5 2 4 2 4 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-1610612025 2 0 0 415 0;}
@font-face
	{font-family:"Bahnschrift SemiBold SemiConden";
	panose-1:2 11 5 2 4 2 4 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-1610612025 2 0 0 415 0;}
@font-face
	{font-family:"Bahnschrift Light Condensed";
	panose-1:2 11 5 2 4 2 4 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-1610612025 2 0 0 415 0;}
@font-face
	{font-family:"Bahnschrift SemiLight Condensed";
	panose-1:2 11 5 2 4 2 4 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-1610612025 2 0 0 415 0;}
@font-face
	{font-family:"Bahnschrift Condensed";
	panose-1:2 11 5 2 4 2 4 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-1610612025 2 0 0 415 0;}
@font-face
	{font-family:"Bahnschrift SemiBold Condensed";
	panose-1:2 11 5 2 4 2 4 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-1610612025 2 0 0 415 0;}
@font-face
	{font-family:Cambria;
	panose-1:2 4 5 3 5 4 6 3 2 4;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-536869121 1107305727 33554432 0 415 0;}
@font-face
	{font-family:Candara;
	panose-1:2 14 5 2 3 3 3 2 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-1610611985 1073783883 0 0 415 0;}
@font-face
	{font-family:"Candara Light";
	panose-1:2 14 5 2 3 3 3 2 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-1610611969 2 0 0 415 0;}
@font-face
	{font-family:"Comic Sans MS";
	panose-1:3 15 7 2 3 3 2 2 2 4;
	mso-font-charset:0;
	mso-generic-font-family:script;
	mso-font-pitch:variable;
	mso-font-signature:647 19 0 0 159 0;}
@font-face
	{font-family:Consolas;
	panose-1:2 11 6 9 2 2 4 3 2 4;
	mso-font-charset:0;
	mso-generic-font-family:modern;
	mso-font-pitch:fixed;
	mso-font-signature:-536869121 64767 1 0 415 0;}
@font-face
	{font-family:Constantia;
	panose-1:2 3 6 2 5 3 6 3 3 3;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-1610611985 1073750091 0 0 415 0;}
@font-face
	{font-family:Corbel;
	panose-1:2 11 5 3 2 2 4 2 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-1610611985 1073783883 0 0 415 0;}
@font-face
	{font-family:"Corbel Light";
	panose-1:2 11 3 3 2 2 4 2 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-1610611985 1073783883 0 0 415 0;}
@font-face
	{font-family:Ebrima;
	panose-1:2 0 0 0 0 0 0 0 0 0;
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-1610612641 33554497 2048 0 147 0;}
@font-face
	{font-family:"Franklin Gothic Medium";
	panose-1:2 11 6 3 2 1 2 2 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:647 0 0 0 159 0;}
@font-face
	{font-family:Gabriola;
	panose-1:4 4 6 5 5 16 2 2 13 2;
	mso-font-charset:0;
	mso-generic-font-family:decorative;
	mso-font-pitch:variable;
	mso-font-signature:-536870161 1342185547 0 0 159 0;}
@font-face
	{font-family:Gadugi;
	panose-1:2 11 5 2 4 2 4 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147483645 33554432 12288 0 1 0;}
@font-face
	{font-family:Georgia;
	panose-1:2 4 5 2 5 4 5 2 3 3;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:647 0 0 0 159 0;}
@font-face
	{font-family:Impact;
	panose-1:2 11 8 6 3 9 2 5 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:647 0 0 0 159 0;}
@font-face
	{font-family:"Ink Free";
	panose-1:3 8 4 2 0 5 0 0 0 0;
	mso-font-charset:0;
	mso-generic-font-family:script;
	mso-font-pitch:variable;
	mso-font-signature:-2147483645 0 0 0 1 0;}
@font-face
	{font-family:"Javanese Text";
	panose-1:2 0 0 0 0 0 0 0 0 0;
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-2147483645 8192 0 0 1 0;}
@font-face
	{font-family:"Leelawadee UI";
	panose-1:2 11 5 2 4 2 4 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-1560281085 0 65536 0 65793 0;}
@font-face
	{font-family:"Leelawadee UI Semilight";
	panose-1:2 11 4 2 4 2 4 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-1560281085 0 65536 0 65793 0;}
@font-face
	{font-family:"Lucida Console";
	panose-1:2 11 6 9 4 5 4 2 2 4;
	mso-font-charset:0;
	mso-generic-font-family:modern;
	mso-font-pitch:fixed;
	mso-font-signature:-2147482993 6144 0 0 31 0;}
@font-face
	{font-family:"Lucida Sans Unicode";
	panose-1:2 11 6 2 3 5 4 2 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147480833 14699 0 0 191 0;}
@font-face
	{font-family:"Malgun Gothic";
	panose-1:2 11 5 3 2 0 0 2 0 4;
	mso-font-charset:129;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-1879048145 701988091 18 0 524289 0;}
@font-face
	{font-family:"\@Malgun Gothic";
	panose-1:2 11 5 3 2 0 0 2 0 4;
	mso-font-charset:129;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-1879048145 701988091 18 0 524289 0;}
@font-face
	{font-family:"Malgun Gothic Semilight";
	panose-1:2 11 5 2 4 2 4 2 2 3;
	mso-font-charset:129;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-1342174545 165641467 18 0 4063677 0;}
@font-face
	{font-family:"\@Malgun Gothic Semilight";
	panose-1:2 11 5 2 4 2 4 2 2 3;
	mso-font-charset:128;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-1342174545 165641467 18 0 4063677 0;}
@font-face
	{font-family:"Microsoft Himalaya";
	panose-1:1 1 1 0 1 1 1 1 1 1;
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-2147483645 65536 64 0 1 0;}
@font-face
	{font-family:"Microsoft JhengHei";
	panose-1:2 11 6 4 3 5 4 4 2 4;
	mso-font-charset:136;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:679 684672000 22 0 1048585 0;}
@font-face
	{font-family:"\@Microsoft JhengHei";
	panose-1:2 11 6 4 3 5 4 4 2 4;
	mso-font-charset:136;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:679 684672000 22 0 1048585 0;}
@font-face
	{font-family:"Microsoft JhengHei UI";
	panose-1:2 11 6 4 3 5 4 4 2 4;
	mso-font-charset:136;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:679 684672000 22 0 1048585 0;}
@font-face
	{font-family:"\@Microsoft JhengHei UI";
	panose-1:2 11 6 4 3 5 4 4 2 4;
	mso-font-charset:136;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:679 684672000 22 0 1048585 0;}
@font-face
	{font-family:"Microsoft JhengHei Light";
	panose-1:2 11 3 4 3 5 4 4 2 4;
	mso-font-charset:136;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147482969 684672000 22 0 1048585 0;}
@font-face
	{font-family:"\@Microsoft JhengHei Light";
	panose-1:2 11 3 4 3 5 4 4 2 4;
	mso-font-charset:136;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147482969 684672000 22 0 1048585 0;}
@font-face
	{font-family:"Microsoft JhengHei UI Light";
	panose-1:2 11 3 4 3 5 4 4 2 4;
	mso-font-charset:136;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147482969 684672000 22 0 1048585 0;}
@font-face
	{font-family:"\@Microsoft JhengHei UI Light";
	panose-1:2 11 3 4 3 5 4 4 2 4;
	mso-font-charset:136;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147482969 684672000 22 0 1048585 0;}
@font-face
	{font-family:"Microsoft New Tai Lue";
	panose-1:2 11 5 2 4 2 4 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:3 0 -2147483648 0 1 0;}
@font-face
	{font-family:"Microsoft PhagsPa";
	panose-1:2 11 5 2 4 2 4 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:3 0 134217728 0 1 0;}
@font-face
	{font-family:"Microsoft Sans Serif";
	panose-1:2 11 6 4 2 2 2 2 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-452972801 -1073717157 41 0 66047 0;}
@font-face
	{font-family:"Microsoft Tai Le";
	panose-1:2 11 5 2 4 2 4 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:3 0 1073741824 0 1 0;}
@font-face
	{font-family:"\@Microsoft YaHei";
	panose-1:2 11 5 3 2 2 4 2 2 4;
	mso-font-charset:134;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147483001 718224464 22 0 262175 0;}
@font-face
	{font-family:"Microsoft YaHei UI";
	panose-1:2 11 5 3 2 2 4 2 2 4;
	mso-font-charset:134;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147483001 718224464 22 0 262175 0;}
@font-face
	{font-family:"\@Microsoft YaHei UI";
	panose-1:2 11 5 3 2 2 4 2 2 4;
	mso-font-charset:134;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147483001 718224464 22 0 262175 0;}
@font-face
	{font-family:"Microsoft YaHei Light";
	panose-1:2 11 5 2 4 2 4 2 2 3;
	mso-font-charset:134;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147483001 718209040 22 0 262175 0;}
@font-face
	{font-family:"\@Microsoft YaHei Light";
	panose-1:2 11 5 2 4 2 4 2 2 3;
	mso-font-charset:134;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147483001 718209040 22 0 262175 0;}
@font-face
	{font-family:"Microsoft YaHei UI Light";
	panose-1:2 11 5 2 4 2 4 2 2 3;
	mso-font-charset:134;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147483001 718209040 22 0 262175 0;}
@font-face
	{font-family:"\@Microsoft YaHei UI Light";
	panose-1:2 11 5 2 4 2 4 2 2 3;
	mso-font-charset:134;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147483001 718209040 22 0 262175 0;}
@font-face
	{font-family:"Microsoft Yi Baiti";
	panose-1:3 0 5 0 0 0 0 0 0 0;
	mso-font-charset:0;
	mso-generic-font-family:script;
	mso-font-pitch:variable;
	mso-font-signature:-2147483645 66562 524290 0 1 0;}
@font-face
	{font-family:MingLiU-ExtB;
	panose-1:2 2 5 0 0 0 0 0 0 0;
	mso-font-charset:136;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-2147483601 168296456 16 0 1048577 0;}
@font-face
	{font-family:"\@MingLiU-ExtB";
	panose-1:2 2 5 0 0 0 0 0 0 0;
	mso-font-charset:136;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-2147483601 168296456 16 0 1048577 0;}
@font-face
	{font-family:PMingLiU-ExtB;
	panose-1:2 2 5 0 0 0 0 0 0 0;
	mso-font-charset:136;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-2147483601 168296456 16 0 1048577 0;}
@font-face
	{font-family:"\@PMingLiU-ExtB";
	panose-1:2 2 5 0 0 0 0 0 0 0;
	mso-font-charset:136;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-2147483601 168296456 16 0 1048577 0;}
@font-face
	{font-family:MingLiU_HKSCS-ExtB;
	panose-1:2 2 5 0 0 0 0 0 0 0;
	mso-font-charset:136;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-2147483601 168296456 16 0 1048577 0;}
@font-face
	{font-family:"\@MingLiU_HKSCS-ExtB";
	panose-1:2 2 5 0 0 0 0 0 0 0;
	mso-font-charset:136;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-2147483601 168296456 16 0 1048577 0;}
@font-face
	{font-family:"Mongolian Baiti";
	panose-1:3 0 5 0 0 0 0 0 0 0;
	mso-font-charset:0;
	mso-generic-font-family:script;
	mso-font-pitch:variable;
	mso-font-signature:-2147483613 0 131072 0 1 0;}
@font-face
	{font-family:"\@MS Gothic";
	panose-1:2 11 6 9 7 2 5 8 2 4;
	mso-font-charset:128;
	mso-generic-font-family:modern;
	mso-font-pitch:fixed;
	mso-font-signature:-536870145 1791491579 134217746 0 131231 0;}
@font-face
	{font-family:"MS UI Gothic";
	panose-1:2 11 6 0 7 2 5 8 2 4;
	mso-font-charset:128;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-536870145 1791491579 134217746 0 131231 0;}
@font-face
	{font-family:"\@MS UI Gothic";
	panose-1:2 11 6 0 7 2 5 8 2 4;
	mso-font-charset:128;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-536870145 1791491579 134217746 0 131231 0;}
@font-face
	{font-family:"MS PGothic";
	panose-1:2 11 6 0 7 2 5 8 2 4;
	mso-font-charset:128;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-536870145 1791491579 134217746 0 131231 0;}
@font-face
	{font-family:"\@MS PGothic";
	panose-1:2 11 6 0 7 2 5 8 2 4;
	mso-font-charset:128;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-536870145 1791491579 134217746 0 131231 0;}
@font-face
	{font-family:"MV Boli";
	panose-1:2 0 5 0 3 2 0 9 0 0;
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:3 0 256 0 1 0;}
@font-face
	{font-family:"Myanmar Text";
	panose-1:2 11 5 2 4 2 4 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147483645 0 1024 0 1 0;}
@font-face
	{font-family:"Nirmala UI";
	panose-1:2 11 5 2 4 2 4 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2130739165 33554506 512 0 1 0;}
@font-face
	{font-family:"Nirmala UI Semilight";
	panose-1:2 11 4 2 4 2 4 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2130739165 33554506 512 0 1 0;}
@font-face
	{font-family:"Palatino Linotype";
	panose-1:2 4 5 2 5 5 5 3 3 4;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-536870265 1073741843 0 0 415 0;}
@font-face
	{font-family:"Segoe MDL2 Assets";
	panose-1:5 10 1 2 1 1 1 1 1 1;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:3 268435456 0 0 1 0;}
@font-face
	{font-family:"Segoe Print";
	panose-1:2 0 6 0 0 0 0 0 0 0;
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:655 0 0 0 159 0;}
@font-face
	{font-family:"Segoe Script";
	panose-1:3 11 5 4 2 0 0 0 0 3;
	mso-font-charset:0;
	mso-generic-font-family:script;
	mso-font-pitch:variable;
	mso-font-signature:655 0 0 0 159 0;}
@font-face
	{font-family:"Segoe UI Black";
	panose-1:2 11 10 2 4 2 4 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-536870145 1073800319 33 0 415 0;}
@font-face
	{font-family:"Segoe UI Emoji";
	panose-1:2 11 5 2 4 2 4 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:3 33554432 0 0 1 0;}
@font-face
	{font-family:"Segoe UI Historic";
	panose-1:2 11 5 2 4 2 4 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147483153 33554434 6340736 0 1 0;}
@font-face
	{font-family:"Segoe UI Light";
	panose-1:2 11 5 2 4 2 4 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-469750017 -1073683329 9 0 511 0;}
@font-face
	{font-family:"Segoe UI Semibold";
	panose-1:2 11 7 2 4 2 4 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-469750017 -1073683329 9 0 511 0;}
@font-face
	{font-family:"Segoe UI Semilight";
	panose-1:2 11 4 2 4 2 4 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-469750017 -1073683329 9 0 511 0;}
@font-face
	{font-family:"Segoe UI Symbol";
	panose-1:2 11 5 2 4 2 4 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147483165 302055407 262144 0 1 0;}
@font-face
	{font-family:"\@SimSun";
	panose-1:2 1 6 0 3 1 1 1 1 1;
	mso-font-charset:134;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:515 680460288 22 0 262145 0;}
@font-face
	{font-family:"\@NSimSun";
	panose-1:2 1 6 9 3 1 1 1 1 1;
	mso-font-charset:134;
	mso-generic-font-family:modern;
	mso-font-pitch:fixed;
	mso-font-signature:515 680460288 22 0 262145 0;}
@font-face
	{font-family:SimSun-ExtB;
	panose-1:2 1 6 9 6 1 1 1 1 1;
	mso-font-charset:134;
	mso-generic-font-family:modern;
	mso-font-pitch:fixed;
	mso-font-signature:3 168689664 16 0 262145 0;}
@font-face
	{font-family:"\@SimSun-ExtB";
	panose-1:2 1 6 9 6 1 1 1 1 1;
	mso-font-charset:134;
	mso-generic-font-family:modern;
	mso-font-pitch:fixed;
	mso-font-signature:3 168689664 16 0 262145 0;}
@font-face
	{font-family:"Sitka Small";
	panose-1:2 0 5 5 0 0 0 2 0 4;
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-1610611985 1073750091 0 0 415 0;}
@font-face
	{font-family:"Sitka Text";
	panose-1:2 0 5 5 0 0 0 2 0 4;
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-1610611985 1073750091 0 0 415 0;}
@font-face
	{font-family:"Sitka Subheading";
	panose-1:2 0 5 5 0 0 0 2 0 4;
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-1610611985 1073750091 0 0 415 0;}
@font-face
	{font-family:"Sitka Heading";
	panose-1:2 0 5 5 0 0 0 2 0 4;
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-1610611985 1073750091 0 0 415 0;}
@font-face
	{font-family:"Sitka Display";
	panose-1:2 0 5 5 0 0 0 2 0 4;
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-1610611985 1073750091 0 0 415 0;}
@font-face
	{font-family:"Sitka Banner";
	panose-1:2 0 5 5 0 0 0 2 0 4;
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-1610611985 1073750091 0 0 415 0;}
@font-face
	{font-family:Tahoma;
	panose-1:2 11 6 4 3 5 4 4 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-520081665 -1073717157 41 0 66047 0;}
@font-face
	{font-family:"Trebuchet MS";
	panose-1:2 11 6 3 2 2 2 2 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:1671 0 0 0 159 0;}
@font-face
	{font-family:Verdana;
	panose-1:2 11 6 4 3 5 4 4 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-1610610945 1073750107 16 0 415 0;}
@font-face
	{font-family:Webdings;
	panose-1:5 3 1 2 1 5 9 6 7 3;
	mso-font-charset:2;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:0 268435456 0 0 -2147483648 0;}
@font-face
	{font-family:"Yu Gothic";
	panose-1:2 11 4 0 0 0 0 0 0 0;
	mso-font-charset:128;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-536870145 717749759 22 0 131231 0;}
@font-face
	{font-family:"\@Yu Gothic";
	panose-1:2 11 4 0 0 0 0 0 0 0;
	mso-font-charset:128;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-536870145 717749759 22 0 131231 0;}
@font-face
	{font-family:"Yu Gothic UI";
	panose-1:2 11 5 0 0 0 0 0 0 0;
	mso-font-charset:128;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-536870145 717749759 22 0 131231 0;}
@font-face
	{font-family:"\@Yu Gothic UI";
	panose-1:2 11 5 0 0 0 0 0 0 0;
	mso-font-charset:128;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-536870145 717749759 22 0 131231 0;}
@font-face
	{font-family:"Yu Gothic UI Semibold";
	panose-1:2 11 7 0 0 0 0 0 0 0;
	mso-font-charset:128;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-536870145 717749759 22 0 131231 0;}
@font-face
	{font-family:"\@Yu Gothic UI Semibold";
	panose-1:2 11 7 0 0 0 0 0 0 0;
	mso-font-charset:128;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-536870145 717749759 22 0 131231 0;}
@font-face
	{font-family:"Yu Gothic Light";
	panose-1:2 11 3 0 0 0 0 0 0 0;
	mso-font-charset:128;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-536870145 717749759 22 0 131231 0;}
@font-face
	{font-family:"\@Yu Gothic Light";
	panose-1:2 11 3 0 0 0 0 0 0 0;
	mso-font-charset:128;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-536870145 717749759 22 0 131231 0;}
@font-face
	{font-family:"Yu Gothic UI Light";
	panose-1:2 11 3 0 0 0 0 0 0 0;
	mso-font-charset:128;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-536870145 717749759 22 0 131231 0;}
@font-face
	{font-family:"\@Yu Gothic UI Light";
	panose-1:2 11 3 0 0 0 0 0 0 0;
	mso-font-charset:128;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-536870145 717749759 22 0 131231 0;}
@font-face
	{font-family:"Yu Gothic Medium";
	panose-1:2 11 5 0 0 0 0 0 0 0;
	mso-font-charset:128;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-536870145 717749759 22 0 131231 0;}
@font-face
	{font-family:"\@Yu Gothic Medium";
	panose-1:2 11 5 0 0 0 0 0 0 0;
	mso-font-charset:128;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-536870145 717749759 22 0 131231 0;}
@font-face
	{font-family:"Yu Gothic UI Semilight";
	panose-1:2 11 4 0 0 0 0 0 0 0;
	mso-font-charset:128;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-536870145 717749759 22 0 131231 0;}
@font-face
	{font-family:"\@Yu Gothic UI Semilight";
	panose-1:2 11 4 0 0 0 0 0 0 0;
	mso-font-charset:128;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-536870145 717749759 22 0 131231 0;}
@font-face
	{font-family:"HoloLens MDL2 Assets";
	panose-1:5 10 1 2 1 1 1 1 1 1;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:3 268435456 0 0 1 0;}
@font-face
	{font-family:"MT Extra";
	panose-1:5 5 1 2 1 2 5 2 2 2;
	mso-font-charset:2;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:0 268435456 0 0 -2147483648 0;}
@font-face
	{font-family:"\@Arial Unicode MS";
	panose-1:2 11 6 4 2 2 2 2 2 4;
	mso-font-charset:128;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-134238209 -371195905 63 0 4129279 0;}
@font-face
	{font-family:"Wingdings 2";
	panose-1:5 2 1 2 1 5 7 7 7 7;
	mso-font-charset:2;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:0 268435456 0 0 -2147483648 0;}
@font-face
	{font-family:"Wingdings 3";
	panose-1:5 4 1 2 1 8 7 7 7 7;
	mso-font-charset:2;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:0 268435456 0 0 -2147483648 0;}
@font-face
	{font-family:"Tempus Sans ITC";
	panose-1:4 2 4 4 3 13 7 2 2 2;
	mso-font-charset:0;
	mso-generic-font-family:decorative;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:Pristina;
	panose-1:3 6 4 2 4 4 6 8 2 4;
	mso-font-charset:0;
	mso-generic-font-family:script;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:Papyrus;
	panose-1:3 7 5 2 6 5 2 3 2 5;
	mso-font-charset:0;
	mso-generic-font-family:script;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:Mistral;
	panose-1:3 9 7 2 3 4 7 2 4 3;
	mso-font-charset:0;
	mso-generic-font-family:script;
	mso-font-pitch:variable;
	mso-font-signature:647 0 0 0 159 0;}
@font-face
	{font-family:"Lucida Handwriting";
	panose-1:3 1 1 1 1 1 1 1 1 1;
	mso-font-charset:0;
	mso-generic-font-family:script;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Kristen ITC";
	panose-1:3 5 5 2 4 2 2 3 2 2;
	mso-font-charset:0;
	mso-generic-font-family:script;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Juice ITC";
	panose-1:4 4 4 3 4 10 2 2 2 2;
	mso-font-charset:0;
	mso-generic-font-family:decorative;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"French Script MT";
	panose-1:3 2 4 2 4 6 7 4 6 5;
	mso-font-charset:0;
	mso-generic-font-family:script;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Freestyle Script";
	panose-1:3 8 4 2 3 2 5 11 4 4;
	mso-font-charset:0;
	mso-generic-font-family:script;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Bradley Hand ITC";
	panose-1:3 7 4 2 5 3 2 3 2 3;
	mso-font-charset:0;
	mso-generic-font-family:script;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"MS Outlook";
	panose-1:5 1 1 0 1 0 0 0 0 0;
	mso-font-charset:2;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:0 268435456 0 0 -2147483648 0;}
@font-face
	{font-family:"Arial Narrow";
	panose-1:2 11 6 6 2 2 2 3 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:647 2048 0 0 159 0;}
@font-face
	{font-family:"Book Antiqua";
	panose-1:2 4 6 2 5 3 5 3 3 4;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:647 0 0 0 159 0;}
@font-face
	{font-family:Garamond;
	panose-1:2 2 4 4 3 3 1 1 8 3;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:647 0 0 0 159 0;}
@font-face
	{font-family:"Monotype Corsiva";
	panose-1:3 1 1 1 1 2 1 1 1 1;
	mso-font-charset:0;
	mso-generic-font-family:script;
	mso-font-pitch:variable;
	mso-font-signature:647 0 0 0 159 0;}
@font-face
	{font-family:"Century Gothic";
	panose-1:2 11 5 2 2 2 2 2 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:647 0 0 0 159 0;}
@font-face
	{font-family:Algerian;
	panose-1:4 2 7 5 4 10 2 6 7 2;
	mso-font-charset:0;
	mso-generic-font-family:decorative;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Baskerville Old Face";
	panose-1:2 2 6 2 8 5 5 2 3 3;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Bauhaus 93";
	panose-1:4 3 9 5 2 11 2 2 12 2;
	mso-font-charset:0;
	mso-generic-font-family:decorative;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Bell MT";
	panose-1:2 2 5 3 6 3 5 2 3 3;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Berlin Sans FB";
	panose-1:2 14 6 2 2 5 2 2 3 6;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Bernard MT Condensed";
	panose-1:2 5 8 6 6 9 5 2 4 4;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Bodoni MT Poster Compressed";
	panose-1:2 7 7 6 8 6 1 5 2 4;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:7 0 0 0 17 0;}
@font-face
	{font-family:"Britannic Bold";
	panose-1:2 11 9 3 6 7 3 2 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:Broadway;
	panose-1:4 4 9 5 8 11 2 2 5 2;
	mso-font-charset:0;
	mso-generic-font-family:decorative;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Brush Script MT";
	panose-1:3 6 8 2 4 4 6 7 3 4;
	mso-font-charset:0;
	mso-generic-font-family:script;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Californian FB";
	panose-1:2 7 4 3 6 8 11 3 2 4;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:Centaur;
	panose-1:2 3 5 4 5 2 5 2 3 4;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:Chiller;
	panose-1:4 2 4 4 3 16 7 2 6 2;
	mso-font-charset:0;
	mso-generic-font-family:decorative;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Colonna MT";
	panose-1:4 2 8 5 6 2 2 3 2 3;
	mso-font-charset:0;
	mso-generic-font-family:decorative;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Cooper Black";
	panose-1:2 8 9 4 4 3 11 2 4 4;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Footlight MT Light";
	panose-1:2 4 6 2 6 3 10 2 3 4;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Harlow Solid Italic";
	panose-1:4 3 6 4 2 15 2 2 13 2;
	mso-font-charset:0;
	mso-generic-font-family:decorative;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:Harrington;
	panose-1:4 4 5 5 5 10 2 2 7 2;
	mso-font-charset:0;
	mso-generic-font-family:decorative;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"High Tower Text";
	panose-1:2 4 5 2 5 5 6 3 3 3;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:Jokerman;
	panose-1:4 9 6 5 6 13 6 2 7 2;
	mso-font-charset:0;
	mso-generic-font-family:decorative;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Kunstler Script";
	panose-1:3 3 4 2 2 6 7 13 13 6;
	mso-font-charset:0;
	mso-generic-font-family:script;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Lucida Bright";
	panose-1:2 4 6 2 5 5 5 2 3 4;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Lucida Calligraphy";
	panose-1:3 1 1 1 1 1 1 1 1 1;
	mso-font-charset:0;
	mso-generic-font-family:script;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Lucida Fax";
	panose-1:2 6 6 2 5 5 5 2 2 4;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:Magneto;
	panose-1:4 3 8 5 5 8 2 2 13 2;
	mso-font-charset:0;
	mso-generic-font-family:decorative;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Matura MT Script Capitals";
	panose-1:3 2 8 2 6 6 2 7 2 2;
	mso-font-charset:0;
	mso-generic-font-family:script;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Modern No\. 20";
	panose-1:2 7 7 4 7 5 5 2 3 3;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Niagara Engraved";
	panose-1:4 2 5 2 7 7 3 3 2 2;
	mso-font-charset:0;
	mso-generic-font-family:decorative;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Niagara Solid";
	panose-1:4 2 5 2 7 7 2 2 2 2;
	mso-font-charset:0;
	mso-generic-font-family:decorative;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Old English Text MT";
	panose-1:3 4 9 2 4 5 8 3 8 6;
	mso-font-charset:0;
	mso-generic-font-family:script;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:Onyx;
	panose-1:4 5 6 2 8 7 2 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:decorative;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:Parchment;
	panose-1:3 4 6 2 4 7 8 4 8 4;
	mso-font-charset:0;
	mso-generic-font-family:script;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:Playbill;
	panose-1:4 5 6 3 10 6 2 2 2 2;
	mso-font-charset:0;
	mso-generic-font-family:decorative;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Poor Richard";
	panose-1:2 8 5 2 5 5 5 2 7 2;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:Ravie;
	panose-1:4 4 8 5 5 8 9 2 6 2;
	mso-font-charset:0;
	mso-generic-font-family:decorative;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Informal Roman";
	panose-1:3 6 4 2 3 4 6 11 2 4;
	mso-font-charset:0;
	mso-generic-font-family:script;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Showcard Gothic";
	panose-1:4 2 9 4 2 1 2 2 6 4;
	mso-font-charset:0;
	mso-generic-font-family:decorative;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Snap ITC";
	panose-1:4 4 10 7 6 10 2 2 2 2;
	mso-font-charset:0;
	mso-generic-font-family:decorative;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:Stencil;
	panose-1:4 4 9 5 13 8 2 2 4 4;
	mso-font-charset:0;
	mso-generic-font-family:decorative;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Viner Hand ITC";
	panose-1:3 7 5 2 3 5 2 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:script;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:Vivaldi;
	panose-1:3 2 6 2 5 5 6 9 8 4;
	mso-font-charset:0;
	mso-generic-font-family:script;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Vladimir Script";
	panose-1:3 5 4 2 4 4 7 7 3 5;
	mso-font-charset:0;
	mso-generic-font-family:script;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Wide Latin";
	panose-1:2 10 10 7 5 5 5 2 4 4;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Tw Cen MT";
	panose-1:2 11 6 2 2 1 4 2 6 3;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:7 0 0 0 3 0;}
@font-face
	{font-family:"Tw Cen MT Condensed";
	panose-1:2 11 6 6 2 1 4 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:7 0 0 0 3 0;}
@font-face
	{font-family:"Script MT Bold";
	panose-1:3 4 6 2 4 6 7 8 9 4;
	mso-font-charset:0;
	mso-generic-font-family:script;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Rockwell Extra Bold";
	panose-1:2 6 9 3 4 5 5 2 4 3;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Rockwell Condensed";
	panose-1:2 6 6 3 5 4 5 2 1 4;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:Rockwell;
	panose-1:2 6 6 3 2 2 5 2 4 3;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Rage Italic";
	panose-1:3 7 5 2 4 5 7 7 3 4;
	mso-font-charset:0;
	mso-generic-font-family:script;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Perpetua Titling MT";
	panose-1:2 2 5 2 6 5 5 2 8 4;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:Perpetua;
	panose-1:2 2 5 2 6 4 1 2 3 3;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Palace Script MT";
	panose-1:3 3 3 2 2 6 7 12 11 5;
	mso-font-charset:0;
	mso-generic-font-family:script;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"OCR A Extended";
	panose-1:2 1 5 9 2 1 2 1 3 3;
	mso-font-charset:0;
	mso-generic-font-family:modern;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Maiandra GD";
	panose-1:2 14 5 2 3 3 8 2 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Lucida Sans Typewriter";
	panose-1:2 11 5 9 3 5 4 3 2 4;
	mso-font-charset:0;
	mso-generic-font-family:modern;
	mso-font-pitch:fixed;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Lucida Sans";
	panose-1:2 11 6 2 3 5 4 2 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Imprint MT Shadow";
	panose-1:4 2 6 5 6 3 3 3 2 2;
	mso-font-charset:0;
	mso-generic-font-family:decorative;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:Haettenschweiler;
	panose-1:2 11 7 6 4 9 2 6 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:647 0 0 0 159 0;}
@font-face
	{font-family:"Goudy Stout";
	panose-1:2 2 9 4 7 3 11 2 4 1;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Goudy Old Style";
	panose-1:2 2 5 2 5 3 5 2 3 3;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Gloucester MT Extra Condensed";
	panose-1:2 3 8 8 2 6 1 1 1 1;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Gill Sans Ultra Bold Condensed";
	panose-1:2 11 10 6 2 1 4 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:7 0 0 0 3 0;}
@font-face
	{font-family:"Gill Sans Ultra Bold";
	panose-1:2 11 10 2 2 1 4 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:7 0 0 0 3 0;}
@font-face
	{font-family:"Gill Sans MT Condensed";
	panose-1:2 11 5 6 2 1 4 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:7 0 0 0 3 0;}
@font-face
	{font-family:"Gill Sans MT";
	panose-1:2 11 5 2 2 1 4 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:7 0 0 0 3 0;}
@font-face
	{font-family:"Gill Sans MT Ext Condensed Bold";
	panose-1:2 11 9 2 2 1 4 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:7 0 0 0 3 0;}
@font-face
	{font-family:Gigi;
	panose-1:4 4 5 4 6 16 7 2 13 2;
	mso-font-charset:0;
	mso-generic-font-family:decorative;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Franklin Gothic Medium Cond";
	panose-1:2 11 6 6 3 4 2 2 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:647 0 0 0 159 0;}
@font-face
	{font-family:"Franklin Gothic Heavy";
	panose-1:2 11 9 3 2 1 2 2 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:647 0 0 0 159 0;}
@font-face
	{font-family:"Franklin Gothic Demi Cond";
	panose-1:2 11 7 6 3 4 2 2 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:647 0 0 0 159 0;}
@font-face
	{font-family:"Franklin Gothic Demi";
	panose-1:2 11 7 3 2 1 2 2 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:647 0 0 0 159 0;}
@font-face
	{font-family:"Franklin Gothic Book";
	panose-1:2 11 5 3 2 1 2 2 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:647 0 0 0 159 0;}
@font-face
	{font-family:Forte;
	panose-1:3 6 9 2 4 5 2 7 2 3;
	mso-font-charset:0;
	mso-generic-font-family:script;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Felix Titling";
	panose-1:4 6 5 5 6 2 2 2 10 4;
	mso-font-charset:0;
	mso-generic-font-family:decorative;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Eras Medium ITC";
	panose-1:2 11 6 2 3 5 4 2 8 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Eras Light ITC";
	panose-1:2 11 4 2 3 5 4 2 8 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Eras Demi ITC";
	panose-1:2 11 8 5 3 5 4 2 8 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Eras Bold ITC";
	panose-1:2 11 9 7 3 5 4 2 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Engravers MT";
	panose-1:2 9 7 7 8 5 5 2 3 4;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:Elephant;
	panose-1:2 2 9 4 9 5 5 2 3 3;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Edwardian Script ITC";
	panose-1:3 3 3 2 4 7 7 13 8 4;
	mso-font-charset:0;
	mso-generic-font-family:script;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Curlz MT";
	panose-1:4 4 4 4 5 7 2 2 2 2;
	mso-font-charset:0;
	mso-generic-font-family:decorative;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Copperplate Gothic Light";
	panose-1:2 14 5 7 2 2 6 2 4 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Copperplate Gothic Bold";
	panose-1:2 14 7 5 2 2 6 2 4 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Century Schoolbook";
	panose-1:2 4 6 4 5 5 5 2 3 4;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:647 0 0 0 159 0;}
@font-face
	{font-family:Castellar;
	panose-1:2 10 4 2 6 4 6 1 3 1;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Calisto MT";
	panose-1:2 4 6 3 5 5 5 3 3 4;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Bookman Old Style";
	panose-1:2 5 6 4 5 5 5 2 2 4;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:647 0 0 0 159 0;}
@font-face
	{font-family:"Bodoni MT Condensed";
	panose-1:2 7 6 6 8 6 6 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Bodoni MT Black";
	panose-1:2 7 10 3 8 6 6 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Bodoni MT";
	panose-1:2 7 6 3 8 6 6 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Blackadder ITC";
	panose-1:4 2 5 5 5 16 7 2 13 2;
	mso-font-charset:0;
	mso-generic-font-family:decorative;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Arial Rounded MT Bold";
	panose-1:2 15 7 4 3 5 4 3 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Agency FB";
	panose-1:2 11 5 3 2 2 2 2 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Bookshelf Symbol 7";
	panose-1:5 1 1 1 1 1 1 1 1 1;
	mso-font-charset:2;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:0 268435456 0 0 -2147483648 0;}
@font-face
	{font-family:"MS Reference Sans Serif";
	panose-1:2 11 6 4 3 5 4 4 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:536871559 0 0 0 415 0;}
@font-face
	{font-family:"MS Reference Specialty";
	panose-1:5 0 5 0 0 0 0 0 0 0;
	mso-font-charset:2;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:0 268435456 0 0 -2147483648 0;}
@font-face
	{font-family:"Berlin Sans FB Demi";
	panose-1:2 14 8 2 2 5 2 2 3 6;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Tw Cen MT Condensed Extra Bold";
	panose-1:2 11 8 3 2 2 2 2 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:7 0 0 0 3 0;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-parent:"";
	margin:0cm;
	margin-bottom:.0001pt;
	mso-pagination:none;
	mso-hyphenate:none;
	font-size:12.0pt;
	font-family:"Liberation Serif","serif";
	mso-fareast-font-family:Roboto;
	mso-bidi-font-family:"Noto Naskh Arabic";
	color:black;
	mso-fareast-language:ZH-CN;
	mso-bidi-language:HI;}
h3
	{mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-parent:Heading;
	mso-style-next:"Body Text";
	margin-top:7.0pt;
	margin-right:0cm;
	margin-bottom:6.0pt;
	margin-left:0cm;
	mso-pagination:none;
	page-break-after:avoid;
	mso-outline-level:3;
	mso-hyphenate:none;
	font-size:14.0pt;
	font-family:"Liberation Serif","serif";
	mso-fareast-font-family:NSimSun;
	mso-bidi-font-family:Arial;
	color:black;
	mso-fareast-language:ZH-CN;
	mso-bidi-language:HI;}
h4
	{mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-parent:Heading;
	mso-style-next:"Body Text";
	margin-top:6.0pt;
	margin-right:0cm;
	margin-bottom:6.0pt;
	margin-left:0cm;
	mso-pagination:none;
	page-break-after:avoid;
	mso-outline-level:4;
	mso-hyphenate:none;
	font-size:12.0pt;
	font-family:"Liberation Serif","serif";
	mso-fareast-font-family:NSimSun;
	mso-bidi-font-family:Arial;
	color:black;
	mso-fareast-language:ZH-CN;
	mso-bidi-language:HI;}
p.MsoCaption, li.MsoCaption, div.MsoCaption
	{mso-style-unhide:no;
	mso-style-qformat:yes;
	margin-top:6.0pt;
	margin-right:0cm;
	margin-bottom:6.0pt;
	margin-left:0cm;
	mso-pagination:no-line-numbers;
	mso-hyphenate:none;
	font-size:12.0pt;
	font-family:"Liberation Serif","serif";
	mso-fareast-font-family:Roboto;
	mso-bidi-font-family:Mangal;
	color:black;
	mso-fareast-language:ZH-CN;
	mso-bidi-language:HI;
	font-style:italic;}
p.MsoList, li.MsoList, div.MsoList
	{mso-style-unhide:no;
	mso-style-parent:"Body Text";
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:7.0pt;
	margin-left:0cm;
	line-height:115%;
	mso-pagination:none;
	mso-hyphenate:none;
	font-size:12.0pt;
	font-family:"Liberation Serif","serif";
	mso-fareast-font-family:Roboto;
	mso-bidi-font-family:Mangal;
	color:black;
	mso-fareast-language:ZH-CN;
	mso-bidi-language:HI;}
p.MsoBodyText, li.MsoBodyText, div.MsoBodyText
	{mso-style-unhide:no;
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:7.0pt;
	margin-left:0cm;
	line-height:115%;
	mso-pagination:none;
	mso-hyphenate:none;
	font-size:12.0pt;
	font-family:"Liberation Serif","serif";
	mso-fareast-font-family:Roboto;
	mso-bidi-font-family:"Noto Naskh Arabic";
	color:black;
	mso-fareast-language:ZH-CN;
	mso-bidi-language:HI;}
a:link, span.MsoHyperlink
	{mso-style-unhide:no;
	mso-style-parent:"";
	color:navy;
	text-decoration:underline;
	text-underline:single;}
a:visited, span.MsoHyperlinkFollowed
	{mso-style-noshow:yes;
	mso-style-priority:99;
	color:#954F72;
	mso-themecolor:followedhyperlink;
	text-decoration:underline;
	text-underline:single;}
span.Bullets
	{mso-style-name:Bullets;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-parent:"";
	font-family:"OpenSymbol","serif";
	mso-ascii-font-family:OpenSymbol;
	mso-fareast-font-family:OpenSymbol;
	mso-hansi-font-family:OpenSymbol;
	mso-bidi-font-family:OpenSymbol;}
span.NumberingSymbols
	{mso-style-name:"Numbering Symbols";
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-parent:"";}
p.Heading, li.Heading, div.Heading
	{mso-style-name:Heading;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-next:"Body Text";
	margin-top:12.0pt;
	margin-right:0cm;
	margin-bottom:6.0pt;
	margin-left:0cm;
	mso-pagination:none;
	page-break-after:avoid;
	mso-hyphenate:none;
	font-size:14.0pt;
	font-family:"Liberation Sans","serif";
	mso-fareast-font-family:"Microsoft YaHei";
	mso-bidi-font-family:Mangal;
	color:black;
	mso-fareast-language:ZH-CN;
	mso-bidi-language:HI;}
p.Index, li.Index, div.Index
	{mso-style-name:Index;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	margin:0cm;
	margin-bottom:.0001pt;
	mso-pagination:no-line-numbers;
	mso-hyphenate:none;
	font-size:12.0pt;
	font-family:"Liberation Serif","serif";
	mso-fareast-font-family:Roboto;
	mso-bidi-font-family:Mangal;
	color:black;
	mso-fareast-language:ZH-CN;
	mso-bidi-language:HI;}
p.Quotations, li.Quotations, div.Quotations
	{mso-style-name:Quotations;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	margin-top:0cm;
	margin-right:1.0cm;
	margin-bottom:14.15pt;
	margin-left:1.0cm;
	mso-pagination:none;
	mso-hyphenate:none;
	font-size:12.0pt;
	font-family:"Liberation Serif","serif";
	mso-fareast-font-family:Roboto;
	mso-bidi-font-family:"Noto Naskh Arabic";
	color:black;
	mso-fareast-language:ZH-CN;
	mso-bidi-language:HI;}
span.msoIns
	{mso-style-type:export-only;
	mso-style-name:"";
	text-decoration:underline;
	text-underline:single;
	color:teal;}
span.msoDel
	{mso-style-type:export-only;
	mso-style-name:"";
	text-decoration:line-through;
	color:red;}
.MsoChpDefault
	{mso-style-type:export-only;
	mso-default-props:yes;
	font-size:12.0pt;
	mso-ansi-font-size:12.0pt;
	mso-bidi-font-size:12.0pt;
	font-family:"Liberation Serif","serif";
	mso-ascii-font-family:"Liberation Serif";
	mso-fareast-font-family:Roboto;
	mso-hansi-font-family:"Liberation Serif";
	mso-bidi-font-family:"Noto Naskh Arabic";
	color:black;
	mso-fareast-language:ZH-CN;
	mso-bidi-language:HI;}
.MsoPapDefault
	{mso-style-type:export-only;
	mso-hyphenate:none;}
@page WordSection1
	{size:595.3pt 841.9pt;
	margin:2.0cm 2.0cm 2.0cm 2.0cm;
	mso-header-margin:0cm;
	mso-footer-margin:0cm;
	mso-forms-protection:no;
	mso-paper-source:0;}
div.WordSection1
	{page:WordSection1;}
 /* List Definitions */
 @list l0
	{mso-list-id:4718955;
	mso-list-template-ids:1265893422;}
@list l0:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l0:level2
	{mso-level-number-format:bullet;
	mso-level-text:\25E6;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:54.0pt;
	text-indent:-18.0pt;
	font-family:0;
	mso-bidi-font-family:0;}
@list l0:level3
	{mso-level-number-format:bullet;
	mso-level-text:\25AA;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:72.0pt;
	text-indent:-18.0pt;
	font-family:0;
	mso-bidi-font-family:0;}
@list l0:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:90.0pt;
	text-indent:-18.0pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l0:level5
	{mso-level-number-format:bullet;
	mso-level-text:\25E6;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:108.0pt;
	text-indent:-18.0pt;
	font-family:0;
	mso-bidi-font-family:0;}
@list l0:level6
	{mso-level-number-format:bullet;
	mso-level-text:\25AA;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:126.0pt;
	text-indent:-18.0pt;
	font-family:0;
	mso-bidi-font-family:0;}
@list l0:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:144.0pt;
	text-indent:-18.0pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l0:level8
	{mso-level-number-format:bullet;
	mso-level-text:\25E6;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:162.0pt;
	text-indent:-18.0pt;
	font-family:0;
	mso-bidi-font-family:0;}
@list l0:level9
	{mso-level-number-format:bullet;
	mso-level-text:\25AA;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:180.0pt;
	text-indent:-18.0pt;
	font-family:0;
	mso-bidi-font-family:0;}
@list l1
	{mso-list-id:18048934;
	mso-list-template-ids:343295980;}
@list l1:level1
	{mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;}
@list l1:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l1:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l1:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l1:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l1:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l1:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l1:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l1:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l2
	{mso-list-id:23290484;
	mso-list-template-ids:1904876782;}
@list l2:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l2:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l2:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l2:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l2:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l2:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l2:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l2:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l2:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l3
	{mso-list-id:39675748;
	mso-list-template-ids:1570555428;}
@list l3:level1
	{mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;}
@list l3:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l3:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l3:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l3:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l3:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l3:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l3:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l3:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l4
	{mso-list-id:56635640;
	mso-list-template-ids:-1310841762;}
@list l4:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l4:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l4:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l4:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l4:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l4:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l4:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l4:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l4:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l5
	{mso-list-id:67267622;
	mso-list-template-ids:-2030685952;}
@list l5:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l5:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l5:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l5:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l5:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l5:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l5:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l5:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l5:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l6
	{mso-list-id:68426095;
	mso-list-template-ids:-1034413386;}
@list l6:level1
	{mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;}
@list l6:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l6:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l6:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l6:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l6:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l6:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l6:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l6:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l7
	{mso-list-id:77945581;
	mso-list-template-ids:-610887638;}
@list l7:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l7:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l7:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l7:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l7:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l7:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l7:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l7:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l7:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l8
	{mso-list-id:92358158;
	mso-list-template-ids:-1386162006;}
@list l8:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l8:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l8:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l8:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l8:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l8:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l8:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l8:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l8:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l9
	{mso-list-id:93093230;
	mso-list-template-ids:1891543318;}
@list l9:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l9:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l9:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l9:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l9:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l9:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l9:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l9:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l9:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l10
	{mso-list-id:93286023;
	mso-list-template-ids:322871382;}
@list l10:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l10:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l10:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l10:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l10:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l10:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l10:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l10:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l10:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l11
	{mso-list-id:122970374;
	mso-list-template-ids:-1137158458;}
@list l11:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l11:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l11:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l11:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l11:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l11:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l11:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l11:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l11:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l12
	{mso-list-id:173498742;
	mso-list-template-ids:1339430288;}
@list l12:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l12:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l12:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l12:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l12:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l12:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l12:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l12:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l12:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l13
	{mso-list-id:178547037;
	mso-list-template-ids:-1313162728;}
@list l13:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l13:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l13:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l13:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l13:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l13:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l13:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l13:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l13:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l14
	{mso-list-id:185797281;
	mso-list-template-ids:-578123348;}
@list l14:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l14:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l14:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l14:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l14:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l14:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l14:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l14:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l14:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l15
	{mso-list-id:220822854;
	mso-list-template-ids:1768201450;}
@list l15:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l15:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l15:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l15:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l15:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l15:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l15:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l15:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l15:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l16
	{mso-list-id:254751895;
	mso-list-template-ids:2130209380;}
@list l16:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l16:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l16:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l16:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l16:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l16:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l16:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l16:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l16:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l17
	{mso-list-id:262347516;
	mso-list-template-ids:-1114888176;}
@list l17:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l17:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l17:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l17:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l17:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l17:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l17:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l17:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l17:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l18
	{mso-list-id:285890381;
	mso-list-template-ids:-113978220;}
@list l18:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l18:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l18:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l18:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l18:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l18:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l18:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l18:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l18:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l19
	{mso-list-id:302544401;
	mso-list-template-ids:1907665716;}
@list l19:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l19:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l19:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l19:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l19:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l19:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l19:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l19:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l19:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l20
	{mso-list-id:325742145;
	mso-list-template-ids:-25923928;}
@list l20:level1
	{mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;}
@list l20:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l20:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l20:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l20:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l20:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l20:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l20:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l20:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l21
	{mso-list-id:376897842;
	mso-list-template-ids:-158677044;}
@list l21:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l21:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l21:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l21:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l21:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l21:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l21:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l21:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l21:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l22
	{mso-list-id:384187695;
	mso-list-template-ids:-818879572;}
@list l22:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l22:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l22:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l22:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l22:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l22:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l22:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l22:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l22:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l23
	{mso-list-id:396825314;
	mso-list-template-ids:1037173466;}
@list l23:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l23:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l23:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l23:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l23:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l23:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l23:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l23:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l23:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l24
	{mso-list-id:415516819;
	mso-list-template-ids:136091628;}
@list l24:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l24:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l24:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l24:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l24:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l24:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l24:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l24:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l24:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l25
	{mso-list-id:422728751;
	mso-list-template-ids:-1813316790;}
@list l25:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l25:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l25:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l25:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l25:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l25:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l25:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l25:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l25:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l26
	{mso-list-id:425804201;
	mso-list-template-ids:1984828344;}
@list l26:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l26:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l26:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l26:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l26:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l26:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l26:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l26:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l26:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l27
	{mso-list-id:442769082;
	mso-list-template-ids:72018538;}
@list l27:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l27:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l27:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l27:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l27:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l27:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l27:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l27:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l27:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l28
	{mso-list-id:445469299;
	mso-list-template-ids:2073851154;}
@list l28:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l28:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l28:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l28:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l28:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l28:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l28:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l28:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l28:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l29
	{mso-list-id:475335960;
	mso-list-template-ids:208928852;}
@list l29:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l29:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l29:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l29:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l29:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l29:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l29:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l29:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l29:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l30
	{mso-list-id:482501685;
	mso-list-template-ids:918688606;}
@list l30:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l30:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l30:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l30:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l30:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l30:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l30:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l30:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l30:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l31
	{mso-list-id:489829502;
	mso-list-template-ids:51666020;}
@list l31:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l31:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l31:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l31:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l31:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l31:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l31:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l31:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l31:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l32
	{mso-list-id:502403519;
	mso-list-template-ids:-159987864;}
@list l32:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l32:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l32:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l32:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l32:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l32:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l32:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l32:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l32:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l33
	{mso-list-id:536550130;
	mso-list-template-ids:-648502402;}
@list l33:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l33:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l33:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l33:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l33:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l33:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l33:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l33:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l33:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l34
	{mso-list-id:539899660;
	mso-list-template-ids:252580242;}
@list l34:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l34:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l34:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l34:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l34:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l34:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l34:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l34:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l34:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l35
	{mso-list-id:550265195;
	mso-list-template-ids:1099467054;}
@list l35:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l35:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l35:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l35:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l35:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l35:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l35:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l35:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l35:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l36
	{mso-list-id:563218833;
	mso-list-template-ids:1905426296;}
@list l36:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l36:level2
	{mso-level-number-format:bullet;
	mso-level-text:\25E6;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:54.0pt;
	text-indent:-18.0pt;
	font-family:0;
	mso-bidi-font-family:0;}
@list l36:level3
	{mso-level-number-format:bullet;
	mso-level-text:\25AA;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:72.0pt;
	text-indent:-18.0pt;
	font-family:0;
	mso-bidi-font-family:0;}
@list l36:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:90.0pt;
	text-indent:-18.0pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l36:level5
	{mso-level-number-format:bullet;
	mso-level-text:\25E6;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:108.0pt;
	text-indent:-18.0pt;
	font-family:0;
	mso-bidi-font-family:0;}
@list l36:level6
	{mso-level-number-format:bullet;
	mso-level-text:\25AA;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:126.0pt;
	text-indent:-18.0pt;
	font-family:0;
	mso-bidi-font-family:0;}
@list l36:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:144.0pt;
	text-indent:-18.0pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l36:level8
	{mso-level-number-format:bullet;
	mso-level-text:\25E6;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:162.0pt;
	text-indent:-18.0pt;
	font-family:0;
	mso-bidi-font-family:0;}
@list l36:level9
	{mso-level-number-format:bullet;
	mso-level-text:\25AA;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:180.0pt;
	text-indent:-18.0pt;
	font-family:0;
	mso-bidi-font-family:0;}
@list l37
	{mso-list-id:603001410;
	mso-list-template-ids:1037959546;}
@list l37:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l37:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l37:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l37:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l37:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l37:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l37:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l37:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l37:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l38
	{mso-list-id:623921669;
	mso-list-template-ids:-1426559014;}
@list l38:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l38:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l38:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l38:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l38:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l38:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l38:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l38:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l38:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l39
	{mso-list-id:628707810;
	mso-list-template-ids:681879442;}
@list l39:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l39:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l39:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l39:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l39:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l39:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l39:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l39:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l39:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l40
	{mso-list-id:632372606;
	mso-list-template-ids:-2027242286;}
@list l40:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l40:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l40:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l40:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l40:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l40:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l40:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l40:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l40:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l41
	{mso-list-id:648899562;
	mso-list-template-ids:-1909049776;}
@list l41:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l41:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l41:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l41:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l41:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l41:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l41:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l41:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l41:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l42
	{mso-list-id:697857826;
	mso-list-template-ids:1733584804;}
@list l42:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l42:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l42:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l42:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l42:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l42:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l42:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l42:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l42:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l43
	{mso-list-id:707533171;
	mso-list-template-ids:389467034;}
@list l43:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l43:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l43:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l43:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l43:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l43:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l43:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l43:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l43:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l44
	{mso-list-id:716007342;
	mso-list-template-ids:-1207002644;}
@list l44:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l44:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l44:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l44:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l44:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l44:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l44:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l44:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l44:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l45
	{mso-list-id:716777313;
	mso-list-template-ids:-14761044;}
@list l45:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l45:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l45:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l45:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l45:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l45:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l45:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l45:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l45:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l46
	{mso-list-id:721905165;
	mso-list-template-ids:-2031307310;}
@list l46:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l46:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l46:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l46:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l46:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l46:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l46:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l46:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l46:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l47
	{mso-list-id:734015997;
	mso-list-template-ids:168459364;}
@list l47:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l47:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l47:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l47:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l47:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l47:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l47:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l47:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l47:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l48
	{mso-list-id:746269417;
	mso-list-template-ids:-602006802;}
@list l48:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l48:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l48:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l48:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l48:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l48:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l48:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l48:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l48:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l49
	{mso-list-id:753433374;
	mso-list-template-ids:229041380;}
@list l49:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l49:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l49:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l49:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l49:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l49:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l49:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l49:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l49:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l50
	{mso-list-id:753669608;
	mso-list-template-ids:758659124;}
@list l50:level1
	{mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;}
@list l50:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l50:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l50:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l50:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l50:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l50:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l50:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l50:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l51
	{mso-list-id:761030626;
	mso-list-template-ids:526918598;}
@list l51:level1
	{mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;}
@list l51:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l51:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l51:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l51:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l51:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l51:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l51:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l51:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l52
	{mso-list-id:761070829;
	mso-list-template-ids:1499625634;}
@list l52:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l52:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l52:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l52:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l52:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l52:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l52:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l52:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l52:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l53
	{mso-list-id:764885868;
	mso-list-template-ids:-1434655076;}
@list l53:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l53:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l53:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l53:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l53:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l53:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l53:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l53:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l53:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l54
	{mso-list-id:767165706;
	mso-list-template-ids:29535404;}
@list l54:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l54:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l54:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l54:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l54:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l54:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l54:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l54:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l54:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l55
	{mso-list-id:808203783;
	mso-list-template-ids:-160672266;}
@list l55:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l55:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l55:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l55:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l55:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l55:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l55:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l55:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l55:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l56
	{mso-list-id:821041402;
	mso-list-template-ids:-800667540;}
@list l56:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l56:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l56:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l56:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l56:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l56:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l56:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l56:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l56:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l57
	{mso-list-id:824198998;
	mso-list-template-ids:-1105946772;}
@list l57:level1
	{mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;}
@list l57:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l57:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l57:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l57:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l57:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l57:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l57:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l57:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l58
	{mso-list-id:845480909;
	mso-list-template-ids:-403432880;}
@list l58:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:40.45pt;
	mso-level-number-position:left;
	margin-left:40.45pt;
	text-indent:-18.0pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l58:level2
	{mso-level-number-format:bullet;
	mso-level-text:\25E6;
	mso-level-tab-stop:58.45pt;
	mso-level-number-position:left;
	margin-left:58.45pt;
	text-indent:-18.0pt;
	font-family:"OpenSymbol","serif";
	mso-bidi-font-family:OpenSymbol;}
@list l58:level3
	{mso-level-number-format:bullet;
	mso-level-text:\25AA;
	mso-level-tab-stop:76.45pt;
	mso-level-number-position:left;
	margin-left:76.45pt;
	text-indent:-18.0pt;
	font-family:"OpenSymbol","serif";
	mso-bidi-font-family:OpenSymbol;}
@list l58:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:94.45pt;
	mso-level-number-position:left;
	margin-left:94.45pt;
	text-indent:-18.0pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l58:level5
	{mso-level-number-format:bullet;
	mso-level-text:\25E6;
	mso-level-tab-stop:112.45pt;
	mso-level-number-position:left;
	margin-left:112.45pt;
	text-indent:-18.0pt;
	font-family:"OpenSymbol","serif";
	mso-bidi-font-family:OpenSymbol;}
@list l58:level6
	{mso-level-number-format:bullet;
	mso-level-text:\25AA;
	mso-level-tab-stop:130.45pt;
	mso-level-number-position:left;
	margin-left:130.45pt;
	text-indent:-18.0pt;
	font-family:"OpenSymbol","serif";
	mso-bidi-font-family:OpenSymbol;}
@list l58:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:148.45pt;
	mso-level-number-position:left;
	margin-left:148.45pt;
	text-indent:-18.0pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l58:level8
	{mso-level-number-format:bullet;
	mso-level-text:\25E6;
	mso-level-tab-stop:166.45pt;
	mso-level-number-position:left;
	margin-left:166.45pt;
	text-indent:-18.0pt;
	font-family:"OpenSymbol","serif";
	mso-bidi-font-family:OpenSymbol;}
@list l58:level9
	{mso-level-number-format:bullet;
	mso-level-text:\25AA;
	mso-level-tab-stop:184.45pt;
	mso-level-number-position:left;
	margin-left:184.45pt;
	text-indent:-18.0pt;
	font-family:"OpenSymbol","serif";
	mso-bidi-font-family:OpenSymbol;}
@list l59
	{mso-list-id:888877485;
	mso-list-template-ids:141872278;}
@list l59:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l59:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l59:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l59:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l59:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l59:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l59:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l59:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l59:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l60
	{mso-list-id:928200118;
	mso-list-template-ids:-1936423062;}
@list l60:level1
	{mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;}
@list l60:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l60:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l60:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l60:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l60:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l60:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l60:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l60:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l61
	{mso-list-id:928849240;
	mso-list-template-ids:-32184882;}
@list l61:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l61:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l61:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l61:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l61:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l61:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l61:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l61:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l61:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l62
	{mso-list-id:931086970;
	mso-list-template-ids:731048980;}
@list l62:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l62:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l62:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l62:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l62:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l62:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l62:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l62:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l62:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l63
	{mso-list-id:933172651;
	mso-list-template-ids:-69568650;}
@list l63:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l63:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l63:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l63:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l63:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l63:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l63:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l63:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l63:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l64
	{mso-list-id:935869135;
	mso-list-template-ids:-938190120;}
@list l64:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l64:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l64:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l64:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l64:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l64:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l64:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l64:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l64:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l65
	{mso-list-id:942758944;
	mso-list-template-ids:609647706;}
@list l65:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l65:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l65:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l65:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l65:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l65:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l65:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l65:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l65:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l66
	{mso-list-id:960301607;
	mso-list-template-ids:930635486;}
@list l66:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l66:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l66:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l66:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l66:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l66:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l66:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l66:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l66:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l67
	{mso-list-id:965164196;
	mso-list-template-ids:898654974;}
@list l67:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l67:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l67:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l67:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l67:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l67:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l67:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l67:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l67:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l68
	{mso-list-id:975570368;
	mso-list-template-ids:-1687804864;}
@list l68:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l68:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l68:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l68:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l68:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l68:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l68:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l68:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l68:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l69
	{mso-list-id:996687657;
	mso-list-template-ids:-1439898024;}
@list l69:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l69:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l69:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l69:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l69:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l69:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l69:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l69:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l69:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l70
	{mso-list-id:1002584044;
	mso-list-template-ids:921763546;}
@list l70:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l70:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l70:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l70:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l70:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l70:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l70:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l70:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l70:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l71
	{mso-list-id:1011104327;
	mso-list-template-ids:-330899510;}
@list l71:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l71:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l71:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l71:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l71:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l71:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l71:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l71:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l71:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l72
	{mso-list-id:1029068484;
	mso-list-template-ids:-1151188820;}
@list l72:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l72:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l72:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l72:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l72:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l72:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l72:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l72:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l72:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l73
	{mso-list-id:1047950404;
	mso-list-template-ids:841897818;}
@list l73:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l73:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l73:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l73:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l73:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l73:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l73:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l73:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l73:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l74
	{mso-list-id:1051732454;
	mso-list-template-ids:1276295274;}
@list l74:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l74:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l74:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l74:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l74:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l74:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l74:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l74:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l74:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l75
	{mso-list-id:1054737667;
	mso-list-template-ids:-167857346;}
@list l75:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l75:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l75:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l75:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l75:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l75:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l75:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l75:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l75:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l76
	{mso-list-id:1068187925;
	mso-list-template-ids:48124962;}
@list l76:level1
	{mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;}
@list l76:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l76:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l76:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l76:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l76:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l76:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l76:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l76:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l77
	{mso-list-id:1082947726;
	mso-list-template-ids:1060437664;}
@list l77:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l77:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l77:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l77:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l77:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l77:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l77:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l77:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l77:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l78
	{mso-list-id:1109932181;
	mso-list-template-ids:-321256040;}
@list l78:level1
	{mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;}
@list l78:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l78:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l78:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l78:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l78:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l78:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l78:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l78:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l79
	{mso-list-id:1111823897;
	mso-list-template-ids:-308238820;}
@list l79:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l79:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l79:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l79:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l79:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l79:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l79:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l79:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l79:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l80
	{mso-list-id:1113398108;
	mso-list-template-ids:2146717760;}
@list l80:level1
	{mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;}
@list l80:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l80:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l80:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l80:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l80:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l80:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l80:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l80:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l81
	{mso-list-id:1118259796;
	mso-list-template-ids:-2069618166;}
@list l81:level1
	{mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;}
@list l81:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l81:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l81:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l81:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l81:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l81:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l81:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l81:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l82
	{mso-list-id:1127549110;
	mso-list-template-ids:-993860624;}
@list l82:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l82:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l82:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l82:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l82:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l82:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l82:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l82:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l82:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l83
	{mso-list-id:1138573414;
	mso-list-template-ids:-1227599624;}
@list l83:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l83:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l83:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l83:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l83:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l83:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l83:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l83:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l83:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l84
	{mso-list-id:1148008750;
	mso-list-template-ids:-1794489282;}
@list l84:level1
	{mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;}
@list l84:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l84:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l84:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l84:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l84:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l84:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l84:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l84:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l85
	{mso-list-id:1152866908;
	mso-list-template-ids:2101085826;}
@list l85:level1
	{mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;}
@list l85:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l85:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l85:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l85:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l85:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l85:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l85:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l85:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l86
	{mso-list-id:1154027674;
	mso-list-template-ids:1282604666;}
@list l86:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l86:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l86:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l86:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l86:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l86:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l86:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l86:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l86:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l87
	{mso-list-id:1176724318;
	mso-list-template-ids:-1389173530;}
@list l87:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l87:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l87:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l87:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l87:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l87:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l87:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l87:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l87:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l88
	{mso-list-id:1185171740;
	mso-list-template-ids:-627926088;}
@list l88:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l88:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l88:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l88:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l88:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l88:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l88:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l88:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l88:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l89
	{mso-list-id:1188833150;
	mso-list-template-ids:-2074323878;}
@list l89:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l89:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l89:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l89:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l89:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l89:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l89:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l89:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l89:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l90
	{mso-list-id:1191916066;
	mso-list-template-ids:-195683222;}
@list l90:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l90:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l90:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l90:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l90:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l90:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l90:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l90:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l90:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l91
	{mso-list-id:1195968401;
	mso-list-template-ids:-275850722;}
@list l91:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l91:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l91:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l91:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l91:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l91:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l91:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l91:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l91:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l92
	{mso-list-id:1201896728;
	mso-list-template-ids:-1094695032;}
@list l92:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l92:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l92:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l92:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l92:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l92:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l92:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l92:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l92:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l93
	{mso-list-id:1216114913;
	mso-list-template-ids:1863626920;}
@list l93:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l93:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l93:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l93:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l93:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l93:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l93:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l93:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l93:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l94
	{mso-list-id:1218393345;
	mso-list-template-ids:1241157398;}
@list l94:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:36.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l94:level2
	{mso-level-number-format:bullet;
	mso-level-text:\25E6;
	mso-level-tab-stop:54.0pt;
	mso-level-number-position:left;
	margin-left:54.0pt;
	text-indent:-18.0pt;
	font-family:"OpenSymbol","serif";
	mso-bidi-font-family:OpenSymbol;}
@list l94:level3
	{mso-level-number-format:bullet;
	mso-level-text:\25AA;
	mso-level-tab-stop:72.0pt;
	mso-level-number-position:left;
	margin-left:72.0pt;
	text-indent:-18.0pt;
	font-family:"OpenSymbol","serif";
	mso-bidi-font-family:OpenSymbol;}
@list l94:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:90.0pt;
	mso-level-number-position:left;
	margin-left:90.0pt;
	text-indent:-18.0pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l94:level5
	{mso-level-number-format:bullet;
	mso-level-text:\25E6;
	mso-level-tab-stop:108.0pt;
	mso-level-number-position:left;
	margin-left:108.0pt;
	text-indent:-18.0pt;
	font-family:"OpenSymbol","serif";
	mso-bidi-font-family:OpenSymbol;}
@list l94:level6
	{mso-level-number-format:bullet;
	mso-level-text:\25AA;
	mso-level-tab-stop:126.0pt;
	mso-level-number-position:left;
	margin-left:126.0pt;
	text-indent:-18.0pt;
	font-family:"OpenSymbol","serif";
	mso-bidi-font-family:OpenSymbol;}
@list l94:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:144.0pt;
	mso-level-number-position:left;
	margin-left:144.0pt;
	text-indent:-18.0pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l94:level8
	{mso-level-number-format:bullet;
	mso-level-text:\25E6;
	mso-level-tab-stop:162.0pt;
	mso-level-number-position:left;
	margin-left:162.0pt;
	text-indent:-18.0pt;
	font-family:"OpenSymbol","serif";
	mso-bidi-font-family:OpenSymbol;}
@list l94:level9
	{mso-level-number-format:bullet;
	mso-level-text:\25AA;
	mso-level-tab-stop:180.0pt;
	mso-level-number-position:left;
	margin-left:180.0pt;
	text-indent:-18.0pt;
	font-family:"OpenSymbol","serif";
	mso-bidi-font-family:OpenSymbol;}
@list l95
	{mso-list-id:1229456512;
	mso-list-template-ids:-1062695806;}
@list l95:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l95:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l95:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l95:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l95:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l95:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l95:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l95:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l95:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l96
	{mso-list-id:1235433877;
	mso-list-template-ids:-1707154412;}
@list l96:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l96:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l96:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l96:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l96:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l96:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l96:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l96:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l96:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l97
	{mso-list-id:1267228689;
	mso-list-template-ids:-1990011296;}
@list l97:level1
	{mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;}
@list l97:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l97:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l97:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l97:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l97:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l97:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l97:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l97:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l98
	{mso-list-id:1268541660;
	mso-list-template-ids:923989268;}
@list l98:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l98:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l98:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l98:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l98:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l98:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l98:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l98:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l98:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l99
	{mso-list-id:1297030380;
	mso-list-template-ids:-2136302004;}
@list l99:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l99:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l99:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l99:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l99:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l99:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l99:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l99:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l99:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l100
	{mso-list-id:1309868829;
	mso-list-template-ids:1511661528;}
@list l100:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l100:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l100:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l100:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l100:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l100:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l100:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l100:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l100:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l101
	{mso-list-id:1321736831;
	mso-list-template-ids:1081794488;}
@list l101:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l101:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l101:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l101:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l101:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l101:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l101:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l101:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l101:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l102
	{mso-list-id:1348752091;
	mso-list-template-ids:-1626301590;}
@list l102:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l102:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l102:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l102:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l102:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l102:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l102:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l102:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l102:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l103
	{mso-list-id:1363435979;
	mso-list-template-ids:-385316396;}
@list l103:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:36.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l103:level2
	{mso-level-number-format:bullet;
	mso-level-text:\25E6;
	mso-level-tab-stop:54.0pt;
	mso-level-number-position:left;
	margin-left:54.0pt;
	text-indent:-18.0pt;
	font-family:"OpenSymbol","serif";
	mso-bidi-font-family:OpenSymbol;}
@list l103:level3
	{mso-level-number-format:bullet;
	mso-level-text:\25AA;
	mso-level-tab-stop:72.0pt;
	mso-level-number-position:left;
	margin-left:72.0pt;
	text-indent:-18.0pt;
	font-family:"OpenSymbol","serif";
	mso-bidi-font-family:OpenSymbol;}
@list l103:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:90.0pt;
	mso-level-number-position:left;
	margin-left:90.0pt;
	text-indent:-18.0pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l103:level5
	{mso-level-number-format:bullet;
	mso-level-text:\25E6;
	mso-level-tab-stop:108.0pt;
	mso-level-number-position:left;
	margin-left:108.0pt;
	text-indent:-18.0pt;
	font-family:"OpenSymbol","serif";
	mso-bidi-font-family:OpenSymbol;}
@list l103:level6
	{mso-level-number-format:bullet;
	mso-level-text:\25AA;
	mso-level-tab-stop:126.0pt;
	mso-level-number-position:left;
	margin-left:126.0pt;
	text-indent:-18.0pt;
	font-family:"OpenSymbol","serif";
	mso-bidi-font-family:OpenSymbol;}
@list l103:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:144.0pt;
	mso-level-number-position:left;
	margin-left:144.0pt;
	text-indent:-18.0pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l103:level8
	{mso-level-number-format:bullet;
	mso-level-text:\25E6;
	mso-level-tab-stop:162.0pt;
	mso-level-number-position:left;
	margin-left:162.0pt;
	text-indent:-18.0pt;
	font-family:"OpenSymbol","serif";
	mso-bidi-font-family:OpenSymbol;}
@list l103:level9
	{mso-level-number-format:bullet;
	mso-level-text:\25AA;
	mso-level-tab-stop:180.0pt;
	mso-level-number-position:left;
	margin-left:180.0pt;
	text-indent:-18.0pt;
	font-family:"OpenSymbol","serif";
	mso-bidi-font-family:OpenSymbol;}
@list l104
	{mso-list-id:1372195507;
	mso-list-template-ids:1658733286;}
@list l104:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l104:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l104:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l104:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l104:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l104:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l104:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l104:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l104:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l105
	{mso-list-id:1390572600;
	mso-list-template-ids:-1251572480;}
@list l105:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l105:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l105:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l105:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l105:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l105:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l105:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l105:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l105:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l106
	{mso-list-id:1434937562;
	mso-list-template-ids:1985133802;}
@list l106:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l106:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l106:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l106:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l106:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l106:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l106:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l106:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l106:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l107
	{mso-list-id:1439830945;
	mso-list-template-ids:1439882534;}
@list l107:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l107:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l107:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l107:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l107:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l107:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l107:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l107:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l107:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l108
	{mso-list-id:1453279925;
	mso-list-template-ids:-2013515924;}
@list l108:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l108:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l108:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l108:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l108:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l108:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l108:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l108:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l108:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l109
	{mso-list-id:1466892892;
	mso-list-template-ids:1383765396;}
@list l109:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l109:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l109:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l109:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l109:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l109:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l109:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l109:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l109:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l110
	{mso-list-id:1491755681;
	mso-list-template-ids:-397796688;}
@list l110:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l110:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l110:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l110:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l110:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l110:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l110:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l110:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l110:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l111
	{mso-list-id:1496991431;
	mso-list-template-ids:542798026;}
@list l111:level1
	{mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;}
@list l111:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l111:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l111:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l111:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l111:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l111:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l111:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l111:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l112
	{mso-list-id:1510682971;
	mso-list-template-ids:1431179686;}
@list l112:level1
	{mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;}
@list l112:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l112:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l112:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l112:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l112:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l112:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l112:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l112:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l113
	{mso-list-id:1532373956;
	mso-list-template-ids:-1743849602;}
@list l113:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l113:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l113:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l113:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l113:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l113:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l113:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l113:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l113:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l114
	{mso-list-id:1538618542;
	mso-list-template-ids:283945180;}
@list l114:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l114:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l114:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l114:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l114:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l114:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l114:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l114:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l114:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l115
	{mso-list-id:1544168119;
	mso-list-template-ids:-240478032;}
@list l115:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l115:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l115:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l115:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l115:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l115:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l115:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l115:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l115:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l116
	{mso-list-id:1550410581;
	mso-list-template-ids:-454003612;}
@list l116:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l116:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l116:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l116:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l116:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l116:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l116:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l116:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l116:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l117
	{mso-list-id:1561399337;
	mso-list-template-ids:1570689018;}
@list l117:level1
	{mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;}
@list l117:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l117:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l117:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l117:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l117:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l117:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l117:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l117:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l118
	{mso-list-id:1566332403;
	mso-list-template-ids:633530168;}
@list l118:level1
	{mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;}
@list l118:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l118:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l118:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l118:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l118:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l118:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l118:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l118:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l119
	{mso-list-id:1578248153;
	mso-list-template-ids:-208250778;}
@list l119:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l119:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l119:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l119:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l119:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l119:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l119:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l119:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l119:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l120
	{mso-list-id:1578982026;
	mso-list-template-ids:1984363470;}
@list l120:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l120:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l120:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l120:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l120:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l120:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l120:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l120:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l120:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l121
	{mso-list-id:1602058536;
	mso-list-template-ids:1846836528;}
@list l121:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l121:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l121:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l121:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l121:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l121:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l121:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l121:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l121:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l122
	{mso-list-id:1605191577;
	mso-list-template-ids:-480746276;}
@list l122:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l122:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l122:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l122:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l122:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l122:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l122:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l122:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l122:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l123
	{mso-list-id:1610308984;
	mso-list-template-ids:576645688;}
@list l123:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l123:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l123:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l123:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l123:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l123:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l123:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l123:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l123:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l124
	{mso-list-id:1642728252;
	mso-list-template-ids:1302115026;}
@list l124:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l124:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l124:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l124:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l124:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l124:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l124:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l124:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l124:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l125
	{mso-list-id:1643342072;
	mso-list-template-ids:-2092285840;}
@list l125:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l125:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l125:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l125:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l125:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l125:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l125:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l125:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l125:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l126
	{mso-list-id:1645550523;
	mso-list-template-ids:516048778;}
@list l126:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l126:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l126:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l126:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l126:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l126:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l126:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l126:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l126:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l127
	{mso-list-id:1657032938;
	mso-list-template-ids:-659130550;}
@list l127:level1
	{mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;}
@list l127:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l127:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l127:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l127:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l127:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l127:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l127:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l127:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l128
	{mso-list-id:1668825865;
	mso-list-template-ids:-857419176;}
@list l128:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l128:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l128:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l128:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l128:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l128:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l128:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l128:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l128:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l129
	{mso-list-id:1671058075;
	mso-list-template-ids:-1235983884;}
@list l129:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:0cm;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l129:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:0cm;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l129:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l129:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l129:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l129:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l129:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l129:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l129:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l130
	{mso-list-id:1674990661;
	mso-list-template-ids:1051902320;}
@list l130:level1
	{mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;}
@list l130:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l130:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l130:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l130:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l130:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l130:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l130:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l130:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l131
	{mso-list-id:1693460143;
	mso-list-template-ids:-2138159806;}
@list l131:level1
	{mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;}
@list l131:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l131:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l131:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l131:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l131:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l131:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l131:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l131:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l132
	{mso-list-id:1708066854;
	mso-list-template-ids:-1224584438;}
@list l132:level1
	{mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;}
@list l132:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l132:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l132:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l132:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l132:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l132:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l132:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l132:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l133
	{mso-list-id:1711109621;
	mso-list-template-ids:-110036334;}
@list l133:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l133:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l133:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l133:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l133:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l133:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l133:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l133:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l133:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l134
	{mso-list-id:1735423965;
	mso-list-template-ids:1796494382;}
@list l134:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l134:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l134:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l134:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l134:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l134:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l134:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l134:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l134:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l135
	{mso-list-id:1752966190;
	mso-list-template-ids:1381762634;}
@list l135:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l135:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l135:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l135:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l135:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l135:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l135:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l135:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l135:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l136
	{mso-list-id:1752972703;
	mso-list-template-ids:-1819874954;}
@list l136:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l136:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l136:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l136:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l136:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l136:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l136:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l136:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l136:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l137
	{mso-list-id:1757940119;
	mso-list-template-ids:454066992;}
@list l137:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l137:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l137:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l137:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l137:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l137:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l137:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l137:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l137:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l138
	{mso-list-id:1775395629;
	mso-list-template-ids:-387164510;}
@list l138:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:36.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l138:level2
	{mso-level-number-format:bullet;
	mso-level-text:\25E6;
	mso-level-tab-stop:54.0pt;
	mso-level-number-position:left;
	margin-left:54.0pt;
	text-indent:-18.0pt;
	font-family:"OpenSymbol","serif";
	mso-bidi-font-family:OpenSymbol;}
@list l138:level3
	{mso-level-number-format:bullet;
	mso-level-text:\25AA;
	mso-level-tab-stop:72.0pt;
	mso-level-number-position:left;
	margin-left:72.0pt;
	text-indent:-18.0pt;
	font-family:"OpenSymbol","serif";
	mso-bidi-font-family:OpenSymbol;}
@list l138:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:90.0pt;
	mso-level-number-position:left;
	margin-left:90.0pt;
	text-indent:-18.0pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l138:level5
	{mso-level-number-format:bullet;
	mso-level-text:\25E6;
	mso-level-tab-stop:108.0pt;
	mso-level-number-position:left;
	margin-left:108.0pt;
	text-indent:-18.0pt;
	font-family:"OpenSymbol","serif";
	mso-bidi-font-family:OpenSymbol;}
@list l138:level6
	{mso-level-number-format:bullet;
	mso-level-text:\25AA;
	mso-level-tab-stop:126.0pt;
	mso-level-number-position:left;
	margin-left:126.0pt;
	text-indent:-18.0pt;
	font-family:"OpenSymbol","serif";
	mso-bidi-font-family:OpenSymbol;}
@list l138:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:144.0pt;
	mso-level-number-position:left;
	margin-left:144.0pt;
	text-indent:-18.0pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l138:level8
	{mso-level-number-format:bullet;
	mso-level-text:\25E6;
	mso-level-tab-stop:162.0pt;
	mso-level-number-position:left;
	margin-left:162.0pt;
	text-indent:-18.0pt;
	font-family:"OpenSymbol","serif";
	mso-bidi-font-family:OpenSymbol;}
@list l138:level9
	{mso-level-number-format:bullet;
	mso-level-text:\25AA;
	mso-level-tab-stop:180.0pt;
	mso-level-number-position:left;
	margin-left:180.0pt;
	text-indent:-18.0pt;
	font-family:"OpenSymbol","serif";
	mso-bidi-font-family:OpenSymbol;}
@list l139
	{mso-list-id:1776484800;
	mso-list-template-ids:-1985293732;}
@list l139:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l139:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l139:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l139:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l139:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l139:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l139:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l139:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l139:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l140
	{mso-list-id:1776899395;
	mso-list-template-ids:1323472560;}
@list l140:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l140:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l140:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l140:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l140:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l140:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l140:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l140:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l140:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l141
	{mso-list-id:1779987369;
	mso-list-template-ids:-992162078;}
@list l141:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l141:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l141:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l141:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l141:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l141:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l141:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l141:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l141:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l142
	{mso-list-id:1787773396;
	mso-list-template-ids:711242816;}
@list l142:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l142:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l142:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l142:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l142:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l142:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l142:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l142:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l142:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l143
	{mso-list-id:1797943970;
	mso-list-template-ids:-539970848;}
@list l143:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l143:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l143:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l143:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l143:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l143:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l143:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l143:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l143:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l144
	{mso-list-id:1807704005;
	mso-list-template-ids:-1707692284;}
@list l144:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l144:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l144:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l144:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l144:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l144:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l144:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l144:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l144:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l145
	{mso-list-id:1841583279;
	mso-list-template-ids:494316422;}
@list l145:level1
	{mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;}
@list l145:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l145:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l145:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l145:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l145:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l145:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l145:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l145:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l146
	{mso-list-id:1865361656;
	mso-list-template-ids:-389109700;}
@list l146:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:36.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l146:level2
	{mso-level-number-format:bullet;
	mso-level-text:\25E6;
	mso-level-tab-stop:54.0pt;
	mso-level-number-position:left;
	margin-left:54.0pt;
	text-indent:-18.0pt;
	font-family:"OpenSymbol","serif";
	mso-bidi-font-family:OpenSymbol;}
@list l146:level3
	{mso-level-number-format:bullet;
	mso-level-text:\25AA;
	mso-level-tab-stop:72.0pt;
	mso-level-number-position:left;
	margin-left:72.0pt;
	text-indent:-18.0pt;
	font-family:"OpenSymbol","serif";
	mso-bidi-font-family:OpenSymbol;}
@list l146:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:90.0pt;
	mso-level-number-position:left;
	margin-left:90.0pt;
	text-indent:-18.0pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l146:level5
	{mso-level-number-format:bullet;
	mso-level-text:\25E6;
	mso-level-tab-stop:108.0pt;
	mso-level-number-position:left;
	margin-left:108.0pt;
	text-indent:-18.0pt;
	font-family:"OpenSymbol","serif";
	mso-bidi-font-family:OpenSymbol;}
@list l146:level6
	{mso-level-number-format:bullet;
	mso-level-text:\25AA;
	mso-level-tab-stop:126.0pt;
	mso-level-number-position:left;
	margin-left:126.0pt;
	text-indent:-18.0pt;
	font-family:"OpenSymbol","serif";
	mso-bidi-font-family:OpenSymbol;}
@list l146:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:144.0pt;
	mso-level-number-position:left;
	margin-left:144.0pt;
	text-indent:-18.0pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l146:level8
	{mso-level-number-format:bullet;
	mso-level-text:\25E6;
	mso-level-tab-stop:162.0pt;
	mso-level-number-position:left;
	margin-left:162.0pt;
	text-indent:-18.0pt;
	font-family:"OpenSymbol","serif";
	mso-bidi-font-family:OpenSymbol;}
@list l146:level9
	{mso-level-number-format:bullet;
	mso-level-text:\25AA;
	mso-level-tab-stop:180.0pt;
	mso-level-number-position:left;
	margin-left:180.0pt;
	text-indent:-18.0pt;
	font-family:"OpenSymbol","serif";
	mso-bidi-font-family:OpenSymbol;}
@list l147
	{mso-list-id:1899513235;
	mso-list-template-ids:-1659840824;}
@list l147:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l147:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l147:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l147:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l147:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l147:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l147:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l147:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l147:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l148
	{mso-list-id:1907836563;
	mso-list-template-ids:1694132462;}
@list l148:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l148:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l148:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l148:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l148:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l148:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l148:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l148:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l148:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l149
	{mso-list-id:1957634235;
	mso-list-template-ids:-836603988;}
@list l149:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l149:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l149:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l149:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l149:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l149:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l149:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l149:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l149:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l150
	{mso-list-id:1960868879;
	mso-list-template-ids:568781504;}
@list l150:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l150:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l150:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l150:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l150:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l150:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l150:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l150:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l150:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l151
	{mso-list-id:1984656834;
	mso-list-template-ids:-451243480;}
@list l151:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l151:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l151:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l151:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l151:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l151:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l151:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l151:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l151:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l152
	{mso-list-id:1984768035;
	mso-list-template-ids:-154659530;}
@list l152:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l152:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l152:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l152:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l152:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l152:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l152:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l152:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l152:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l153
	{mso-list-id:1997224238;
	mso-list-template-ids:-1542798306;}
@list l153:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l153:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l153:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l153:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l153:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l153:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l153:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l153:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l153:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l154
	{mso-list-id:1998682490;
	mso-list-template-ids:1094982168;}
@list l154:level1
	{mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;}
@list l154:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l154:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l154:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l154:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l154:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l154:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l154:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l154:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l155
	{mso-list-id:2002076984;
	mso-list-template-ids:2035158510;}
@list l155:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l155:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l155:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l155:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l155:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l155:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l155:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l155:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l155:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l156
	{mso-list-id:2014064281;
	mso-list-template-ids:-1268367088;}
@list l156:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:36.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l156:level2
	{mso-level-number-format:bullet;
	mso-level-text:\25E6;
	mso-level-tab-stop:54.0pt;
	mso-level-number-position:left;
	margin-left:54.0pt;
	text-indent:-18.0pt;
	font-family:"OpenSymbol","serif";
	mso-bidi-font-family:OpenSymbol;}
@list l156:level3
	{mso-level-number-format:bullet;
	mso-level-text:\25AA;
	mso-level-tab-stop:72.0pt;
	mso-level-number-position:left;
	margin-left:72.0pt;
	text-indent:-18.0pt;
	font-family:"OpenSymbol","serif";
	mso-bidi-font-family:OpenSymbol;}
@list l156:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:90.0pt;
	mso-level-number-position:left;
	margin-left:90.0pt;
	text-indent:-18.0pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l156:level5
	{mso-level-number-format:bullet;
	mso-level-text:\25E6;
	mso-level-tab-stop:108.0pt;
	mso-level-number-position:left;
	margin-left:108.0pt;
	text-indent:-18.0pt;
	font-family:"OpenSymbol","serif";
	mso-bidi-font-family:OpenSymbol;}
@list l156:level6
	{mso-level-number-format:bullet;
	mso-level-text:\25AA;
	mso-level-tab-stop:126.0pt;
	mso-level-number-position:left;
	margin-left:126.0pt;
	text-indent:-18.0pt;
	font-family:"OpenSymbol","serif";
	mso-bidi-font-family:OpenSymbol;}
@list l156:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:144.0pt;
	mso-level-number-position:left;
	margin-left:144.0pt;
	text-indent:-18.0pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l156:level8
	{mso-level-number-format:bullet;
	mso-level-text:\25E6;
	mso-level-tab-stop:162.0pt;
	mso-level-number-position:left;
	margin-left:162.0pt;
	text-indent:-18.0pt;
	font-family:"OpenSymbol","serif";
	mso-bidi-font-family:OpenSymbol;}
@list l156:level9
	{mso-level-number-format:bullet;
	mso-level-text:\25AA;
	mso-level-tab-stop:180.0pt;
	mso-level-number-position:left;
	margin-left:180.0pt;
	text-indent:-18.0pt;
	font-family:"OpenSymbol","serif";
	mso-bidi-font-family:OpenSymbol;}
@list l157
	{mso-list-id:2038500169;
	mso-list-template-ids:821180100;}
@list l157:level1
	{mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;}
@list l157:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l157:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l157:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l157:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l157:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l157:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l157:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l157:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l158
	{mso-list-id:2042053415;
	mso-list-template-ids:-803679738;}
@list l158:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l158:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l158:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l158:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l158:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l158:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l158:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l158:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l158:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l159
	{mso-list-id:2084911765;
	mso-list-template-ids:930488864;}
@list l159:level1
	{mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;}
@list l159:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l159:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l159:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l159:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l159:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l159:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l159:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l159:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:0cm;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l160
	{mso-list-id:2123987666;
	mso-list-template-ids:1549718822;}
@list l160:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l160:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l160:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l160:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l160:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l160:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l160:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l160:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l160:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l161
	{mso-list-id:2131968117;
	mso-list-template-ids:148265670;}
@list l161:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l161:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l161:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l161:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l161:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l161:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l161:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l161:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l161:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l162
	{mso-list-id:2146850991;
	mso-list-template-ids:-675489480;}
@list l162:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:35.45pt;
	mso-level-number-position:left;
	margin-left:35.45pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l162:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:70.9pt;
	mso-level-number-position:left;
	margin-left:70.9pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l162:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:106.35pt;
	mso-level-number-position:left;
	margin-left:106.35pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l162:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:141.8pt;
	mso-level-number-position:left;
	margin-left:141.8pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l162:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:177.25pt;
	mso-level-number-position:left;
	margin-left:177.25pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l162:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:212.7pt;
	mso-level-number-position:left;
	margin-left:212.7pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l162:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:248.15pt;
	mso-level-number-position:left;
	margin-left:248.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l162:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:283.6pt;
	mso-level-number-position:left;
	margin-left:283.6pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l162:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:319.05pt;
	mso-level-number-position:left;
	margin-left:319.05pt;
	text-indent:-14.15pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
ol
	{margin-bottom:0cm;}
ul
	{margin-bottom:0cm;}
-->
</style>
<!--[if gte mso 10]>
<style>
 /* Style Definitions */
 table.MsoNormalTable
	{mso-style-name:"Table Normal";
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-parent:"";
	mso-padding-alt:0cm 5.4pt 0cm 5.4pt;
	mso-para-margin:0cm;
	mso-para-margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	mso-hyphenate:none;
	font-size:12.0pt;
	font-family:"Liberation Serif","serif";
	color:black;
	mso-fareast-language:ZH-CN;
	mso-bidi-language:HI;}
</style>
<![endif]--><!--[if gte mso 9]><xml>
 <o:shapedefaults v:ext="edit" spidmax="1026"/>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <o:shapelayout v:ext="edit">
  <o:idmap v:ext="edit" data="1"/>
 </o:shapelayout></xml><![endif]-->
</head>

<body lang=EN-IN link=navy vlink="#954F72" style='tab-interval:2.0cm'>

<div class=WordSection1>

<p class=MsoNormal>1[Q] A 52 year old man with history of coronary artery
disease is currently on sublingual nitroglycerin 0.5 mg, SOS, metoprolol 50 mg
twice a day, aspirin 75 mg once a day, enalapril 5 mg once a day, for the last
one year. The patient is now complaining of breathlessness and wheeze. Which
one of the following drugs is most likely to be implicated for this new symptom
?</p>

<p class=MsoNormal>(a) Enalapril </p>

<p class=MsoNormal>(b) Metoprolol </p>

<p class=MsoNormal>(c) Nitroglycerin </p>

<p class=MsoNormal>(d) Aspirin</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[ANS] b</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[SOL]</p>

<p class=MsoNormal><span style='mso-spacerun:yes'></span>Impotence,
exacerbation of COPD and asthma, cardiovascular effects (bradycardia, AV block,
HF), CNS effects (sedation, sleep alterations). </p>

<p class=MsoNormal>May mask the signs of hypoglycemia.</p>

<p class=MsoNormal>Metoprolol can cause dyslipidemia. </p>

<p class=MsoNormal>Propranolol can exacerbate vasospasm in vasospastic angina. </p>

<p class=MsoNormal>&#946;-blockers (except the nonselective &#945;- and
&#946;-antagonists carvedilol and labetalol) cause unopposed &#945;1-agonism if
given alone for pheochromocytoma or for cocaine toxicity (unsubstantiated). </p>

<p class=MsoNormal>Treat &#946;-blocker overdose with saline, atropine,
glucagon.<br style='mso-special-character:line-break'>
<![if !supportLineBreakNewLine]><br style='mso-special-character:line-break'>
<![endif]></p>

<p class=MsoNormal>2[Q] A patient with ischaemic heart disease on regular
follow-up has a resting heart rate of 90 beats/minute. The patient is taking
metoprolol 50 mg twice a day. Which one of the following drugs may be added to
his prescription if he also has signs of heart failure ? </p>

<p class=MsoNormal>(a) Ranolazine </p>

<p class=MsoNormal>(b) Diclofenac </p>

<p class=MsoNormal>(c) Prednisolone </p>

<p class=MsoNormal>(d) Ivabradine</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[ANS] d</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[SOL] <strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Ivabradine:</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l45 level1 lfo2;tab-stops:list 0cm'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Mechanism:</span></strong> Acts on SA
node, reducing heart rate via If inward current.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l45 level1 lfo2;tab-stops:list 0cm'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Dosage:</span></strong> 2.57.5 mg
twice daily.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l45 level1 lfo2;tab-stops:list 0cm'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Benefits:</span></strong> Reduces
hospitalization and mortality in heart failure due to moderate or severe left ventricular
systolic impairment, most effective with high baseline heart rate.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l45 level1 lfo2;tab-stops:list 0cm'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Use Cases:</span></strong> Suited for
patients unable to take &#946;-blockers or with persistent high heart rate
despite &#946;-blockade.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l45 level1 lfo2;tab-stops:list 0cm'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Limitation:</span></strong>
Ineffective in atrial fibrillation.</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>Ref: Davidson 24<sup>th</sup> edition pg407</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>3[Q] An 18 year old boy got frost bite of left feet after
working in a snowy field for 5-6 hours. He complained of pain, numbness and
limited moment of his toes. The skin appeared white and waxy. Which one of the
following is contradicted as initial treatment ?</p>

<p class=MsoNormal>(a) Rewarming by immersion of feet in water bath at 40-44C </p>

<p class=MsoNormal>(b) Massage </p>

<p class=MsoNormal>(c) Cleaning of injured area with soap </p>

<p class=MsoNormal>(d) Use of dressing</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[ANS] b</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[SOL] </p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>FROSTBITE Overview:</span></strong></p>

<p class=MsoNormal>Frostbite occurs due to severe cold exposure or contact with
extremely cold objects, causing tissue damage through freezing and
vasoconstriction. Typically affects distal extremities and exposed facial areas
(ears, nose, chin, cheeks).</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Types of Frostbite:</span></strong></p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Superficial Frostbite:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l44 level2 lfo3;tab-stops:list 0cm'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Involves skin and subcutaneous tissue.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l44 level2 lfo3;tab-stops:list 0cm'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Symptoms: Pain, paresthesia, white and waxy
skin.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l44 level2 lfo3;tab-stops:list 0cm'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>After rewarming: Cyanosis, erythema,
wheal-and-flare formation, edema, and superficial blisters.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Deep Frostbite:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l44 level2 lfo3;tab-stops:list 0cm'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Affects muscles, nerves, and deeper blood
vessels.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l44 level2 lfo3;tab-stops:list 0cm'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Manifestations: Edema, vesicles, bullae, tissue
necrosis, and potential gangrene.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Initial Treatment:</span></strong></p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Rewarming:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l90 level2 lfo4;tab-stops:list 0cm'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Conducted in an environment preventing
reexposure to freezing conditions.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l90 level2 lfo4;tab-stops:list 0cm'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Immersion in water bath (4044C / 104111F)
is effective.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l90 level2 lfo4;tab-stops:list 0cm'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Contraindicated: Massage, ice water, extreme heat.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Cleansing and Dressing:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l90 level2 lfo4;tab-stops:list 0cm'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Cleanse the injured area with soap or
antiseptic.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l90 level2 lfo4;tab-stops:list 0cm'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Apply sterile dressings.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Analgesics and Antibiotics:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l90 level2 lfo4;tab-stops:list 0cm'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Analgesics often required during rewarming.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l90 level2 lfo4;tab-stops:list 0cm'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Antibiotics used if infection is evident.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Post-recovery Considerations:</span></strong></p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Increased Sensitivity:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l75 level2 lfo5;tab-stops:list 0cm'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Affected extremity may exhibit heightened
sensitivity to cold after recovery.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Note:</span></strong> The efficacy of
sympathetic blocking drugs is uncertain in frostbite management.</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><b>Ref: Harrisons principles of INTERNAL MEDICINE 21<sup>th</sup>
edition pg3634<o:p></o:p></b></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>4[Q] Which of the following anti-coagulant agents can be
administered orally? </p>

<p class=MsoNormal>1. Rivaroxaban </p>

<p class=MsoNormal>2. Fondaparinux </p>

<p class=MsoNormal>3. Apixaban </p>

<p class=MsoNormal>4. Dabigatran </p>

<p class=MsoNormal>Select the correct answer using the code given below:</p>

<p class=MsoNormal>(a) 1 and 3 only </p>

<p class=MsoNormal>(b) 1, 2 and 4 </p>

<p class=MsoNormal>(c) 1, 3 and 4 </p>

<p class=MsoNormal>(d) 2, 3 and 4</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[ANS] c</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[SOL] <strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Parenteral Anticoagulants:</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l131 level1 lfo6;tab-stops:list 0cm'><![if !supportLists]><span
style='mso-fareast-font-family:"Liberation Serif";mso-bidi-font-family:"Liberation Serif"'><span
style='mso-list:Ignore'>1.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Heparin:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l131 level2 lfo6;tab-stops:list 0cm'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Traditional anticoagulant.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l131 level1 lfo6;tab-stops:list 0cm'><![if !supportLists]><span
style='mso-fareast-font-family:"Liberation Serif";mso-bidi-font-family:"Liberation Serif"'><span
style='mso-list:Ignore'>2.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Low-Molecular-Weight Heparin (LMWH):</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l131 level2 lfo6;tab-stops:list 0cm'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Similar to heparin but with specific molecular
weight characteristics.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l131 level1 lfo6;tab-stops:list 0cm'><![if !supportLists]><span
style='mso-fareast-font-family:"Liberation Serif";mso-bidi-font-family:"Liberation Serif"'><span
style='mso-list:Ignore'>3.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Fondaparinux:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l131 level2 lfo6;tab-stops:list 0cm'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Synthetic pentasaccharide, inhibits factor Xa.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l131 level1 lfo6;tab-stops:list 0cm'><![if !supportLists]><span
style='mso-fareast-font-family:"Liberation Serif";mso-bidi-font-family:"Liberation Serif"'><span
style='mso-list:Ignore'>4.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Lepirudin, Desirudin, Bivalirudin,
Argatroban:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l131 level2 lfo6;tab-stops:list 0cm'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Alternative parenteral anticoagulants with
specific mechanisms.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Oral Anticoagulants:</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l84 level1 lfo7;tab-stops:list 0cm'><![if !supportLists]><span
style='mso-fareast-font-family:"Liberation Serif";mso-bidi-font-family:"Liberation Serif"'><span
style='mso-list:Ignore'>1.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Warfarin:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l84 level2 lfo7;tab-stops:list 0cm'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Traditional oral anticoagulant, vitamin K
antagonist.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l84 level1 lfo7;tab-stops:list 0cm'><![if !supportLists]><span
style='mso-fareast-font-family:"Liberation Serif";mso-bidi-font-family:"Liberation Serif"'><span
style='mso-list:Ignore'>2.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Dabigatran Etexilate:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l84 level2 lfo7;tab-stops:list 0cm'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Oral thrombin inhibitor.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l84 level1 lfo7;tab-stops:list 0cm'><![if !supportLists]><span
style='mso-fareast-font-family:"Liberation Serif";mso-bidi-font-family:"Liberation Serif"'><span
style='mso-list:Ignore'>3.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Rivaroxaban, Apixaban, Edoxaban:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l84 level2 lfo7;tab-stops:list 0cm'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Oral factor Xa inhibitors.</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>Ref: Harrisons principles of INTERNAL MEDICINE 21<sup>th</sup>
edition pg928</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>5[Q] Which of the following drugs may be associated with leg
swelling? </p>

<p class=MsoNormal>1. Calcium channel blockers </p>

<p class=MsoNormal>2. NSAIDs </p>

<p class=MsoNormal>3. Glucocorticoids </p>

<p class=MsoNormal>4. Mineralocorticoids </p>

<p class=MsoNormal>Select the correct answer using the code given below:</p>

<p class=MsoNormal>(a) 1 and 2 only </p>

<p class=MsoNormal>(b) 2, 3 and 4 only </p>

<p class=MsoNormal>(c) 3 and 4 only </p>

<p class=MsoNormal>(d) 1, 2, 3 and 4</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[ANS] d</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[SOL] </p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>6[Q] Which of the following produce loud S1 on cardiac
auscultation ? </p>

<p class=MsoNormal>1. Anaemia </p>

<p class=MsoNormal>2. Pregnancy </p>

<p class=MsoNormal>3. Thyrotoxicosis </p>

<p class=MsoNormal>4. Mitral regurgitation </p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>(a) 1, 2 and 3 </p>

<p class=MsoNormal>(b) 1, 2 and 4 </p>

<p class=MsoNormal>(c) 1, 3 and 4 </p>

<p class=MsoNormal>(d) 2 and 3 only </p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[ANS] a</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[SOL] The intensity of S1 on cardiac auscultation depends on
the closure of mitral and tricuspid valves. Conditions that increase the rate
of blood flow across the mitral and tricuspid valves or that bring the valves
closer to the chest wall can produce a louder S1 sound. These conditions
include pregnancy and thyrotoxicosis. Mitral regurgitation, on the other hand,
may cause a soft or absent S1 sound.</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>7[Q] Which of the following are correct about Ivabradine ? </p>

<p class=MsoNormal>1. It may be of use in severe heart failure</p>

<p class=MsoNormal>2. It acts on SA node</p>

<p class=MsoNormal>3. It reduces heart rate</p>

<p class=MsoNormal>4. It is effective in atrial fibrillation </p>

<p class=MsoNormal>Select the correct answer using the code given below : </p>

<p class=MsoNormal>(a) 1, 2 and 3 </p>

<p class=MsoNormal>(b) 1, 2 and </p>

<p class=MsoNormal>(c) 1, 3 and 4 </p>

<p class=MsoNormal>(d) 2 and 3</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[ANS] a</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[SOL]<span style='mso-spacerun:yes'> </span><strong><span
style='font-family:"Liberation Serif","serif";mso-bidi-font-family:"Noto Naskh Arabic"'>Ivabradine:</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l45 level1 lfo2;tab-stops:list 0cm'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Mechanism:</span></strong> Acts on SA
node, reducing heart rate via If inward current.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l45 level1 lfo2;tab-stops:list 0cm'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Dosage:</span></strong> 2.57.5 mg
twice daily.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l45 level1 lfo2;tab-stops:list 0cm'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Benefits:</span></strong> Reduces
hospitalization and mortality in heart failure due to moderate or severe left
ventricular systolic impairment, most effective with high baseline heart rate.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l45 level1 lfo2;tab-stops:list 0cm'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Use Cases:</span></strong> Suited for
patients unable to take &#946;-blockers or with persistent high heart rate
despite &#946;-blockade.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l45 level1 lfo2;tab-stops:list 0cm'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Limitation:</span></strong>
Ineffective in atrial fibrillation.</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>Ref: Davidson 24<sup>th</sup> edition pg407</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>8[Q] Left atrial dilatation on X-ray chest is characterised
by which of the following? </p>

<p class=MsoNormal>1. Straight left heart border </p>

<p class=MsoNormal>2. Rounding of left heart border </p>

<p class=MsoNormal>3. Double cardiac shadow </p>

<p class=MsoNormal>4. Widening of the angle of carina</p>

<p class=MsoNormal>Select the correct answer using the code given below : </p>

<p class=MsoNormal>(a) 1 and 3 only </p>

<p class=MsoNormal>(b) 1, 2 and 4 </p>

<p class=MsoNormal>(c) 1,3 and 4</p>

<p class=MsoNormal>(d) 2,3 and 4 </p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[ANS] c</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[SOL] Left atrial dilatation on X-ray chest is characterized
by widening of the angle of carina, Double cardiac shadow (DOUBLE DENSITY SIGN)
and straightening of the left heart border. </p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>9[Q] A 30 year old male is being evaluated for shortness of
breath. On examination of the jugular venous pulse (JVP), there is a rise in
the JVP on inspiration. Which one of the following is most likely diagnosis ?</p>

<p class=MsoNormal>(a) Constrictive pericarditis </p>

<p class=MsoNormal>(b) Atrial septal defect </p>

<p class=MsoNormal>(c) Aortic regurgitation </p>

<p class=MsoNormal>(d) Severe mitral stenosis </p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[ANS] a</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[SOL] Kussmauls sign is defined by either a rise or a lack
of fall of the JVP with inspiration and is classically associated with
constrictive pericarditis, although it has been reported in patients with
restrictive cardiomyopathy, massive pulmonary embolism, right ventricular
infarction, and advanced left ventricular (LV) systolic heart failure. It is
also a common, isolated finding in patients after cardiac surgery without other
hemodynamic abnormalities.</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>Ref: Harrisons principles of INTERNAL MEDICINE 21<sup>th</sup>
edition pg1858</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>10[Q] A 24 year old man presents with acute onset shortness
of breath with precordial chest pain. ECG reveals ST elevation with upward
concavity and PR segment depression in lead V2 to V6 and reciprocal changes in
aVR. The most likely diagnosis is </p>

<p class=MsoNormal>(a) Anterior wall myocardial infarction </p>

<p class=MsoNormal>(b) Acute pericarditis </p>

<p class=MsoNormal>(c) Anterior wall aneurysm</p>

<p class=MsoNormal>(d)<span style='mso-spacerun:yes'> </span>Aortic dissection
</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[ANS] b</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[SOL] </p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Electrocardiogram (ECG) in Acute
Pericarditis:</span></strong></p>

<p class=MsoNormal>The ECG findings in acute pericarditis, particularly without
massive effusion, are reflective of acute subepicardial inflammation and
typically progress through distinct stages:</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l85 level1 lfo8;tab-stops:list 0cm'><![if !supportLists]><span
style='mso-fareast-font-family:"Liberation Serif";mso-bidi-font-family:"Liberation Serif"'><span
style='mso-list:Ignore'>1.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Stage 1:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l85 level2 lfo8;tab-stops:list 0cm'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Widespread elevation of ST segments, often with
upward concavity.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l85 level2 lfo8;tab-stops:list 0cm'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Involves two or three standard limb leads and
V2V6.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l85 level2 lfo8;tab-stops:list 0cm'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Reciprocal depressions appear in aVR and
sometimes V1.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l85 level2 lfo8;tab-stops:list 0cm'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Depression of the PR segment below the TP
segment indicates atrial involvement.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l85 level2 lfo8;tab-stops:list 0cm'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Typically, no significant changes in QRS
complexes are observed, unless a large pericardial effusion develops.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l85 level1 lfo8;tab-stops:list 0cm'><![if !supportLists]><span
style='mso-fareast-font-family:"Liberation Serif";mso-bidi-font-family:"Liberation Serif"'><span
style='mso-list:Ignore'>2.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Stage 2:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l85 level2 lfo8;tab-stops:list 0cm'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>ST segments return to normal after several days.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l85 level1 lfo8;tab-stops:list 0cm'><![if !supportLists]><span
style='mso-fareast-font-family:"Liberation Serif";mso-bidi-font-family:"Liberation Serif"'><span
style='mso-list:Ignore'>3.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Stage 3:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l85 level2 lfo8;tab-stops:list 0cm'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>T waves become inverted, occurring only after
the normalization of ST segments.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l85 level1 lfo8;tab-stops:list 0cm'><![if !supportLists]><span
style='mso-fareast-font-family:"Liberation Serif";mso-bidi-font-family:"Liberation Serif"'><span
style='mso-list:Ignore'>4.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Stage 4:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l85 level2 lfo8;tab-stops:list 0cm'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Weeks or months post-onset, the ECG returns to
normal.</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>Ref: Harrisons principles of INTERNAL MEDICINE 21<sup>th</sup>
edition pg2020</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>11[Q] Which of the following are Controller Therapies in the
management of acute asthma ?</p>

<p class=MsoNormal>1. Anticholinergics</p>

<p class=MsoNormal>2. Systemic glucocorticoids</p>

<p class=MsoNormal>3. Inhaled glucocorticoids</p>

<p class=MsoNormal>4. Omalizumab</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>Select the correct answer using the code given below:</p>

<p class=MsoNormal>(a) 1, 2 and 3</p>

<p class=MsoNormal>(b) 1, 2 and 4</p>

<p class=MsoNormal>(c) 1, 3 and 4</p>

<p class=MsoNormal>(d) 2, 3 and 4</p>

<p class=MsoNormal>[ANS] d</p>

<p class=MsoNormal>[SOL]</p>

<p class=MsoNormal>Controller (Anti-Inflammatory/Antimediator) Therapies :</p>

<p class=MsoNormal><span style='font-family:"S hne;ui-sans-serif;system-ui;a","serif";
color:#0F0F0F'>So-called controller therapies reduce asthma exacerbations and
improve long-term control, decreasing the need for intermittent use of
bronchodilator therapies</span> </p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>CONTROLLER THERAPIES</p>

<p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt;mso-list:l0 level1 lfo9;
tab-stops:list 0cm'><![if !supportLists]><span style='font-family:Symbol;
mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol'><span
style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Inhaled Corticosteroids </p>

<p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt;mso-list:l0 level1 lfo9;
tab-stops:list 0cm'><![if !supportLists]><span style='font-family:Symbol;
mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol'><span
style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Systemic Corticosteroids </p>

<p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt;mso-list:l0 level1 lfo9;
tab-stops:list 0cm'><![if !supportLists]><span style='font-family:Symbol;
mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol'><span
style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Leukotriene Modifiers </p>

<p class=MsoNormal><span style='mso-spacerun:yes'> </span>CysLT1
Antagonists<span style='mso-spacerun:yes'> </span>: Montelukast and
Zafirlukast</p>

<p class=MsoNormal><span style='mso-spacerun:yes'> </span>5-Lipoxygenase
Inhibition<span style='mso-spacerun:yes'> </span>:Zileuton</p>

<p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt;mso-list:l0 level1 lfo9;
tab-stops:list 0cm'><![if !supportLists]><span style='font-family:Symbol;
mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol'><span
style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Cromolyn sodium</p>

<p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt;mso-list:l0 level1 lfo9;
tab-stops:list 0cm'><![if !supportLists]><span style='font-family:Symbol;
mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol'><span
style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Anti-IgE : Omalizumab</p>

<p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt;mso-list:l0 level1 lfo9;
tab-stops:list 0cm'><![if !supportLists]><span style='font-family:Symbol;
mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol'><span
style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Anti-IL-5 : Antibodies that block IL-5
(mepolizumab, reslizumab) or its receptor (benralizumab)</p>

<p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt;mso-list:l0 level1 lfo9;
tab-stops:list 0cm'><![if !supportLists]><span style='font-family:Symbol;
mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol'><span
style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>AntiIL-4/13 : Dupilumab</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><b>Ref: Harrisons principles of INTERNAL MEDICINE 21<sup>th</sup>
edition pg2156<o:p></o:p></b></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>12[Q] Low pleural fluid glucose (&lt; 60 mg%) may be
observed in which of the following ?</p>

<p class=MsoNormal>1. Pyogenic pleural effusion</p>

<p class=MsoNormal>2. Rheumatoid pleuritis</p>

<p class=MsoNormal>3. Malignant pleural effusion</p>

<p class=MsoNormal>4. Hepatic hydrothorax</p>

<p class=MsoNormal>Select the correct answer using the code given below :</p>

<p class=MsoNormal>(a) 1, 2 and 3</p>

<p class=MsoNormal>(b) 1 and 2 only</p>

<p class=MsoNormal>(c) 1, 3 and 4</p>

<p class=MsoNormal>(d) 2, 3 and 4</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[ANS] a</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[SOL] Low pleural fluid glucose (&lt;60 mg/dL) can be
observed in </p>

<p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt;mso-list:l36 level1 lfo10;
tab-stops:list 0cm'><![if !supportLists]><span style='font-family:Symbol;
mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol'><span
style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Bacterial infection</p>

<p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt;mso-list:l36 level1 lfo10;
tab-stops:list 0cm'><![if !supportLists]><span style='font-family:Symbol;
mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol'><span
style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Reumatoid pleuritis</p>

<p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt;mso-list:l36 level1 lfo10;
tab-stops:list 0cm'><![if !supportLists]><span style='font-family:Symbol;
mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol'><span
style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Malignancy</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>Ref: Harrisons principles of INTERNAL MEDICINE 20<sup>th</sup>
edition pg2197</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>13[Q] Which of the following are correct regarding
Idiopathic Pulmonary Fibrosis?</p>

<p class=MsoNormal>1. Radiological pattern interstitial pneumonia</p>

<p class=MsoNormal>2. Finger clubbing</p>

<p class=MsoNormal>3. More common in elderly</p>

<p class=MsoNormal>Select the correct answer using the code given below:</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>(a) 1 and 2 only </p>

<p class=MsoNormal>(b) 2 and 3 only </p>

<p class=MsoNormal>(c) 1 and 3 only </p>

<p class=MsoNormal>(d) 1, 2 and 3</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[ANS] d</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[SOL] </p>

<p class=MsoNormal>Idiopathic Pulmonary Fibrosis<b><o:p></o:p></b></p>

<p class=MsoNormal><br>
<strong><span style='font-family:"Liberation Serif","serif";mso-bidi-font-family:
"Noto Naskh Arabic"'>Clinical Features:</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l73 level1 lfo11;tab-stops:list 0cm'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Typically presents in older adults; uncommon
before 50 years.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l73 level1 lfo11;tab-stops:list 0cm'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>May be incidentally found through widespread CT
scanning.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l73 level1 lfo11;tab-stops:list 0cm'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Common symptoms include progressive
breathlessness and a non-productive cough.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l73 level1 lfo11;tab-stops:list 0cm'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Constitutional symptoms are unusual.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l73 level1 lfo11;tab-stops:list 0cm'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Clinical findings include finger clubbing and
late inspiratory crackles resembling Velcro.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Investigations:</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l79 level1 lfo12;tab-stops:list 0cm'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Chest X-ray reveals bilateral lower lobe and
subpleural reticular shadowing.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l79 level1 lfo12;tab-stops:list 0cm'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>HRCT shows a patchy, predominantly peripheral,
subpleural, and basal reticular pattern.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l79 level1 lfo12;tab-stops:list 0cm'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Advanced disease may exhibit honeycombing cysts
and traction bronchiectasis.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l79 level1 lfo12;tab-stops:list 0cm'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>HRCT has a high positive predictive value for
IPF diagnosis; biopsy is seldom necessary.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l79 level1 lfo12;tab-stops:list 0cm'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Pulmonary function tests show a restrictive
defect, potentially preserved in concomitant emphysema.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l79 level1 lfo12;tab-stops:list 0cm'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Bronchoscopy is rarely indicated; lung biopsy
may be considered in cases of diagnostic uncertainty.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Management:</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l19 level1 lfo13;tab-stops:list 0cm'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Pirfenidone or nintedanib may be offered for
vital capacity between 50% and 80% predicted.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l19 level1 lfo13;tab-stops:list 0cm'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Medications can slow lung function decline but
have limited impact on symptoms.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l19 level1 lfo13;tab-stops:list 0cm'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Patients taking pirfenidone should avoid direct
sunlight; nintedanib may cause diarrhea.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l19 level1 lfo13;tab-stops:list 0cm'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Treatment should be discontinued if lung
function declines by more than 10% in the first year.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l19 level1 lfo13;tab-stops:list 0cm'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Medication for gastro-oesophageal reflux may
improve cough.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l19 level1 lfo13;tab-stops:list 0cm'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Smoking cessation is advised due to an increased
risk of lung cancer.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l19 level1 lfo13;tab-stops:list 0cm'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Influenza and pneumococcal vaccinations are
recommended.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l19 level1 lfo13;tab-stops:list 0cm'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Patients should be encouraged to exercise,
participate in pulmonary rehabilitation, and consider lung transplantation if
appropriate.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Acute Exacerbations:</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l100 level1 lfo14;tab-stops:list 0cm'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Optimal treatment is unknown; largely
supportive.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l100 level1 lfo14;tab-stops:list 0cm'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Broad-spectrum antibiotics may be combined with
glucocorticoids and additional immunosuppression, but evidence is limited.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l100 level1 lfo14;tab-stops:list 0cm'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>Ref: Davidson principles and practice of medicine 24<sup>th</sup>
edition pg534</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>14[Q] Diagnostic work-up for suspected Bronchial asthma case
of should reveal which of the following abnormalities?</p>

<p class=MsoNormal>1. Reduced FEV1/FVC</p>

<p class=MsoNormal>2. Increased functional residual volume</p>

<p class=MsoNormal>3. Reduced diffusion capacity</p>

<p class=MsoNormal>4. Increment in FEV1 in response to inhaled bronchodilators</p>

<p class=MsoNormal>Select the correct answer using the code given below:</p>

<p class=MsoNormal>(a) 1, 2 and 3</p>

<p class=MsoNormal>(b) 1, 2 and 4</p>

<p class=MsoNormal>(c) 1 and 4 only</p>

<p class=MsoNormal>(d) 2, 3 and 4</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[ANS] b</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[SOL] <strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Lung Function Tests for bronchial
asthma:</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l159 level1 lfo15;tab-stops:list 0cm'><![if !supportLists]><span
style='mso-fareast-font-family:"Liberation Serif";mso-bidi-font-family:"Liberation Serif"'><span
style='mso-list:Ignore'>1.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Simple Spirometry:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l159 level2 lfo15;tab-stops:list 0cm'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Confirms airflow limitation.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l159 level2 lfo15;tab-stops:list 0cm'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Demonstrates reduced Forced Expiratory Volume in
1 second (FEV1), FEV1/FVC ratio, and Peak Expiratory Flow (PEF).</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l159 level1 lfo15;tab-stops:list 0cm'><![if !supportLists]><span
style='mso-fareast-font-family:"Liberation Serif";mso-bidi-font-family:"Liberation Serif"'><span
style='mso-list:Ignore'>2.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Reversibility Testing:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l159 level2 lfo15;tab-stops:list 0cm'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Reveals reversibility with a &gt;12% and 200-mL
increase in FEV1 15 minutes after inhaling a short-acting &#946;2-agonist
(SABA) like inhaled albuterol 400 &#956;g.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l159 level2 lfo15;tab-stops:list 0cm'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>In some cases, reversibility may be assessed
through a 24 week trial of oral corticosteroids (OCS) like prednisone or
prednisolone (3040 mg daily).</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l159 level1 lfo15;tab-stops:list 0cm'><![if !supportLists]><span
style='mso-fareast-font-family:"Liberation Serif";mso-bidi-font-family:"Liberation Serif"'><span
style='mso-list:Ignore'>3.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Diurnal Variations:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l159 level2 lfo15;tab-stops:list 0cm'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Monitoring Peak Expiratory Flow (PEF) twice
daily confirms diurnal variations in airflow obstruction.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l159 level1 lfo15;tab-stops:list 0cm'><![if !supportLists]><span
style='mso-fareast-font-family:"Liberation Serif";mso-bidi-font-family:"Liberation Serif"'><span
style='mso-list:Ignore'>4.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Flow-Volume Loops:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l159 level2 lfo15;tab-stops:list 0cm'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Illustrate reduced peak flow and maximum
expiratory flow.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l159 level1 lfo15;tab-stops:list 0cm'><![if !supportLists]><span
style='mso-fareast-font-family:"Liberation Serif";mso-bidi-font-family:"Liberation Serif"'><span
style='mso-list:Ignore'>5.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Whole Body Plethysmography:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l159 level2 lfo15;tab-stops:list 0cm'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Rarely necessary but may be used.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l159 level2 lfo15;tab-stops:list 0cm'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Shows increased airway resistance.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l159 level2 lfo15;tab-stops:list 0cm'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>May indicate increased total lung capacity and
residual volume.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l159 level1 lfo15;tab-stops:list 0cm'><![if !supportLists]><span
style='mso-fareast-font-family:"Liberation Serif";mso-bidi-font-family:"Liberation Serif"'><span
style='mso-list:Ignore'>6.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Gas Diffusion:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l159 level2 lfo15;tab-stops:list 0cm'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Measured by carbon monoxide transfer.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l159 level2 lfo15;tab-stops:list 0cm'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Typically normal, but some patients may exhibit
a slight increase.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l159 level2 lfo15;tab-stops:list 0cm'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>Ref: Harrisons principles of INTERNAL MEDICINE 20<sup>th</sup>
edition pg2154</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>15[Q] Which of the following conditions predispose to
obstructive sleep apnea?</p>

<p class=MsoNormal>1. Hyperthyroidism</p>

<p class=MsoNormal>2. Acromegaly</p>

<p class=MsoNormal>3. Obesity</p>

<p class=MsoNormal>4. Use of alcohol/sedatives</p>

<p class=MsoNormal>Select the correct answer using the code given below:</p>

<p class=MsoNormal>(a) 2 and 3 only</p>

<p class=MsoNormal>(b) 1, 2 and 4</p>

<p class=MsoNormal>(c) 1,3 and 4</p>

<p class=MsoNormal>(d) 2,3 and 4</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[ANS] d</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[SOL] </p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Risk Factors and Prevalence of
Obstructive Sleep Apnea-Hypopnea Syndrome (OSAHS):</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l80 level1 lfo16;tab-stops:list 0cm'><![if !supportLists]><span
style='mso-fareast-font-family:"Liberation Serif";mso-bidi-font-family:"Liberation Serif"'><span
style='mso-list:Ignore'>1.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Major Risk Factors:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l80 level2 lfo16;tab-stops:list 0cm'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Obesity: 4060% of cases attributed to excess
weight.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l80 level2 lfo16;tab-stops:list 0cm'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Male sex: Prevalence two- to fourfold higher
among men.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l80 level2 lfo16;tab-stops:list 0cm'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Mandibular retrognathia and micrognathia.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l80 level2 lfo16;tab-stops:list 0cm'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Positive family history of OSAHS.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l80 level2 lfo16;tab-stops:list 0cm'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Genetic syndromes reducing upper airway patency
(e.g., Down syndrome, Treacher-Collins syndrome).</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l80 level2 lfo16;tab-stops:list 0cm'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Adenotonsillar hypertrophy (especially in children).</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l80 level2 lfo16;tab-stops:list 0cm'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Menopause (in women).</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l80 level2 lfo16;tab-stops:list 0cm'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Various endocrine syndromes (e.g., acromegaly,
hypothyroidism).</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l80 level1 lfo16;tab-stops:list 0cm'><![if !supportLists]><span
style='mso-fareast-font-family:"Liberation Serif";mso-bidi-font-family:"Liberation Serif"'><span
style='mso-list:Ignore'>2.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Impact of Obesity:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l80 level2 lfo16;tab-stops:list 0cm'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Obese individuals have a fourfold or greater
risk for OSAHS.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l80 level2 lfo16;tab-stops:list 0cm'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Obesity narrows the pharyngeal lumen and reduces
chest wall compliance.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l80 level2 lfo16;tab-stops:list 0cm'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>A 10% weight gain is associated with a &gt;30%
increase in Apnea-Hypopnea Index (AHI).</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l80 level2 lfo16;tab-stops:list 0cm'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Even modest weight changes can influence the
risk and severity of OSAHS.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l80 level1 lfo16;tab-stops:list 0cm'><![if !supportLists]><span
style='mso-fareast-font-family:"Liberation Serif";mso-bidi-font-family:"Liberation Serif"'><span
style='mso-list:Ignore'>3.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Sex Differences:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l80 level2 lfo16;tab-stops:list 0cm'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Prevalence higher in men, influenced by android
patterns of obesity and pharyngeal length.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l80 level2 lfo16;tab-stops:list 0cm'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Premenopausal women are relatively protected;
increased prevalence after menopause.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l80 level1 lfo16;tab-stops:list 0cm'><![if !supportLists]><span
style='mso-fareast-font-family:"Liberation Serif";mso-bidi-font-family:"Liberation Serif"'><span
style='mso-list:Ignore'>4.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Craniofacial Morphology:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l80 level2 lfo16;tab-stops:list 0cm'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Variations in craniofacial features increase
OSAHS risk.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l80 level2 lfo16;tab-stops:list 0cm'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Nonobese patients may show evident hard-tissue
structural contributions.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l80 level2 lfo16;tab-stops:list 0cm'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Features like retrognathia can impact
therapeutic decisions.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l80 level1 lfo16;tab-stops:list 0cm'><![if !supportLists]><span
style='mso-fareast-font-family:"Liberation Serif";mso-bidi-font-family:"Liberation Serif"'><span
style='mso-list:Ignore'>5.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Genetic Factors:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l80 level2 lfo16;tab-stops:list 0cm'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Strong genetic basis with significant familial
aggregation and heritability.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l80 level2 lfo16;tab-stops:list 0cm'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>First-degree relatives have a twofold higher
odds ratio for OSAHS.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l80 level2 lfo16;tab-stops:list 0cm'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Several genetic variants associated with OSAHS prevalence
and related traits.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l80 level1 lfo16;tab-stops:list 0cm'><![if !supportLists]><span
style='mso-fareast-font-family:"Liberation Serif";mso-bidi-font-family:"Liberation Serif"'><span
style='mso-list:Ignore'>6.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Age-Related Variations:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l80 level2 lfo16;tab-stops:list 0cm'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Prevalence varies with age, ranging from 2 to
15% in middle-aged adults to &gt;20% in the elderly.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l80 level2 lfo16;tab-stops:list 0cm'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Peak prevalence in children (3-8 years) due to
lymphoid hypertrophy; declines with airway growth.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l80 level2 lfo16;tab-stops:list 0cm'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Resurgence in middle age and menopause,
associated with increased obesity prevalence.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l80 level1 lfo16;tab-stops:list 0cm'><![if !supportLists]><span
style='mso-fareast-font-family:"Liberation Serif";mso-bidi-font-family:"Liberation Serif"'><span
style='mso-list:Ignore'>7.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Association with Other Conditions:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l80 level2 lfo16;tab-stops:list 0cm'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>High prevalence among patients with diabetes or
hypertension.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l80 level2 lfo16;tab-stops:list 0cm'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Asians at increased risk at lower body mass
index.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l80 level2 lfo16;tab-stops:list 0cm'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>African Americans, especially children and young
adults, have a higher risk.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l80 level1 lfo16;tab-stops:list 0cm'><![if !supportLists]><span
style='mso-fareast-font-family:"Liberation Serif";mso-bidi-font-family:"Liberation Serif"'><span
style='mso-list:Ignore'>8.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Underdiagnosis:</span></strong>Majority
of adults with OSAHS remain undiagnosed.</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>16[Q] Which of the following are correct with regard to
acute fatty liver of pregnancy? </p>

<p class=MsoNormal>1. It is typically first trimester</p>

<p class=MsoNormal>2. It is more common in multiple pregnancies</p>

<p class=MsoNormal>3. Liver biopsy is rarely needed </p>

<p class=MsoNormal>4. Delivery of fetus is indicated</p>

<p class=MsoNormal>Select the correct answer using the code given below:</p>

<p class=MsoNormal>(a) 1, 2 and 3 </p>

<p class=MsoNormal>(b) 1, 3 and 4</p>

<p class=MsoNormal>(c) 1 and 4 only </p>

<p class=MsoNormal>(d) 2, 3 and 4 </p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[ANS] d</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[SOL]Acute Fatty Liver of Pregnancy (AFLP):</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l18 level1 lfo17;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Definition:</span></strong> Rare and
serious condition in pregnancy characterized by the accumulation of fat in
liver cells, leading to dysfunction.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l18 level1 lfo17;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Onset:</span></strong> Typically
presents in the third trimester.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l18 level1 lfo17;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Symptoms:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l18 level2 lfo17;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Vomiting</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l18 level2 lfo17;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Abdominal pain</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l18 level2 lfo17;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Jaundice (yellowing of skin and eyes)</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l18 level2 lfo17;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Liver dysfunction</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l18 level1 lfo17;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Risk Factors:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l18 level2 lfo17;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>More common in first pregnancies</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l18 level2 lfo17;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Associated with multiple pregnancies (twins,
triplets)</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l18 level2 lfo17;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Higher incidence with male fetuses</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l18 level1 lfo17;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Complications:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l18 level2 lfo17;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Rarely progresses to fulminant liver failure</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l18 level1 lfo17;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Diagnosis:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l18 level2 lfo17;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Clinical features</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l18 level2 lfo17;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Abnormal liver function tests (LFTs)</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l18 level2 lfo17;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Fatty liver appearance on ultrasound</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l18 level2 lfo17;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Liver biopsy rarely needed, may show
microvascular steatosis</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l18 level1 lfo17;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Association with LCHAD Deficiency:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l18 level2 lfo17;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Link with an inherited deficiency of long-chain
acyl-CoA dehydrogenase (LCHAD) in the baby</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l18 level1 lfo17;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Management:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l18 level2 lfo17;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Supportive care</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l18 level2 lfo17;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Prompt delivery of the fetus</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l18 level2 lfo17;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Delivery may need to be expedited in severe
cases, even if premature</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Ref: Davidson principles and practice
of medicine 24<sup>th</sup> edition pg1277</span></strong></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>17[Q] Which one of the following are markers of poor
prognosis in acute pancreatitis? </p>

<p class=MsoNormal>1. Elderly individual </p>

<p class=MsoNormal>2. Increased white blood cell count </p>

<p class=MsoNormal>3. Low serum calcium </p>

<p class=MsoNormal>4. Hypercarbia</p>

<p class=MsoNormal>Select the correct answer using the code given below: </p>

<p class=MsoNormal>(a) 1,2 and 3 </p>

<p class=MsoNormal>(b) 1, 2 and 4 </p>

<p class=MsoNormal>(c) 1,3 and 4 </p>

<p class=MsoNormal>(d) 2,3 and 4</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[ANS] a</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[SOL]<strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Glasgow Criteria for Prognosis in
Acute Pancreatitis:</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l153 level1 lfo18;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Age:</span></strong> &gt; 55 years</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l153 level1 lfo18;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>P O2 (Partial Pressure of Oxygen):</span></strong>
&lt; 8 kPa (60 mmHg)</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l153 level1 lfo18;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>White Blood Cell Count:</span></strong>
&gt; 15  10^9/L</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l153 level1 lfo18;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Albumin:</span></strong> &lt; 32 g/L
(3.2 g/dL)</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l153 level1 lfo18;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Serum Calcium:</span></strong> &lt; 2
mmol/L (8 mg/dL) (corrected)</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l153 level1 lfo18;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Glucose:</span></strong> &gt; 10
mmol/L (180 mg/dL)</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l153 level1 lfo18;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Urea:</span></strong> &gt; 16 mmol/L
(45 mg/dL) (after rehydration)</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l153 level1 lfo18;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Alanine Aminotransferase (ALT):</span></strong>
&gt; 200 U/L</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l153 level1 lfo18;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Lactate Dehydrogenase (LDH):</span></strong>
&gt; 600 U/L</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>*Severity and prognosis worsen as the number of these
factors increases. More than three implies severe disease</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Ref: Davidson principles and practice
of medicine 24<sup>th</sup> edition pg850</span></strong></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>18[Q] Which of the following are the common causes of acute
pancreatitis? </p>

<p class=MsoNormal>1. Gallstone</p>

<p class=MsoNormal>2. Alcohol</p>

<p class=MsoNormal>3. Post-ERCP</p>

<p class=MsoNormal>4. Campylobacter jejuni</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>(a) 1, 2 and 3 </p>

<p class=MsoNormal>(b) 1,2 and 4 </p>

<p class=MsoNormal>(c) 1,3 and 4 </p>

<p class=MsoNormal>(d) 2, 3 and 4 </p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[ANS] a</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[SOL] <strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Causes of Acute Pancreatitis:</span></strong></p>

<p class=MsoNormal><em><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Common (90% of cases)</span></em></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l35 level1 lfo19;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Gallstones</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l35 level1 lfo19;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Alcohol</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l35 level1 lfo19;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Idiopathic causes</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l35 level1 lfo19;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Post-ERCP (Endoscopic Retrograde
Cholangiopancreatography)</span></strong></p>

<p class=MsoNormal><em><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Rare</span></em></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l7 level1 lfo20;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Post-surgical (abdominal,
cardiopulmonary bypass)</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l7 level1 lfo20;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Trauma</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l7 level1 lfo20;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Drugs (azathioprine/mercaptopurine,
thiazide diuretics, sodium valproate)</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l7 level1 lfo20;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Metabolic (hypercalcaemia,
hypertriglyceridaemia)</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l7 level1 lfo20;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Pancreas divisum</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l7 level1 lfo20;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Sphincter of Oddi dysfunction</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l7 level1 lfo20;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Infection (mumps, Coxsackie virus)</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l7 level1 lfo20;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Hereditary factors</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l7 level1 lfo20;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Renal failure</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l7 level1 lfo20;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Organ transplantation (kidney, liver)</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l7 level1 lfo20;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Severe hypothermia</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l7 level1 lfo20;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Petrochemical exposure</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l7 level1 lfo20;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Scorpion sting</span></strong></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Ref: Davidson principles and practice
of medicine 24<sup>th</sup> edition pg851</span></strong></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>19[Q] Which of the following are aetiologies of
haemochromatosis? </p>

<p class=MsoNormal>1. Thalassaemia</p>

<p class=MsoNormal>2. Anaemia of pyruvate kinase deficiency</p>

<p class=MsoNormal>3. Chronic cor pulmonale </p>

<p class=MsoNormal>4. Porphyria cutanea tarda </p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>Select the correct answer using the code given below :</p>

<p class=MsoNormal>(a)1, 2 and 3 </p>

<p class=MsoNormal>(b) 1, 2 and 4</p>

<p class=MsoNormal>(c) 1 and 4 only </p>

<p class=MsoNormal>(d) 2,3 and 4</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[ANS] c</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[SOL] <strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Aetiology of Haemochromatosis:</span></strong></p>

<p class=MsoNormal><em><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Primary Haemochromatosis</span></em></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l161 level1 lfo21;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>HFE-associated haemochromatosis
(Autosomal Recessive)</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l161 level1 lfo21;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Juvenile haemochromatosis
(Hemojuvelin/Hepcidin Mutation, Autosomal Recessive)</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l161 level1 lfo21;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Transferrin Receptor 2 Deficiency
(TFR2 Mutation, Autosomal Recessive)</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l161 level1 lfo21;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Ferroportin Disease (SLC40A1 Mutation,
Autosomal Dominant)</span></strong></p>

<p class=MsoNormal><em><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Secondary Iron Overload</span></em></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l142 level1 lfo22;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Transfusional or Dietary Iron
Overload</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l142 level1 lfo22;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Iron-Loading Anaemia (Thalassaemia,
Sideroblastic Anaemia, Chronic Haemolytic Anaemias,)</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l142 level1 lfo22;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Liver Disease (ALD - Alcoholic Liver
Disease, NAFLD - Non-Alcoholic Fatty Liver Disease, Hepatitis C)</span></strong></p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic";font-weight:normal'><o:p>&nbsp;</o:p></span></strong></p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Ref: Davidson principles and practice
of medicine 24<sup>th</sup> edition pg906</span></strong></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>20[Q] Which of the following drugs are implicated in peptic
ulcer disease, not caused by Helicobacter pylori and NSAIDs? </p>

<p class=MsoNormal>1. Clopidogrel </p>

<p class=MsoNormal>2. Glucocorticoids </p>

<p class=MsoNormal>3. Bisphosphonates </p>

<p class=MsoNormal>4. Colloidal bismuth subcitrate </p>

<p class=MsoNormal>Select the correct answer using the code given below: </p>

<p class=MsoNormal>(a) 1, 2 and 3 </p>

<p class=MsoNormal>(b) 1 and 2 only </p>

<p class=MsoNormal>(c) 1, 3 and 4 </p>

<p class=MsoNormal>(d) 2 and 4 only </p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[ANS] a</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[SOL] Colloidal bismuth subcitrate can be used as treatment
for ulcer.</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>21[Q] Which of the following are symptoms of irritable bowel
syndrome?</p>

<p class=MsoNormal>1. Gas and flatulence</p>

<p class=MsoNormal>2. Abdominal pain</p>

<p class=MsoNormal>3. Blood in stools</p>

<p class=MsoNormal>4. Diarrhoea</p>

<p class=MsoNormal>Select the correct answer using the code given below:</p>

<p class=MsoNormal>(a) 1, 2 and 3</p>

<p class=MsoNormal>(b) 1, 2 and 4</p>

<p class=MsoNormal>(c) 1, 3 and 4</p>

<p class=MsoNormal>(d) 2, 3 and 4</p>

<p class=MsoNormal>[ANS] b</p>

<p class=MsoNormal>[SOL]</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Irritable Bowel Syndrome (IBS):</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l89 level1 lfo23;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Key Symptoms:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l89 level2 lfo23;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Recurrent abdominal pain</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l89 level2 lfo23;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Altered bowel habit</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l89 level1 lfo23;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Abdominal Pain:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l89 level2 lfo23;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Colicky or cramping</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l89 level2 lfo23;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Felt in the lower abdomen</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l89 level2 lfo23;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Related to defecation</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l89 level1 lfo23;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Bowel Habit Variability:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l89 level2 lfo23;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Stratified by predominant bowel habit:</p>

<p class=MsoNormal style='margin-left:106.35pt;text-indent:-14.15pt;mso-list:
l89 level3 lfo23;tab-stops:list 106.35pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>IBS with constipation (IBS-C)</p>

<p class=MsoNormal style='margin-left:106.35pt;text-indent:-14.15pt;mso-list:
l89 level3 lfo23;tab-stops:list 106.35pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>IBS with diarrhea (IBS-D)</p>

<p class=MsoNormal style='margin-left:106.35pt;text-indent:-14.15pt;mso-list:
l89 level3 lfo23;tab-stops:list 106.35pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Mixed bowel habit (IBS-M)</p>

<p class=MsoNormal style='margin-left:106.35pt;text-indent:-14.15pt;mso-list:
l89 level3 lfo23;tab-stops:list 106.35pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Unsubtyped (IBS-U)</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l89 level1 lfo23;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>IBS-C:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l89 level2 lfo23;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Infrequent, pellety stools</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l89 level2 lfo23;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Associated with abdominal pain or proctalgia</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l89 level1 lfo23;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>IBS-D:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l89 level2 lfo23;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Frequent defecation</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l89 level2 lfo23;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Low-volume stools</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l89 level2 lfo23;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Rarely nocturnal symptoms</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l89 level1 lfo23;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Common Features:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l89 level2 lfo23;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Passage of mucus is common</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l89 level2 lfo23;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>No rectal bleeding</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l89 level2 lfo23;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>No weight loss</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l89 level2 lfo23;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Patients are constitutionally well</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l89 level1 lfo23;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Diagnosis:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l89 level2 lfo23;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Clinical in nature</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l89 level2 lfo23;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Utilizes Rome IV criteria</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l89 level2 lfo23;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Absence of alarm symptoms</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l89 level2 lfo23;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Comprehensive history exploration (diet,
medical, surgical, psychological)</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l89 level2 lfo23;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Consideration of other functional
gastrointestinal disorders</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l89 level2 lfo23;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Associated non-gastrointestinal symptoms
(migraine headaches, dyspareunia, interstitial cystitis)</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l89 level2 lfo23;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Onset after gastroenteritis may suggest
post-infectious IBS</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l89 level1 lfo23;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Physical Examination:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l89 level2 lfo23;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Generally unremarkable</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l89 level2 lfo23;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Variable tenderness to palpation</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Investigations:</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l91 level1 lfo24;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Limited laboratory tests performed, including:</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l91 level2 lfo24;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Full blood count</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l91 level2 lfo24;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Faecal calprotectin</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l91 level2 lfo24;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>C-reactive protein</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l91 level2 lfo24;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Typically normal in IBS</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l91 level1 lfo24;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Colonoscopy:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l91 level2 lfo24;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Indicated in patients with alarm features</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l91 level2 lfo24;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>To exclude other diagnoses (colorectal cancer,
inflammatory bowel disease)</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l91 level1 lfo24;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Additional Investigations for
Atypical Presentation:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l91 level2 lfo24;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Diarrhea-predominant patients may require
investigations to exclude:</p>

<p class=MsoNormal style='margin-left:106.35pt;text-indent:-14.15pt;mso-list:
l91 level3 lfo24;tab-stops:list 106.35pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Coeliac disease</p>

<p class=MsoNormal style='margin-left:106.35pt;text-indent:-14.15pt;mso-list:
l91 level3 lfo24;tab-stops:list 106.35pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Microscopic colitis</p>

<p class=MsoNormal style='margin-left:106.35pt;text-indent:-14.15pt;mso-list:
l91 level3 lfo24;tab-stops:list 106.35pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Lactose intolerance</p>

<p class=MsoNormal style='margin-left:106.35pt;text-indent:-14.15pt;mso-list:
l91 level3 lfo24;tab-stops:list 106.35pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Bile acid diarrhea</p>

<p class=MsoNormal style='margin-left:106.35pt;text-indent:-14.15pt;mso-list:
l91 level3 lfo24;tab-stops:list 106.35pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Thyrotoxicosis</p>

<p class=MsoNormal style='margin-left:106.35pt;text-indent:-14.15pt;mso-list:
l91 level3 lfo24;tab-stops:list 106.35pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Parasitic infection in relevant countries</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Ref: Davidson principles and practice
of medicine 24<sup>th</sup> edition pg849</span></strong></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>22[Q] Vertical transmission of hepatitis B can be prevented
by which of the following interventions?</p>

<p class=MsoNormal>1. Passive immunisation of infant at birth</p>

<p class=MsoNormal>2. Active immunisation of infant at birth</p>

<p class=MsoNormal>3. Antiviral therapy in the third trimester for mother with
HBV-DNA level of &gt; 2,00,000 IU/mL</p>

<p class=MsoNormal>Select the correct answer using the code given below:</p>

<p class=MsoNormal>(a) 1 and 2 only</p>

<p class=MsoNormal>(b) 2 and 3 only</p>

<p class=MsoNormal>(c) 1 and 3 only</p>

<p class=MsoNormal>(d) 1, 2 and 3</p>

<p class=MsoNormal>[ANS] d</p>

<p class=MsoNormal>[SOL]</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Prophylaxis for Hepatitis B Virus
(HBV) Exposure:</span></strong></p>

<p class=MsoNormal><em><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Perinatal Exposure (Infants born to
HBsAg-positive mothers):</span></em></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l22 level1 lfo25;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Single IM dose of HBIG (0.5 mL) immediately
after birth.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l22 level1 lfo25;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Followed by a complete course of three injections
of recombinant hepatitis B vaccine within the first 12 hours of life.</p>

<p class=MsoNormal><em><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Direct Percutaneous Inoculation or
Transmucosal Exposure (e.g., accidental needle stick):</span></em></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l148 level1 lfo26;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Single IM dose of HBIG (0.06 mL/kg) as soon as
possible after exposure.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l148 level1 lfo26;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Followed by a complete course of hepatitis B
vaccine to begin within the first week.</p>

<p class=MsoNormal><em><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Pregnant Mothers with High-level HBV
DNA (&gt;2  10^5 IU/mL):</span></em></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l2 level1 lfo27;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Consider adding antiviral nucleoside analogues
(e.g., pregnancy class B tenofovir) during the third trimester to reduce perinatal
transmission.</p>

<p class=MsoNormal><em><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Persons Exposed by Sexual Contact to
a Patient with Acute Hepatitis B:</span></em></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l52 level1 lfo28;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Single IM dose of HBIG (0.06 mL/kg) within 14
days of exposure.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l52 level1 lfo28;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Followed by a complete course of hepatitis B
vaccine.</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><b>Ref: Harrisons principles of INTERNAL MEDICINE 21<sup>th</sup>
edition pg2582<o:p></o:p></b></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>23[Q] Which of the following are correct in respect of
jaundice?</p>

<p class=MsoNormal>1. Patients complain of darkening of urine before they
notice jaundice</p>

<p class=MsoNormal>2. Jaundice is usually detectable with a serum bilirubin
level of over 1-8 mg/dl</p>

<p class=MsoNormal>3. In Gilbert syndrome, jaundice is more noticeable after
fasting</p>

<p class=MsoNormal>Select the correct answer using the code given below:</p>

<p class=MsoNormal>(a) 1 and 2 only</p>

<p class=MsoNormal>(b) 2 and 3 only</p>

<p class=MsoNormal>(c) 1 and 3 only</p>

<p class=MsoNormal>(d) 1, 2 and 3</p>

<p class=MsoNormal>[ANS] c</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[SOL] </p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Jaundice in Liver Disease:</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l42 level1 lfo29;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Hallmark Symptom:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l42 level2 lfo29;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Jaundice is the hallmark symptom of liver
disease and a reliable marker of severity.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l42 level1 lfo29;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Patient Perception:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l42 level2 lfo29;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Patients often report darkening of urine before
noticing scleral icterus.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l42 level1 lfo29;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Bilirubin Level and Jaundice
Detection:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l42 level2 lfo29;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Jaundice is rarely detectable with a bilirubin
level &lt;43 &#956;mol/L (2.5 mg/dL).</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l42 level1 lfo29;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Additional Features with Severe
Cholestasis:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l42 level2 lfo29;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Lightening of stool color</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l42 level2 lfo29;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Steatorrhea</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l42 level1 lfo29;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Jaundice Without Dark Urine:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l42 level2 lfo29;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Indicates indirect (unconjugated)
hyperbilirubinemia.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l42 level2 lfo29;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Typical of hemolytic anemia and genetic
disorders of bilirubin conjugation.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l42 level1 lfo29;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Genetic Disorders:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l42 level2 lfo29;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Common and benign: Gilbert syndrome</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l42 level2 lfo29;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Rare and severe: Crigler-Najjar syndrome</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l42 level1 lfo29;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Gilbert Syndrome:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l42 level2 lfo29;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Affects up to 5% of the general population.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l42 level2 lfo29;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Jaundice is more noticeable after fasting and
during stress.</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><b>Ref: Harrisons principles of INTERNAL MEDICINE 21<sup>th</sup>
edition pg2548<o:p></o:p></b></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>24[Q] Irritable bowel syndrome is favored by which of the
following?</p>

<p class=MsoNormal>1. Worsening of symptoms by stress</p>

<p class=MsoNormal>2. Recurrent abdominal discomfort</p>

<p class=MsoNormal>3. Age more than 50 years at onset</p>

<p class=MsoNormal>4. Alternating diarrhea and constipation</p>

<p class=MsoNormal>Select the correct answer using the code given below:</p>

<p class=MsoNormal>(a) 1, 2 and 3</p>

<p class=MsoNormal>(b) 1, 2 and 4</p>

<p class=MsoNormal>(c) 1, 3 and 4</p>

<p class=MsoNormal>(d) 2, 3 and 4</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[ANS] b</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[SOL] <strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Irritable Bowel Syndrome (IBS)
overview:</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l98 level1 lfo30;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Prevalence:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l98 level2 lfo30;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Estimated worldwide prevalence around 5%.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l98 level1 lfo30;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Characteristics:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l98 level2 lfo30;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Recurrent abdominal pain associated with
abnormal defecation.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l98 level2 lfo30;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Absence of structural abnormalities in the gut.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l98 level1 lfo30;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Impact:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l98 level2 lfo30;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Accounts for frequent absenteeism from work.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l98 level2 lfo30;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Impairs the quality of life.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l98 level1 lfo30;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Demographics:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l98 level2 lfo30;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Young women are affected more often than men.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Pathophysiology:</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l125 level1 lfo31;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Factors Involved:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l125 level2 lfo31;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Biopsychosocial factors, luminal factors (diet,
gut microbiota).</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l125 level1 lfo31;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Biopsychosocial Factors:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l125 level2 lfo31;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Early learning difficulties or emotionally
challenging interactions during childhood may contribute.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l125 level1 lfo31;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Psychological Aspects:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l125 level2 lfo31;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Most patients in general practice do not have
psychological problems.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l125 level2 lfo31;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>About 50% of patients referred to the hospital
may have psychiatric illnesses:</p>

<p class=MsoNormal style='margin-left:106.35pt;text-indent:-14.15pt;mso-list:
l125 level3 lfo31;tab-stops:list 106.35pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Anxiety</p>

<p class=MsoNormal style='margin-left:106.35pt;text-indent:-14.15pt;mso-list:
l125 level3 lfo31;tab-stops:list 106.35pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Depression</p>

<p class=MsoNormal style='margin-left:106.35pt;text-indent:-14.15pt;mso-list:
l125 level3 lfo31;tab-stops:list 106.35pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Somatization</p>

<p class=MsoNormal style='margin-left:106.35pt;text-indent:-14.15pt;mso-list:
l125 level3 lfo31;tab-stops:list 106.35pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Neurosis</p>

<p class=MsoNormal style='margin-left:106.35pt;text-indent:-14.15pt;mso-list:
l125 level3 lfo31;tab-stops:list 106.35pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Panic attacks</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Ref: Davidson principles and practice
of medicine 24<sup>th</sup> edition pg849</span></strong></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>25[Q] The diagnosis of protein loosing enteropathy can be
confirmed by:</p>

<p class=MsoNormal>(a) Hydrogen breath test</p>

<p class=MsoNormal>(b) Fecal clearance of alpha-1 trypsin </p>

<p class=MsoNormal>(c) Fecal 51Cr- labelled transthyretin level</p>

<p class=MsoNormal>(d) Fecal calprotectin level</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[ANS] b</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[SOL] <strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Protein-Losing Enteropathy:</span></strong></p>

<p class=MsoNormal>Protein-losing enteropathy is a term used to describe the
condition characterized by excessive loss of protein into the gut lumen,
leading to hypoproteinemia. </p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Clinical Presentation:</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l71 level1 lfo35;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Peripheral Edema:</span></strong>
Patients present with peripheral edema.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l71 level1 lfo35;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Hypoproteinaemia:</span></strong>
Reduced serum albumin and immunoglobulins.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l71 level1 lfo35;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Normal Liver Function:</span></strong>
Typically, liver function is normal.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l71 level1 lfo35;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Absent Proteinuria:</span></strong>
Lack of proteinuria in urinalysis.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Diagnosis:</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l133 level1 lfo36;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Confirmatory Tests:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l133 level2 lfo36;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Measurement of faecal clearance of &#945;1-antitrypsin.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l133 level2 lfo36;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>51Cr-labeled albumin after intravenous
injection.</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Causes of Protein-Losing Enteropathy:</span></strong></p>

<p class=MsoNormal><em><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>With Lymphatic Obstruction:</span></em></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l72 level1 lfo33;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Intestinal Lymphangiectasia</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l72 level1 lfo33;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Constrictive Pericarditis</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l72 level1 lfo33;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Lymphoma</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l72 level1 lfo33;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Whipple's Disease</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l72 level1 lfo33;tab-stops:list 35.45pt'><![if !supportLists]><strong><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol;font-weight:normal'><span style='mso-list:Ignore'><span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span></strong><![endif]><strong><span
style='font-family:"Liberation Serif","serif";mso-bidi-font-family:"Noto Naskh Arabic";
font-weight:normal'><o:p>&nbsp;</o:p></span></strong></p>

<p class=MsoNormal><em><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>With Mucosal Erosions or Ulceration:</span></em></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l43 level1 lfo32;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Crohn's Disease</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l43 level1 lfo32;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Ulcerative Colitis</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l43 level1 lfo32;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Radiation Damage</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l43 level1 lfo32;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Oesophageal, Gastric, or Colonic
Cancer</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l43 level1 lfo32;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Lymphoma</span></strong></p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic";font-weight:normal'><o:p>&nbsp;</o:p></span></strong></p>

<p class=MsoNormal><em><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Without Mucosal Erosions or
Ulceration:</span></em></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l48 level1 lfo34;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Mntriers Disease</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l48 level1 lfo34;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Bacterial Overgrowth</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l48 level1 lfo34;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Coeliac Disease</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l48 level1 lfo34;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Tropical Sprue</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l48 level1 lfo34;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Eosinophilic Gastroenteritis</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l48 level1 lfo34;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Systemic Lupus Erythematosus</span></strong></p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic";font-weight:normal'><o:p>&nbsp;</o:p></span></strong></p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Ref: Davidson principles and practice
of medicine 24<sup>th</sup> edition pg824</span></strong></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>26[Q] RBC casts on urine analysis are seen in which of the
following?</p>

<p class=MsoNormal>1. Glomerulonephritis</p>

<p class=MsoNormal>2. Intestitial nephritis</p>

<p class=MsoNormal>3. Vasculitis</p>

<p class=MsoNormal>4. Malignant hypertension</p>

<p class=MsoNormal>Select the correct answer using the code given below :</p>

<p class=MsoNormal>(a) 1, 2 and 3</p>

<p class=MsoNormal>(b) 1, 2 and 4</p>

<p class=MsoNormal>(c) 1,3 and 4</p>

<p class=MsoNormal>(d) 2 and 3 only</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[ANS] c</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[SOL] </p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>27[Q] Which of the following are correct regarding Essential
Tremors?</p>

<p class=MsoNormal>1. It may present at any age</p>

<p class=MsoNormal>2. Head is almost never involved</p>

<p class=MsoNormal>3. Tremor may improve with a small amount of alcohol</p>

<p class=MsoNormal>Select the correct answer using the code given below :</p>

<p class=MsoNormal>(a) 1 and 2 only</p>

<p class=MsoNormal>(b) 2 and 3 only</p>

<p class=MsoNormal>(c) 1 and 3 only</p>

<p class=MsoNormal>(d) 1, 2 and 3</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[ANS] c</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[SOL] </p>

<p class=MsoNormal>Essential tremor</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Prevalence:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l60 level2 lfo37;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Essential tremor has a prevalence of about 300
per 100,000 people.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Genetic Factors:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l60 level2 lfo37;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Essential tremor may display a dominant pattern
of inheritance, suggesting a genetic component. However, as of the information
available, specific genes responsible for essential tremor have not been
identified.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Clinical Presentation:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l60 level2 lfo37;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Essential tremor can present at any age and is
characterized by a bilateral arm tremor with a frequency of 810 Hz.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l60 level2 lfo37;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>The tremor is rarely present at rest but is
typical with movement.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l60 level2 lfo37;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>In some cases, the tremor may also affect the head
and voice.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Alcohol Responsiveness:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l60 level2 lfo37;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Approximately 50% of patients experience
improvement in tremors with the consumption of small amounts of alcohol.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Diagnostic Challenges:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l60 level2 lfo37;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>There are no specific tests for essential
tremor, and the diagnosis is often based on clinical features and the exclusion
of other potential causes of tremors.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l60 level2 lfo37;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>It's important to distinguish essential tremor
from other tremor syndromes, including dystonic tremor.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Treatment Options:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l60 level2 lfo37;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Betablockers and primidone are mentioned as
potential treatment options for essential tremor.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l60 level2 lfo37;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Deep Brain Stimulation (DBS) of the thalamus is
noted as an effective treatment for severe cases. This involves the surgical
implantation of electrodes to modulate abnormal brain activity causing the
tremors.</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Ref: Davidson principles and practice
of medicine 24<sup>th</sup> edition pg1169</span></strong></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>28[Q] Which of the following drugs may be associated with
Parkinsons disease?</p>

<p class=MsoNormal>1. Atypical anti-psychotic drugs</p>

<p class=MsoNormal>2. Lithium</p>

<p class=MsoNormal>3. MPTP (methyl-phenyl-tetrahydropyridine)</p>

<p class=MsoNormal>Select the correct answer using the code given below :</p>

<p class=MsoNormal>(a) 1 and 2 only</p>

<p class=MsoNormal>(b) 2 and 3 only</p>

<p class=MsoNormal>(c) 1 and 3 only</p>

<p class=MsoNormal>(d) 1, 2 and 3</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[ANS] d</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[SOL] <b>Causes of parkinsonism:</b></p>

<p class=MsoNormal style='margin-left:40.45pt;text-indent:-18.0pt;mso-list:
l58 level1 lfo38;tab-stops:list 40.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Idiopathic Parkinsons Disease:</span></strong></p>

<p class=MsoNormal>This is the most common cause, accounting for at least 80%
of cases. &quot;Idiopathic&quot; means that the cause is unknown.</p>

<ul style='margin-top:0cm' type=disc>
 <li class=MsoNormal style='mso-list:l156 level1 lfo39;tab-stops:list 36.0pt'><strong><span
     style='font-family:"Liberation Serif","serif";mso-bidi-font-family:"Noto Naskh Arabic"'>Cerebrovascular
     Disease</span></strong></li>
</ul>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<ul style='margin-top:0cm' type=disc>
 <li class=MsoNormal style='mso-list:l156 level1 lfo39;tab-stops:list 36.0pt'><strong><span
     style='font-family:"Liberation Serif","serif";mso-bidi-font-family:"Noto Naskh Arabic"'>Drugs
     and Toxins:</span></strong></li>
</ul>

<p class=MsoNormal>Antipsychotic drugs (both older and 'atypical')</p>

<p class=MsoNormal>Metoclopramide</p>

<p class=MsoNormal>Prochlorperazine</p>

<p class=MsoNormal>Tetrabenazine</p>

<p class=MsoNormal>Sodium valproate</p>

<p class=MsoNormal>Lithium, manganese </p>

<p class=MsoNormal>MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine).</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<ul style='margin-top:0cm' type=disc>
 <li class=MsoNormal style='mso-list:l94 level1 lfo40;tab-stops:list 36.0pt'><strong><span
     style='font-family:"Liberation Serif","serif";mso-bidi-font-family:"Noto Naskh Arabic"'>Other
     Degenerative Diseases:</span></strong></li>
</ul>

<p class=MsoNormal>Dementia with Lewy bodies</p>

<p class=MsoNormal>Progressive supranuclear palsy</p>

<p class=MsoNormal>Multiple system atrophy</p>

<p class=MsoNormal>Corticobasal degeneration</p>

<p class=MsoNormal>Alzheimers disease.</p>

<ul style='margin-top:0cm' type=disc>
 <li class=MsoNormal style='mso-list:l138 level1 lfo41;tab-stops:list 36.0pt'><strong><span
     style='font-family:"Liberation Serif","serif";mso-bidi-font-family:"Noto Naskh Arabic"'>Genetic
     Causes:</span></strong></li>
</ul>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'><span style='mso-spacerun:yes'>
</span></span></strong>Huntingtons disease</p>

<p class=MsoNormal><span style='mso-spacerun:yes'> </span>Fragile X tremor
ataxia syndrome</p>

<p class=MsoNormal><span style='mso-spacerun:yes'> </span>Dopa-responsive
dystonia,</p>

<p class=MsoNormal><span style='mso-spacerun:yes'> </span>Spinocerebellar
ataxias (particularly SCA 3)</p>

<p class=MsoNormal><span style='mso-spacerun:yes'> </span>Wilsons
disease.</p>

<ul style='margin-top:0cm' type=disc>
 <li class=MsoNormal style='mso-list:l146 level1 lfo42;tab-stops:list 36.0pt'><strong><span
     style='font-family:"Liberation Serif","serif";mso-bidi-font-family:"Noto Naskh Arabic"'>Anoxic
     Brain Injury</span></strong></li>
</ul>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Ref: Davidson principles and practice
of medicine 24<sup>th</sup> edition pg1165</span></strong></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>29[Q] Which of the following are suggestive of Parkinsons
disease ?</p>

<p class=MsoNormal>1. Lead pipe rigidity</p>

<p class=MsoNormal>2. Cog wheel rigidity</p>

<p class=MsoNormal>3. Festinating gait</p>

<p class=MsoNormal>4. Romberg test positive</p>

<p class=MsoNormal>Select the correct answer using the code given below:</p>

<p class=MsoNormal>(a) 1, 2 and 3 </p>

<p class=MsoNormal>(b) 1 and 2 only </p>

<p class=MsoNormal>(c) 1 and 3 only</p>

<p class=MsoNormal>(d) 2,3 and 4</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[ANS] a</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[SOL] <b>Physical signs in Parkinsons disease</b></p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>General:</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l62 level1 lfo43;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Expressionless face (hypomimia)</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l62 level1 lfo43;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Soft, rapid, indistinct speech (dysphonia)</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l62 level1 lfo43;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Flexed (stooped) posture</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l62 level1 lfo43;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Impaired postural reflexes</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Gait:</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l74 level1 lfo44;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Slow to start walking (failure of gait ignition)</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l74 level1 lfo44;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Rapid, short stride length, tendency to shorten
(festination)</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l74 level1 lfo44;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Reduction of arm swing</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l74 level1 lfo44;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Impaired balance on turning</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Tremor:</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l54 level1 lfo45;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Resting (34 Hz, moderate amplitude): most
common</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l54 level1 lfo45;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Asymmetric, usually first in arm/hand ('pill
rolling')</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l54 level1 lfo45;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>May affect legs, jaw, and chin but not head</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l54 level1 lfo45;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Intermittent, present at rest, often briefly
abolished by movement of limb, exacerbated by walking</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Postural Tremor (68 Hz, moderate
amplitude):</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l115 level1 lfo46;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Present immediately on stretching out arms</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Re-emergent Tremor (34 Hz, moderate
amplitude):</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l33 level1 lfo47;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Initially no tremor on stretching arms out, rest
tremor re-emerges after a few seconds</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Rigidity:</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l126 level1 lfo48;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Cogwheel type, mostly upper limbs (due to tremor
superimposed on rigidity)</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l126 level1 lfo48;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Lead pipe type</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Akinesia (fundamental feature):</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l140 level1 lfo49;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Slowness of movement</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l140 level1 lfo49;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Fatiguing and decrease in size of repetitive
movements</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Normal Findings (if abnormal,
consider other causes):</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l39 level1 lfo50;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Power, deep tendon reflexes, plantar responses</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l39 level1 lfo50;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Eye movements</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l39 level1 lfo50;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Sensory and cerebellar examination</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Ref: Davidson principles and practice
of medicine 24<sup>th</sup> edition pg1166</span></strong></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>30[Q] Which of the following are correct regarding
Idiopathic Parkinsons disease ? </p>

<p class=MsoNormal>1. Motor symptoms are always initially symmetrical </p>

<p class=MsoNormal>2. Non-motor symptoms include hyposmia and constipation </p>

<p class=MsoNormal>3. Cognition is spared in early disease </p>

<p class=MsoNormal>4. Speech may become softer and indistinct</p>

<p class=MsoNormal>Select the correct answer using the code given below:</p>

<p class=MsoNormal>(a) 2 and 3 only</p>

<p class=MsoNormal>(b) 1 and 4 only </p>

<p class=MsoNormal>(c) 1, 3 and 4</p>

<p class=MsoNormal>(d) 2,3 and 4</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[ANS] d</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[SOL] Clinical features of<span style='mso-spacerun:yes'>
</span>Idiopathic Parkinsons disease</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Motor Symptoms:</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l21 level1 lfo51;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Non-motor symptoms, such as hyposmia (reduction
in sense of smell), anxiety/depression, constipation, and REM sleep behavioral
disturbance (RBD), may precede typical motor features by many years.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l21 level1 lfo51;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Patients rarely present at this early stage, and
motor symptoms are almost always initially asymmetrical.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l21 level1 lfo51;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Bradykinesia is the hallmark, leading to classic
symptoms like micrographia (small handwriting), difficulty with tasks like
tying shoelaces or buttoning clothes, and challenges in rolling over in bed.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l21 level1 lfo51;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Tremor is an early feature but may not be
present in at least 20% of people with PD. It is typically a unilateral rest
tremor affecting limbs, jaw, and chin but not the head.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l21 level1 lfo51;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Rigidity causes stiffness and a flexed posture.
Falls tend not to occur until later in the disease.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l21 level1 lfo51;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>As PD advances, speech becomes softer and
indistinct.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l21 level1 lfo51;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Neurological examination reveals various
abnormalities. Although features start as unilateral, gradual bilateral
involvement occurs over time.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Cognitive Function:</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l49 level1 lfo52;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Cognition is usually spared in early PD.
Impairment in cognition, if present, may suggest alternative diagnoses, such as
dementia with Lewy bodies.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Non-Motor Symptoms:</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l101 level1 lfo53;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Non-motor symptoms may precede typical symptoms
and become increasingly common and disabling as PD progresses.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l101 level1 lfo53;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Cognitive impairment, including dementia, is a
significant symptom, affecting quality of life. Estimates of dementia frequency
range from 30% to 80%.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l101 level1 lfo53;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Other non-motor symptoms include
neuropsychiatric features (anxiety, depression, apathy,
hallucinosis/psychosis), sleep disturbance and hypersomnolence, fatigue, pain,
sphincter disturbance and constipation, sexual problems (erectile failure, loss
of libido or hypersexuality), drooling, and weight loss.</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Ref: Davidson principles and practice
of medicine 24<sup>th</sup> edition pg1166</span></strong></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>31[Q] Which of the following are correct with regard to Levodopa?</p>

<p class=MsoNormal>1. It is most effective for relieving tremors </p>

<p class=MsoNormal>2. Only a small portion of total drug reaches the brain </p>

<p class=MsoNormal>3. Nausea may be offset by domperidone </p>

<p class=MsoNormal>4. It may trigger hallucinations</p>

<p class=MsoNormal>Select the correct answer using the code given below:</p>

<p class=MsoNormal>(a) 1,2 and 3 </p>

<p class=MsoNormal>(b) 1 and 4 only </p>

<p class=MsoNormal>(c) 1, 3 and 4</p>

<p class=MsoNormal>(d) 2,3 and 4</p>

<p class=MsoNormal>[ANS] d</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[SOL] PARKINSON DRUG : LEVADOPA</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Peripheral Decarboxylation:</span></strong>
When administered orally, over 90% of levodopa is decarboxylated to dopamine in
the peripheral tissues (gastrointestinal tract and blood vessels), leading to
adverse effects. The small proportion that reaches the brain is responsible for
therapeutic effects.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Dopa Decarboxylase Inhibitors (DDIs):</span></strong>
To enhance levodopa's effectiveness and reduce peripheral side effects, it is
often combined with dopa decarboxylase inhibitors such as carbidopa and
benserazide. These inhibitors do not cross the bloodbrain barrier, preventing
unwanted decarboxylation in the brain.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Effectiveness:</span></strong>
Levodopa is most effective for relieving akinesia (lack of voluntary muscle
movement) and rigidity in PD. Its effectiveness on tremors may be less
satisfactory, and it may not address all motor and non-motor symptoms.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Controlled-Release Versions:</span></strong>
Controlled-release versions of levodopa exist but are typically reserved for
overnight use due to their variable bioavailability, making them challenging
for daytime use.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Adverse Effects:</span></strong>
Adverse effects of levodopa include postural hypotension, nausea, vomiting, and
the potential for hallucinations. Domperidone may be prescribed to offset
nausea and vomiting, but its use is limited due to the risk of prolonged QTc
interval and arrhythmia.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Progression of PD:</span></strong> As
PD progresses, the response to levodopa may become less predictable, leading to
motor fluctuations. End-of-dose deterioration is attributed to the progressive
loss of dopamine storage capacity in the brain.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Motor Complications:</span></strong>
Motor complications associated with levodopa use include dyskinesia
(involuntary movements), wearing-off effects, and more complex fluctuations
involving alternating periods of parkinsonism and improved mobility with
dyskinesias.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Management of Motor Complications:</span></strong>
Managing motor complications can be challenging. Approaches may include
adjusting the dose or frequency of levodopa, adding a COMT inhibitor,
incorporating dopamine agonists, continuous infusion of apomorphine,
intraintestinal levodopa via a percutaneous endoscopic jejunostomy, or deep
brain stimulator implantation.</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Ref: Davidson principles and practice
of medicine 24<sup>th</sup> edition pg1167</span></strong></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>32[Q] Which of the following factors are risk factors for
Stroke?</p>

<p class=MsoNormal>1. Sickle cell disease</p>

<p class=MsoNormal>2. Cigarette smoking</p>

<p class=MsoNormal>3. Hypofibrinogenaemia</p>

<p class=MsoNormal>4. Atrial fibrillation</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>Select the correct answer using the code given below :</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>(a) 1 and 2 only</p>

<p class=MsoNormal>(b) 1, 2 and 4</p>

<p class=MsoNormal>(c) 1, 3 and 4</p>

<p class=MsoNormal>(d) 2 and 4 only</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[ANS] b</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[SOL]<strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Fixed Risk Factors:</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l38 level1 lfo54;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Age</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l38 level1 lfo54;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Sex (Male &gt; Female)</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l38 level1 lfo54;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Previous Vascular Event (Myocardial infarction,
Stroke, Peripheral vascular disease)</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l38 level1 lfo54;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Genetic Mutations (e.g., CADASIL - Cerebral
Autosomal Dominant Arteriopathy with Subcortical Infarcts and
Leukoencephalopathy)</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l38 level1 lfo54;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Sickle Cell Disease</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Modifiable Risk Factors:</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l63 level1 lfo55;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Blood Pressure</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l63 level1 lfo55;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Cigarette Smoking</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l63 level1 lfo55;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>High LDL Cholesterol</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l63 level1 lfo55;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Diabetes Mellitus</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l63 level1 lfo55;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Atrial Fibrillation</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l63 level1 lfo55;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Chronic Kidney Disease</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l63 level1 lfo55;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Excessive Alcohol Intake</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l63 level1 lfo55;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Oestrogen-Containing Drugs (Oral contraceptive
pill, Hormone replacement therapy)</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l63 level1 lfo55;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Polycythaemia</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l63 level1 lfo55;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Drugs (e.g., Cocaine)</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l63 level1 lfo55;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Heart Disease (Congestive Cardiac Failure, Infective
Endocarditis)</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Ref: Davidson principles and practice
of medicine 24<sup>th</sup> edition pg1207</span></strong></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>33[Q] Which of the following are correct in respect of
Myasthenia gravis ?</p>

<p class=MsoNormal>1. Symptoms worsen towards end of the day</p>

<p class=MsoNormal>2. There may be difficulty in chewing and swallowing</p>

<p class=MsoNormal>3. Acetylcholine receptors in the pre-junctional membrane
are involved</p>

<p class=MsoNormal>4. Penicillamine may precipitate similar illness</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>Select the correct answer using the code given below : </p>

<p class=MsoNormal>(a) 1, 2 and 3 </p>

<p class=MsoNormal>(b) 1, 2 and 4 </p>

<p class=MsoNormal>(c) 1 and 3 only</p>

<p class=MsoNormal>(d) 2 and 4 only </p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[ANS] b</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[SOL] </p>

<p class=MsoNormal>Myasthenia Gravis:</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>Pathophysiology:</p>

<p class=MsoNormal>- Autoimmune disease.</p>

<p class=MsoNormal>- Caused by antibodies (most commonly to acetylcholine
receptors) in the post-junctional membrane of the neuromuscular junction.</p>

<p class=MsoNormal>- Results in blockage of neuromuscular transmission,
complement-mediated inflammatory response, and damage to the end plate.</p>

<p class=MsoNormal>- About 80% of cases involve acetylcholine receptor
antibodies, while 15% (mainly late-onset cases) may have a thymoma.</p>

<p class=MsoNormal>- Other antibodies, like those to muscle-specific kinase
(MuSK), can produce a similar clinical picture.</p>

<p class=MsoNormal>- Triggers may include certain drugs (e.g., penicillamine),
while others (aminoglycosides, quinolones) can exacerbate neuromuscular
blockade.</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>Clinical Features:</p>

<p class=MsoNormal>- Typically presents between ages 15 and 50 years.</p>

<p class=MsoNormal>- Female preponderance in younger patients; males more
commonly affected in older patients.</p>

<p class=MsoNormal>- Relapsing and remitting course.</p>

<p class=MsoNormal>- Fatigable muscle weakness, worsens with muscle use.</p>

<p class=MsoNormal>- Symptoms often affect ocular, facial, and bulbar muscles.</p>

<p class=MsoNormal>- Initial symptoms may include intermittent ptosis or
diplopia.</p>

<p class=MsoNormal>- Weakness of chewing, swallowing, speaking, or limb
movement may also occur.</p>

<p class=MsoNormal>- Weakness worsens towards the end of the day or following
exercise.</p>

<p class=MsoNormal>- No sensory signs or signs of central nervous system
involvement.</p>

<p class=MsoNormal>- Respiratory muscles may be affected, leading to
respiratory failure.</p>

<p class=MsoNormal>- Subtypes include ocular myasthenia and generalized
myasthenia.</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>Investigations:</p>

<p class=MsoNormal>- Serological testing for acetylcholine receptor antibodies.</p>

<p class=MsoNormal>- If seronegative, further testing for MuSK antibodies.</p>

<p class=MsoNormal>- Neurophysiological assessment, including repetitive
stimulation during nerve conduction studies.</p>

<p class=MsoNormal>- Thoracic CT or MRI to exclude thymoma.</p>

<p class=MsoNormal>- Screening for associated autoimmune disorders, especially
thyroid disease.</p>

<p class=MsoNormal>- The Tensilon test (intravenous injection of edrophonium
bromide) in cases of diagnostic doubt.</p>

<p class=MsoNormal>- Structural imaging (e.g., MRI of brainstem) to exclude
alternative diagnoses.</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>Management:</p>

<p class=MsoNormal>- Goals: Maximize acetylcholine activity, limit
immunological attack on motor end plates.</p>

<p class=MsoNormal>- Anticholinesterase drug: Pyridostigmine.</p>

<p class=MsoNormal>- Muscarinic side-effects controlled by propantheline.</p>

<p class=MsoNormal>- Myasthenic crisis (bulbar and respiratory failure)
requires prompt acute immunotherapy (intravenous immunoglobulin, plasma
exchange), along with long-term immunosuppressive therapy.</p>

<p class=MsoNormal>- Supportive respiratory care and involvement of intensive
care teams during crisis.</p>

<p class=MsoNormal>- Thymoma management involves joint oncology and thoracic
surgery input.</p>

<p class=MsoNormal>- Prognosis varies; remissions may occur spontaneously.</p>

<p class=MsoNormal>- Thymectomy may benefit younger seropositive patients with
generalized disease.</p>

<p class=MsoNormal>- Rapid progression more than 5 years after onset is
uncommon.</p>

<p class=MsoNormal>- Some medications, like aminoglycoside antibiotics, can
worsen myasthenia gravis.</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Ref: Davidson principles and practice
of medicine 24<sup>th</sup> edition pg1195</span></strong></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>34[Q] Which of the following are the tests for functional
assessment of encephalopathy?</p>

<p class=MsoNormal>1. Flapping tremors</p>

<p class=MsoNormal>2. Number connection test </p>

<p class=MsoNormal>3. Constructional apraxia</p>

<p class=MsoNormal>Select the correct answer using the code given below:</p>

<p class=MsoNormal>(a) 1 and 2 only</p>

<p class=MsoNormal>(b) 2 and 3 only</p>

<p class=MsoNormal>(c) 1 and 3 only</p>

<p class=MsoNormal>(d) 1, 2 and 3</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[ANS] d</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[SOL] </p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>35[Q] Which one of the following is correct regarding blood
components in clinical practice?</p>

<p class=MsoNormal>(a) ABO blood group antigens are polypeptide chains on the
surface of RBCs</p>

<p class=MsoNormal>(b) Platelets can be stored for up to 35 days</p>

<p class=MsoNormal>(c) Hemolytic disease of the newborn occurs when the
mothers IgA anti-RhD antibodies cross the placenta and lyse fetal RBCs</p>

<p class=MsoNormal>(d) Transfusion-associated GVHD can be prevented by prior
irradiation of transfused blood</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[ANS] d</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[SOL] </p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>ABO Blood Groups:</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l41 level1 lfo56;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Antigens: Oligosaccharide chains projecting from
the red cell surface.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l41 level1 lfo56;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>ABO gene encodes glycosyltransferase, with three
common alleles: A, B, and O.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l41 level1 lfo56;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>O allele results in an inactive enzyme, leaving
the H antigen unmodified.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l41 level1 lfo56;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>A and B alleles encode enzymes attaching
different sugars to the chain.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l41 level1 lfo56;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Individuals tolerant to their own ABO antigens
but can mount an immune response to foreign ABO antigens.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>ABO-Incompatible Red Cell
Transfusion:</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l9 level1 lfo57;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Incompatible transfusion can lead to IgM anti-A,
anti-B, or anti-AB binding to transfused red cells.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l9 level1 lfo57;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Activates complement pathway, causing
intravascular hemolysis.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l9 level1 lfo57;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Anaphylatoxins and inflammatory mediators
released, leading to inflammation, increased vascular permeability,
hypotension, and potential complications.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l9 level1 lfo57;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>About 20%-30% cause some morbidity; 5%-10%
contribute to patient death.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Rhesus D Blood Group and Hemolytic
Disease of the Newborn (HDN):</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l34 level1 lfo58;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>About 15% of European populations are
RhD-negative.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l34 level1 lfo58;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>RhD-negative individuals don't produce substantial
anti-RhD antibodies.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l34 level1 lfo58;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>RhD-negative pregnant women exposed to
RhD-positive fetal cells may produce antibodies causing HDN in subsequent
pregnancies.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l34 level1 lfo58;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Anti-RhD immunoglobulin (anti-D) can prevent RhD
sensitization in RhD-negative pregnant women.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Other Immunological Complications of
Transfusion:</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l77 level1 lfo59;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Transfusion-Associated Lung Injury (TRALI) and
Transfusion-Associated Graft-Versus-Host Disease (TA GVHD) are rare but serious
complications.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l77 level1 lfo59;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>TA GVHD occurs when there's sharing of an HLA
haplotype between donor and recipient, leading to acute GVHD.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l77 level1 lfo59;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Prevention involves gamma or X-ray irradiation
of blood components to prevent lymphocyte proliferation.</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Ref: Davidson principles and practice
of medicine 24<sup>th</sup> edition pg941</span></strong></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>36[Q] Which one of the following is an oral direct Thrombin
inhibitor ?</p>

<p class=MsoNormal>Select the correct answer using the</p>

<p class=MsoNormal>(a) Apixaban </p>

<p class=MsoNormal>(b) Rivaroxaban </p>

<p class=MsoNormal>(c) Dabigatran </p>

<p class=MsoNormal>(d) Argatroban</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[ANS] c</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[SOL] </p>

<p class=MsoNormal>Dabigatran is an oral direct thrombin inhibitor. </p>

<p class=MsoNormal>Apixaban and Rivaroxaban are oral factor Xa inhibitors</p>

<p class=MsoNormal>Argatroban is an intravenous direct thrombin inhibitor.</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>37[Q] Which of the following are correct with regard to
metformin?</p>

<p class=MsoNormal>1. The maximum tolerated dose is 2000 mg/day</p>

<p class=MsoNormal>2. Lactic acidosis is the adverse effect of metformin</p>

<p class=MsoNormal>3. It may lower the blood levels of Vitamin B12 level</p>

<p class=MsoNormal>Select the correct answer using the code given below:</p>

<p class=MsoNormal>(a) 1 and 2 only</p>

<p class=MsoNormal>(b) 2 and 3 only</p>

<p class=MsoNormal>(c) 1 and 3 only</p>

<p class=MsoNormal>(d) 1, 2 and 3</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[ANS] d</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[SOL] </p>

<p class=MsoNormal>Biguanides, Metformin:</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l162 level1 lfo60;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Mechanism of Action:</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l162 level2 lfo60;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Reduces hepatic glucose production.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l162 level2 lfo60;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Improves peripheral glucose utilization.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l162 level2 lfo60;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Activates AMP-dependent protein kinase.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l162 level2 lfo60;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Enters cells through organic cation
transporters.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l162 level1 lfo60;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Hepatic Glucose Production:</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l162 level2 lfo60;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Antagonizes glucagon's ability to generate cAMP
in hepatocytes.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l162 level2 lfo60;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Reduces fasting plasma glucose (FPG) and insulin
levels.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l162 level1 lfo60;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Benefits:</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l162 level2 lfo60;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Improves lipid profile.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l162 level2 lfo60;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Promotes modest weight loss.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l162 level2 lfo60;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Associated with reduced microvascular and
possibly macrovascular complications with long-term use.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l162 level1 lfo60;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Formulation:</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l162 level2 lfo60;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Extended-release form available with potentially
fewer gastrointestinal side effects.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l162 level1 lfo60;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Dosage and Administration:</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l162 level2 lfo60;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Initial dose should be low, escalated every 12
weeks based on self-monitoring of blood glucose (SMBG) measurements.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l162 level2 lfo60;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Maximal tolerated dose: 2000 mg daily.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l162 level1 lfo60;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Combination Therapy:</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l162 level2 lfo60;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Effective as monotherapy.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l162 level2 lfo60;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Can be used in combination with other oral
agents or insulin.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l162 level1 lfo60;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Toxicity:</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l162 level2 lfo60;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Major toxicity: Lactic acidosis (very rare).</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l162 level2 lfo60;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Vitamin B12 levels may be lower during metformin
treatment and should be monitored.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l162 level1 lfo60;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Contraindications:</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l162 level2 lfo60;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Moderate renal insufficiency (glomerular filtration
rate [GFR] &lt;45 mL/min).</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l162 level2 lfo60;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Acidosis.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l162 level2 lfo60;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Unstable congestive heart failure (CHF).</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l162 level2 lfo60;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Liver disease.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l162 level2 lfo60;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Severe hypoxemia.</p>

<p class=MsoNormal><b>Ref: Harrisons principles of INTERNAL MEDICINE 21<sup>th</sup>
edition pg3110<o:p></o:p></b></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>38[Q] Which of the following statements are correct
regarding short stature?</p>

<p class=MsoNormal>1. Linear bone growth pituitary dependent</p>

<p class=MsoNormal>2. Normal bone age in a child with short stature suggests
hormonal disorder</p>

<p class=MsoNormal>3. Final height in boys can be estimated by adding 6.5cm to
mid-parental height</p>

<p class=MsoNormal>4. Replacement therapy with recombinant GH restores growth
velocity in GH-deficient children </p>

<p class=MsoNormal>Select the correct answer using the code given below:</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>(a) 1 and 2 only</p>

<p class=MsoNormal>(b) 1, 2 and 4 </p>

<p class=MsoNormal>(c) 1, 3 and 4</p>

<p class=MsoNormal>(d) 3 and 4 only </p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[ANS] c</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[SOL]</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>DISORDERS OF GROWTH AND DEVELOPMENT:
Skeletal Maturation and Somatic Growth</span></strong></p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Growth Plate Stimuli:</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l121 level1 lfo61;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Dependent on hormonal stimuli: GH, IGF-I, sex
steroids, thyroid hormones, paracrine growth factors, and cytokines.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l121 level1 lfo61;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Requires caloric energy, amino acids, vitamins,
and trace metals.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Effect of Malnutrition:</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l24 level1 lfo62;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Impairs chondrocyte activity.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l24 level1 lfo62;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Increases GH resistance.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l24 level1 lfo62;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Reduces circulating IGF-I and IGF binding
protein (IGBP)-3 levels.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Linear Bone Growth:</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l143 level1 lfo63;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Very high in infancy (pituitary-dependent).</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l143 level1 lfo63;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Mean growth velocity ~6 cm/year in later
childhood.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l143 level1 lfo63;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Peak growth rates during midpuberty (bone age 12
in girls, 13 in boys).</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l143 level1 lfo63;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Secondary sexual development causes progressive
epiphyseal growth plate closure.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l143 level1 lfo63;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Delayed bone age in true GH deficiency or GH
receptor defects.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Short Stature:</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l151 level1 lfo64;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Constitutive intrinsic growth defects or
acquired extrinsic factors.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l151 level1 lfo64;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Delayed bone age in short stature suggests
hormonal or systemic disorder.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l151 level1 lfo64;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Normal bone age in a short child more likely due
to genetic cartilage dysplasia or growth plate disorder.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>GH Deficiency in Children:</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l113 level1 lfo65;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Characterized by short stature, micropenis,
increased fat, high-pitched voice, and propensity to hypoglycemia.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l113 level1 lfo65;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Familial modes of inheritance (autosomal
dominant, recessive, or X-linked).</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l113 level1 lfo65;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>About 10% have mutations in the GH-N gene.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l113 level1 lfo65;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Idiopathic GH deficiency (IGHD) diagnosis after
known molecular defects excluded.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>GHRH Receptor Mutations:</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l31 level1 lfo66;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Recessive mutations in severe proportionate
dwarfism.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l31 level1 lfo66;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Associated with low basal GH levels not
stimulated by exogenous GHRH, GHRP, or insulin-induced hypoglycemia.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l31 level1 lfo66;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Importance of GHRH receptor for somatotrope cell
proliferation and hormonal responsiveness.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>GH Insensitivity:</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l137 level1 lfo67;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Caused by defects of GH receptor structure or
signaling.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l137 level1 lfo67;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Homozygous or heterozygous mutations associated
with partial or complete GH insensitivity and growth failure (Laron syndrome).</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l137 level1 lfo67;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Diagnosis based on normal or high GH levels,
decreased GH-binding protein (GHBP), and low IGF-I levels.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l137 level1 lfo67;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Rarely, defective IGF-I, IGF-I receptor, or
IGF-I signaling defects encountered.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l137 level1 lfo67;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>STAT5B mutations result in immunodeficiency and
abrogated GH signaling.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Nutritional Short Stature:</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l55 level1 lfo68;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Caloric deprivation, malnutrition, uncontrolled
diabetes, and chronic renal failure.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l55 level1 lfo68;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Conditions stimulate proinflammatory cytokines,
exacerbating GH-mediated signal transduction block.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l55 level1 lfo68;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Features: acquired short stature, normal or
elevated GH, low IGF-I levels.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Psychosocial Short Stature:</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l13 level1 lfo69;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Emotional and social deprivation leads to growth
retardation.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l13 level1 lfo69;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Features: delayed speech, discordant
hyperphagia, attenuated response to administered GH.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l13 level1 lfo69;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Nurturing environment restores growth rates.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Presentation and Diagnosis:</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l109 level1 lfo70;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Short stature evaluated comprehensively if
height &gt;3 SD below the mean for age or if growth rate decelerated.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l109 level1 lfo70;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Skeletal maturation assessed by measuring
radiologic bone age, based on wrist bone growth plate fusion.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l109 level1 lfo70;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Final height prediction using standardized
scales (Bayley-Pinneau or Tanner-Whitehouse) or estimated by adding 6.5 cm
(boys) or subtracting 6.5 cm (girls) from midparental height.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Laboratory Investigation:</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l141 level1 lfo71;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>GH deficiency assessed by examining response to
provocative stimuli (exercise, insulin-induced hypoglycemia, pharmacologic
tests).</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l141 level1 lfo71;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Random GH measurements not distinguish normal
children from those with true GH deficiency.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l141 level1 lfo71;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Adequate adrenal and thyroid hormone replacement
assured before testing.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l141 level1 lfo71;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Age- and sex-matched IGF-I levels not sufficiently
sensitive or specific; useful to confirm GH deficiency.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l141 level1 lfo71;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Pituitary MRI may reveal pituitary mass lesions
or structural defects.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l141 level1 lfo71;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Molecular analyses for known mutations
undertaken when the cause of short stature remains cryptic or when additional clinical
features suggest a genetic cause.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Treatment:</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l61 level1 lfo72;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Replacement therapy with recombinant GH
(0.020.05 mg/kg per day SC) restores growth velocity in GH-deficient children
to ~10 cm/year.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l61 level1 lfo72;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>If pituitary insufficiency documented, correct
other associated hormone deficits, especially adrenal steroids.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l61 level1 lfo72;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>GH treatment moderately effective for
accelerating growth rates in children with Turner syndrome and chronic renal
failure.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l61 level1 lfo72;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>In patients with GH insensitivity and growth
retardation due to mutations of the GH receptor, treatment with IGF-I bypasses
the dysfunction</p>

<p class=MsoNormal><b>Ref: Harrisons principles of INTERNAL MEDICINE 21<sup>th</sup>
edition pg2899<o:p></o:p></b></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>39[Q] Which one of the following drugs used to treat
Diabetes mellitus is least likely to cause hypoglycemia?</p>

<p class=MsoNormal>(a) Insulin</p>

<p class=MsoNormal>(b) Glimepiride</p>

<p class=MsoNormal>(c) Sitagliptin</p>

<p class=MsoNormal>(d) Repaglinide </p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[ANS] c</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[SOL] </p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>40[Q] Which of the following is a differential diagnosis of
Hypocalcemia?</p>

<p class=MsoNormal>1. Hypomagnesaemia</p>

<p class=MsoNormal>2. Chronic alcoholism</p>

<p class=MsoNormal>3. Pseudohypoparathyroidism</p>

<p class=MsoNormal>4. Pagets disease</p>

<p class=MsoNormal>Select the correct answer using the code given below:</p>

<p class=MsoNormal>(a) 1, 2 and 3</p>

<p class=MsoNormal>(b) 1 and 2 only</p>

<p class=MsoNormal>(c) 3 and 4 only </p>

<p class=MsoNormal>(d) 2, 3 and 4 </p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[ANS] a</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[SOL] </p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>41[Q] Which of the following are for the treatment of
Hirsutism?</p>

<p class=MsoNormal>1. Amiloride</p>

<p class=MsoNormal>2. Oestrogen </p>

<p class=MsoNormal>3. Finasteride </p>

<p class=MsoNormal>4. Spironolactone</p>

<p class=MsoNormal>Select the correct answer using the code given below:</p>

<p class=MsoNormal>(a) 1, 2 and 3</p>

<p class=MsoNormal>(b) 1, 2 and 4 </p>

<p class=MsoNormal>(c) 3 and 4 only </p>

<p class=MsoNormal>(d) 2, 3 and 4 </p>

<p class=MsoNormal>[ANS] d</p>

<p class=MsoNormal>[SOL] </p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>42[Q] Which of the following is long-acting insulin?</p>

<p class=MsoNormal>(a) Aspart </p>

<p class=MsoNormal>(b) Glargine </p>

<p class=MsoNormal>(c) Lispro </p>

<p class=MsoNormal>(d) Regular</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[ANS] b</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[SOL] </p>

<ul style='margin-top:0cm' type=disc>
 <li class=MsoNormal style='mso-list:l103 level1 lfo73;tab-stops:list 36.0pt'>Rapid-acting
     insulin analogues: lispro, aspart, glulisine, fiasp</li>
 <li class=MsoNormal style='mso-list:l103 level1 lfo73;tab-stops:list 36.0pt'>Short-acting:
     soluble (regular)</li>
 <li class=MsoNormal style='mso-list:l103 level1 lfo73;tab-stops:list 36.0pt'>Intermediate
     acting: isophane (NPH), lente</li>
 <li class=MsoNormal style='mso-list:l103 level1 lfo73;tab-stops:list 36.0pt'>Long-acting
     insulin analogues: glargine, detemir, degludec</li>
</ul>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Ref: Davidson principles and practice
of medicine 24<sup>th</sup> edition pg739</span></strong></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>43[Q] A 15 year girl presents to the hospital with severe
abdominal pain, vomiting and cold extremities. She has tachycardia and
hypotension. Lab investigations show blood glucose 400 mg/dL, blood pH 6.9,
urine ketones +++ and serum creatinine of 1-4 mg/dL. She is promptly administered
IV fluids and insulin. After 4 hours, she complains of inability to lift her
limbs. What is the next step to be considered in her management?</p>

<p class=MsoNormal>(a) Intravenous normal saline </p>

<p class=MsoNormal>(b) Intravenous sodium bicarbonate </p>

<p class=MsoNormal>(c) Urine sample for ketones </p>

<p class=MsoNormal>(d) Potassium repletion </p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[ANS] d</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[SOL] The patient is likely experiencing diabetic
ketoacidosis (DKA). The symptoms of inability to lift her limbs are suggestive
of hypokalemia, which can occur in DKA .</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>MANAGEMENT OF DKA</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Confirm Diagnosis:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l20 level2 lfo74;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Elevated plasma glucose</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l20 level2 lfo74;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Positive serum ketones</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l20 level2 lfo74;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Metabolic acidosis</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Admit to Hospital:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l20 level2 lfo74;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Consider intensive care setting if pH &lt;7.00
or unconscious.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Assessment:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l20 level2 lfo74;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Serum electrolytes (K+, Na+, Mg2+, Cl,
bicarbonate, phosphate)</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l20 level2 lfo74;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Acid-base statuspH, HCO3, PCO2,
&#946;-hydroxybutyrate</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l20 level2 lfo74;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Renal function (creatinine, urine output)</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Fluid Replacement:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l20 level2 lfo74;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>23 L of 0.9% saline over the first 13 hours</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l20 level2 lfo74;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Subsequently, adjust fluid composition based on
plasma glucose levels.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l20 level2 lfo74;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Change to 5% glucose and 0.45% saline at 150250
mL/h when plasma glucose reaches 250 mg/dL (13.9 mmol/L).</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Administer Short-Acting Regular
Insulin:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l20 level2 lfo74;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>IV (0.1 units/kg)</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l20 level2 lfo74;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Then 0.1 units/kg per hour by continuous IV
infusion</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l20 level2 lfo74;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Increase two- to threefold if no response by 24
hours.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l20 level2 lfo74;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>If the initial serum potassium is &lt;3.3 mmol/L
(3.3 meq/L), do not administer insulin until the potassium is corrected.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Assess Patient:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l20 level2 lfo74;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Identify precipitating factors (noncompliance,
infection, trauma, pregnancy, infarction, cocaine).</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l20 level2 lfo74;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Initiate appropriate workup for precipitating
event (cultures, CXR, ECG).</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Monitoring:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l20 level2 lfo74;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Measure capillary glucose every 12 hours</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l20 level2 lfo74;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Measure electrolytes (especially K+,
bicarbonate, phosphate) and anion gap every 4 hours for the first 24 hours.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Vital Signs and Fluid Balance
Monitoring:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l20 level2 lfo74;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Monitor blood pressure, pulse, respirations,
mental status, fluid intake and output every 14 hours.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Replace K+:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l20 level2 lfo74;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>10 meq/h when plasma K+ &lt;5.05.2 meq/L (or
2030 meq/L of infusion fluid), ECG normal, urine flow, and normal creatinine
documented.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l20 level2 lfo74;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Administer 4080 meq/h when plasma K+ &lt;3.5
meq/L or if bicarbonate is given.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l20 level2 lfo74;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>If the initial serum potassium is &gt;5.2 mmol/L
(5.2 meq/L), do not supplement K+ until the potassium is corrected.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l20 level1 lfo74;tab-stops:list 35.45pt'><![if !supportLists]><span
style='mso-fareast-font-family:"Liberation Serif";mso-bidi-font-family:"Liberation Serif"'><span
style='mso-list:Ignore'>2.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Continue Treatment:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l20 level2 lfo74;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Follow guidelines until the patient is stable,
glucose goal is 8.311.1 mmol/L (150200 mg/dL), and acidosis is resolved.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l20 level2 lfo74;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Insulin infusion may be decreased to 0.020.1
units/kg per hour.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l20 level1 lfo74;tab-stops:list 35.45pt'><![if !supportLists]><span
style='mso-fareast-font-family:"Liberation Serif";mso-bidi-font-family:"Liberation Serif"'><span
style='mso-list:Ignore'>3.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Administer Long-Acting Insulin:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l20 level2 lfo74;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>As soon as the patient is eating.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l20 level2 lfo74;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Allow for a 24 hour overlap in insulin infusion
and SC long-acting insulin injection.</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><b>Ref: Harrisons principles of INTERNAL MEDICINE 21<sup>th</sup>
edition pg3116<o:p></o:p></b></p>

<p class=MsoNormal><b><o:p>&nbsp;</o:p></b></p>

<p class=MsoNormal>44[Q] Composition of oral rehydration solution (WHO) is</p>

<p class=MsoNormal>(a) Na-90 m mol/L, K-20 m mol/L, Cl-80 m mol/L, Energy54
kca/L</p>

<p class=MsoNormal>(b) Na-80 m mol/L, K-20 m mol/L, Cl-70 m mol/L, Energy54
kca/L</p>

<p class=MsoNormal>(c) Na-90 m mol/L, K-40 m mol/L, Cl-80 m mol/L, Energy27
kca/L</p>

<p class=MsoNormal>(d) Na-80 m mol/L, K-20 m mol/L, Cl-70 m mol/L, Energy54
kca/L</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[ANS] a</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[SOL] </p>

<p class=MsoNormal>Na-90 m mol/L, K-20 m mol/L, Cl-80 m mol/L, Energy54 kca/L</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Ref: Davidson principles and practice
of medicine 24<sup>th</sup> edition pg274</span></strong></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>45[Q] Which of the following are correct regarding
tuberculous meningitis?</p>

<p class=MsoNormal>1. Acid-Fast Bacilli are infrequently seen on direct smear
of CSF</p>

<p class=MsoNormal>2. CSF culture for MTB is the gold standard for diagnosis</p>

<p class=MsoNormal>3. Xpert MTB/RIF assay is preferred initial diagnostic option</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>Select the correct answer using the code given below:</p>

<p class=MsoNormal>(a) 1 and 2 only</p>

<p class=MsoNormal>(b) 2 and 3 only</p>

<p class=MsoNormal>(c) 1 and 3 only</p>

<p class=MsoNormal>(d) 1, 2 and 3</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[ANS] d</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[SOL]</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>CSF features in Tuberculous
Meningitis:</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l119 level1 lfo75;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Opening Pressure:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l119 level2 lfo75;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Elevated opening pressure is a classic finding.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l119 level1 lfo75;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Cellular Composition (Pleocytosis):</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l119 level2 lfo75;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Lymphocytic pleocytosis: 10500 cells/&#956;L.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l119 level1 lfo75;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Protein Concentration:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l119 level2 lfo75;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Elevated protein concentration in the range of
15 g/L.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l119 level1 lfo75;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Glucose Concentration:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l119 level2 lfo75;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Decreased glucose concentration in the range of
1.12.2 mmol/L (2040 mg/dL).</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l119 level1 lfo75;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Clinical Presentation:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l119 level2 lfo75;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Symptoms like unrelenting headache, stiff neck,
fatigue, night sweats, and fever.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l119 level2 lfo75;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Presence of CSF lymphocytic pleocytosis and
mildly decreased glucose concentration is highly suspicious for tuberculous
meningitis.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l119 level1 lfo75;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>CSF Collection for Diagnosis:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l119 level2 lfo75;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>The last tube of fluid collected during lumbar
puncture (LP) is preferred for a smear for acid-fast bacilli (AFB).</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l119 level2 lfo75;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>AFB can be best demonstrated in a smear of a
pellicle or cobweb-like clot if present.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l119 level1 lfo75;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Diagnostic Tests:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l119 level2 lfo75;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Positive smears are reported in 1040% of cases
in adults.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l119 level2 lfo75;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Cultures of CSF take 48 weeks and are positive
in ~50% of adults.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l119 level2 lfo75;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Culture remains the gold standard for diagnosing
tuberculous meningitis.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l119 level2 lfo75;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>PCR for M. tuberculosis DNA in CSF is
recommended, but sensitivity and specificity have not been clearly defined.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l119 level2 lfo75;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>The CDC recommends nucleic acid amplification
tests for pulmonary tuberculosis diagnosis.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l119 level2 lfo75;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>WHO recommends additional nucleic acid
amplification tests (NAATs), specifically Xpert MT/RIF Ultra, in addition to
smear and culture studies.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l119 level2 lfo75;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Brain imaging may reveal hydrocephalus, basal
meningeal enhancement, and/or<span style='mso-spacerun:yes'>
</span>intracranial tuberculoma.</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Ref: Davidson principles and practice
of medicine 24<sup>th</sup> edition pg1174</span></strong></p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Ref: Harrisons principles of
INTERNAL MEDICINE 21<sup>th</sup> edition pg1109</span></strong><b><o:p></o:p></b></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>46[Q] Which one of the following subcutaneous preparations
is used for the treatment of osteoporosis?</p>

<p class=MsoNormal>(a) Denosumab</p>

<p class=MsoNormal>(b) Alendronate</p>

<p class=MsoNormal>(c) Zoledronic acid</p>

<p class=MsoNormal>(d) Raloxifene</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[ANS] a</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[SOL] Denosumab is a subcutaneous preparation that is used
for the treatment of osteoporosis. It is a monoclonal antibody that inhibits
osteoclast activity, leading to increased bone mineral density and reduced
fracture risk. Alendronate and zoledronic acid are both bisphosphonates that
are typically administered orally or intravenously. Raloxifene is a selective
estrogen receptor modulator (SERM) that is also administered orally.</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>47[Q] Which of the following are correct with regard to
osteoporosis ? </p>

<p class=MsoNormal>1. It does not cause symptoms until a fracture occurs </p>

<p class=MsoNormal>2. Vertebra fracture can present with loss of height, in
absence pain </p>

<p class=MsoNormal>3. Smoking is protective </p>

<p class=MsoNormal>4. It sometimes presents incidentally with radiological
osteopenia </p>

<p class=MsoNormal>Select the correct answer using the code given below :</p>

<p class=MsoNormal>(a) 1, 2 and 3 </p>

<p class=MsoNormal>(b) 1, 2 and 4 </p>

<p class=MsoNormal>(c) 1, 3 and 4 </p>

<p class=MsoNormal>(d) 2, 3 and 4 </p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[ANS] b</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[SOL] </p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Osteoporosis:</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l139 level1 lfo76;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Definition:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l139 level2 lfo76;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Osteoporosis is a condition characterized by
decreased bone strength, leading to an increased risk of fractures.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l139 level2 lfo76;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>World Health Organization (WHO) defines it as a
bone density falling 2.5 standard deviations below the mean for young healthy
adults (T-score of 2.5).</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l139 level1 lfo76;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Clinical Assessment:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l139 level2 lfo76;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Absolute fracture risk is assessed,
incorporating factors such as bone mineral density (BMD), age, gender, and
other clinical risk factors.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l139 level1 lfo76;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Epidemiology:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l139 level2 lfo76;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Prevalent in the United States, affecting over
10 million individuals.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l139 level2 lfo76;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>More than 40 million individuals have bone mass
levels putting them at increased risk.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l139 level1 lfo76;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Fracture Risk:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l139 level2 lfo76;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Lifetime osteoporotic fracture risk is about 50%
for a 50-year-old woman and 20% for a 50-year-old man.</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l139 level1 lfo76;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Vertebral Fractures:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l139 level2 lfo76;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>&quot;Silent&quot; vertebral fractures, when
asymptomatic, are a sign of skeletal fragility, identified incidentally during
radiography for other purposes.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l139 level1 lfo76;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Characteristics of Osteoporosis:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l139 level2 lfo76;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Often asymptomatic until a fracture occurs.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l139 level2 lfo76;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Vertebral fractures can present with loss of
height even in the absence of pain.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l139 level2 lfo76;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Smoking is not protective against osteoporosis.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l139 level2 lfo76;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Osteoporosis can sometimes present incidentally
with radiological osteopenia, especially when detecting silent vertebral
fractures during other imaging procedures.</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Ref: Harrisons principles of
INTERNAL MEDICINE 21<sup>th</sup> edition pg3191</span></strong><b><o:p></o:p></b></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>48[Q] Which of the following are correct with regard to
Ankylosing spondylitis ?</p>

<p class=MsoNormal>1. Bamboo spine may be seen</p>

<p class=MsoNormal>2. Early morning back pain is rare </p>

<p class=MsoNormal>3. Uveitis is most common extra-articular feature </p>

<p class=MsoNormal>4. It is more common in males</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>Select the correct answer using the code given below:</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>(a) 1, 2, and 3</p>

<p class=MsoNormal>(b) 1, 2, and 4</p>

<p class=MsoNormal>(c) 1, 3, and 4</p>

<p class=MsoNormal>(d) 2, 3, and 4</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[ANS] c</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[SOL] </p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Inflammatory Back Pain and Stiffness:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l117 level2 lfo77;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Cardinal feature of axial spondyloarthritis
(axSpA).</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l117 level2 lfo77;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Morning stiffness and low back pain radiating to
the buttocks or posterior thighs.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l117 level2 lfo77;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Symptoms worsen with inactivity and improve with
movement.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Musculoskeletal Symptoms:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l117 level2 lfo77;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Entheses involvement, leading to episodic
musculoskeletal symptoms.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l117 level2 lfo77;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Persistent symptoms may present as widespread
pain, sometimes confused with fibromyalgia.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l117 level2 lfo77;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Fatigue is a common accompanying symptom.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Historical Clues:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l117 level2 lfo77;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>History of psoriasis (current, previous, or in a
first-degree relative).</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l117 level2 lfo77;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>History of inflammatory bowel symptoms (current
or previous).</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Physical Signs:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l117 level2 lfo77;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Reduced range of lumbar spine movements in all
directions.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l117 level2 lfo77;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Pain upon sacroiliac stressing.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l117 level2 lfo77;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>High enthesitis index.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l117 level2 lfo77;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Entheses commonly affected include Achilles
insertion, plantar fascia origin, patellar ligament entheses, gluteus medius
insertion at the greater trochanter, and tendon attachments at humeral
epicondyles.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Extra-articular Features:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l117 level2 lfo77;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Acute anterior uveitis is the most common
extra-articular feature, occasionally preceding joint disease.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Clinical Questionnaires:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l117 level2 lfo77;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Utilization of validated clinical
questionnaires, such as BASDAI, BASFI, and ASDAS-CRP, to assess disease
activity and functional status.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Spinal Changes:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l117 level2 lfo77;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Spinal fusion development over many years.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l117 level2 lfo77;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Varied extent; usually does not cause a gross
flexion deformity.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l117 level2 lfo77;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Some patients may develop marked kyphosis of the
dorsal and cervical spine, potentially interfering with forward vision.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l117 level2 lfo77;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Associated with fixed flexion contractures of
hips or knees in some cases.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Osteoporosis:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l117 level2 lfo77;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Common complication, particularly affecting the
spine.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l117 level2 lfo77;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Increased risk of vertebral fractures.</p>

<p class=MsoNormal>Investigations:</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Imaging:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l51 level2 lfo78;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Ultrasound or MRI of entheses.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l51 level2 lfo78;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>MRI of sacroiliac joints and spine.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l51 level2 lfo78;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>X-rays in advanced cases (AS) show irregularity,
loss of cortical margins, joint space changes, sclerosis, and fusion.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l51 level2 lfo78;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Lateral thoracolumbar spine X-rays may show
anterior 'squaring' of vertebrae, bridging syndesmophytes, and a 'bamboo' spine
in advanced disease.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l51 level2 lfo78;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Erosive changes in symphysis pubis, ischial
tuberosities, and peripheral joints.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Laboratory Tests:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l51 level2 lfo78;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Raised ESR and CRP (though these can be normal).</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l51 level2 lfo78;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Anemia.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l51 level2 lfo78;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Positive HLA-B27.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Additional Screening:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l51 level2 lfo78;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Faecal calprotectin as a useful screening test
for associated inflammatory bowel disease.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>DXA Scanning or Vertebral
Quantitative CT:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l51 level2 lfo78;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Important for fragility fracture assessment,
especially due to common osteoporosis in axSpA.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Ref: Davidson principles and practice
of medicine 24<sup>th</sup> edition pg1033</span></strong></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>49[Q] Carpel Tunnel Syndrome is associated with which of the
following features ?</p>

<p class=MsoNormal>1. Pain and tingling in hands at night</p>

<p class=MsoNormal>2. Weakness of thumb abduction </p>

<p class=MsoNormal>3. Loss of sensation over lateral half of the palm</p>

<p class=MsoNormal>4. Atrophy of hypothenar eminence</p>

<p class=MsoNormal>Select the correct answer using the code given below :</p>

<p class=MsoNormal>(a) 1, 2 and 3</p>

<p class=MsoNormal>(b) 1, 2 and 4 </p>

<p class=MsoNormal>(c) 1,3 and 4 </p>

<p class=MsoNormal>(d) 2, 3 and 4</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[ANS] a</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[SOL] </p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Median Neuropathy - Carpal Tunnel
Syndrome (CTS):</span></strong></p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Definition and Pathophysiology:</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l114 level1 lfo79;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Compression of the median nerve in the carpal
tunnel at the wrist.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l114 level1 lfo79;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Median nerve courses under the transverse carpal
ligament as it enters the hand through the carpal tunnel.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Clinical Presentation:</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l64 level1 lfo80;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Symptoms:</span></strong> Numbness
and paresthesias variably in the thumb, index, middle, and half of the ring
finger.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l64 level1 lfo80;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Paresthesias may extend into the forearm or
upper arm and can be isolated to specific fingers.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l64 level1 lfo80;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Pain in the hand, forearm, and proximal arm is
common.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Diagnosis:</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l69 level1 lfo81;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Signs:</span></strong> Decreased
sensation in the median nerve distribution; Tinel sign (tingling sensation with
percussion over the wrist); Phalen sign (tingling with wrist flexion for 3060
s); weakness of thumb opposition and abduction.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l69 level1 lfo81;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Electrodiagnosis (EDx):</span></strong>
Shows slowing of sensory and, to a lesser extent, motor median potentials
across the wrist.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l69 level1 lfo81;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Ultrasound:</span></strong> Can
reveal focal swelling of the median nerve at the wrist.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Treatment Options:</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l68 level1 lfo82;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Avoidance:</span></strong> Avoid
precipitating activities.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l68 level1 lfo82;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Systemic Control:</span></strong>
Manage underlying systemic-associated conditions if present.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l68 level1 lfo82;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Medications:</span></strong>
Nonsteroidal anti-inflammatory medications.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l68 level1 lfo82;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Splints:</span></strong> Neutral
(volar) position wrist splints, especially for nighttime use.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l68 level1 lfo82;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Injections:</span></strong>
Glucocorticoid/anesthetic injection into the carpal tunnel.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l68 level1 lfo82;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Surgical Decompression:</span></strong>
Involves dividing the transverse carpal ligament; considered if poor response
to nonsurgical treatments, presence of thenar muscle atrophy or weakness, and
significant denervation potentials on EMG.</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Ref: Harrisons principles of
INTERNAL MEDICINE 21<sup>th</sup> edition pg3191</span></strong><b><o:p></o:p></b></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>50[Q] Which of the following can be used to monitor disease
activity in rheumatoid arthritis ?</p>

<p class=MsoNormal>1. Pain (visual analogue scale)</p>

<p class=MsoNormal>2. X-Ray of hands and wrists </p>

<p class=MsoNormal>3. DAS 28 score </p>

<p class=MsoNormal>4. ESR</p>

<p class=MsoNormal>Select the correct answer using the code given below :</p>

<p class=MsoNormal>(a) 1, 2, 3 and 4</p>

<p class=MsoNormal>(b) 1, 2 and 4 </p>

<p class=MsoNormal>(c) 1,3 and 4 </p>

<p class=MsoNormal>(d) 2,3 and 4</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[ANS] c</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[SOL] </p>

<p class=MsoNormal>Investigations and monitoring of rheumatoid arthritis</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>To Establish Diagnosis:</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l15 level1 lfo83;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Clinical criteria</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l15 level1 lfo83;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Erythrocyte sedimentation rate and C-reactive
protein</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l15 level1 lfo83;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Ultrasound or magnetic resonance imaging</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l15 level1 lfo83;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Rheumatoid factor and anti-citrullinated peptide
antibodies</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>To Monitor Disease Activity and Drug
Efficacy:</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l40 level1 lfo84;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Pain (visual analogue scale)</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l40 level1 lfo84;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Early morning stiffness (minutes)</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l40 level1 lfo84;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Joint tenderness</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l40 level1 lfo84;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Joint swelling</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l40 level1 lfo84;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>DAS28</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l40 level1 lfo84;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Erythrocyte sedimentation rate and C-reactive
protein</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>To Monitor Disease Damage:</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l28 level1 lfo85;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>X-rays</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l28 level1 lfo85;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Functional assessment</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>To Monitor Drug Safety:</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l92 level1 lfo86;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Urinalysis</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l92 level1 lfo86;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Full blood count</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l92 level1 lfo86;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Chest X-ray</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l92 level1 lfo86;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Urea and creatinine</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l92 level1 lfo86;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Liver function tests</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Ref: Davidson principles and practice
of medicine 24<sup>th</sup> edition pg1030</span></strong></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>51[Q] Which one associated of the following HIV infections
is least likely with CD4 count &gt; 100 cells/mm? </p>

<p class=MsoNormal>(a) Cerebral toxoplasmosis </p>

<p class=MsoNormal>(b) Tuberculosis </p>

<p class=MsoNormal>(c) Herpes zoster </p>

<p class=MsoNormal>(d) Pneumocystis jirovecii pneumonia</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[ANS] a</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[SOL] </p>

<p class=MsoNormal>CD4 count and risk of common HIV-associated diseases</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>&lt; 500 cells/mm3:</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l108 level1 lfo87;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Tuberculosis</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l108 level1 lfo87;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Bacterial pneumonia</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l108 level1 lfo87;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Herpes zoster</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l108 level1 lfo87;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Oropharyngeal candidiasis</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l108 level1 lfo87;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Non-typhoid salmonellosis</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l108 level1 lfo87;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Kaposi's sarcoma</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l108 level1 lfo87;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Non-Hodgkin lymphoma</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l108 level1 lfo87;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>HIV-associated idiopathic thrombocytopenic
purpura</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>&lt; 200 cells/mm3:</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l116 level1 lfo88;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Pneumocystis jirovecii pneumonia</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l116 level1 lfo88;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Chronic herpes simplex ulcers</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l116 level1 lfo88;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Oesophageal candidiasis</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l116 level1 lfo88;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Cystoisospora belli (syn. Isospora belli)
diarrhoea</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l116 level1 lfo88;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>HIV wasting syndrome</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l116 level1 lfo88;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>HIV-associated dementia</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l116 level1 lfo88;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Peripheral neuropathy</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l116 level1 lfo88;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Endemic mycoses</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>&lt; 100 cells/mm3:</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l96 level1 lfo89;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Cerebral toxoplasmosis</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l96 level1 lfo89;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Cryptococcal meningitis</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l96 level1 lfo89;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Cryptosporidiosis and microsporidiosis</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l96 level1 lfo89;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Primary CNS lymphoma</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l96 level1 lfo89;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Cytomegalovirus</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l96 level1 lfo89;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Disseminated Mycobacterium avium complex (MAC)</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l96 level1 lfo89;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Progressive multifocal leucoencephalopathy</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Ref: Davidson principles and practice
of medicine 24<sup>th</sup> edition pg356</span></strong></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>52[Q] Tests for graphesthesia and stereognosis are used
clinically to assess </p>

<p class=MsoNormal>(a) Cortical sensation </p>

<p class=MsoNormal>(b) Posterior column </p>

<p class=MsoNormal>(c) Cerebellar function </p>

<p class=MsoNormal>(d) Lateral spinothalamic tract </p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[ANS] a</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[SOL]</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Cortical Sensation and Parietal
Lobes:</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l56 level1 lfo90;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Definition:</span></strong> Cortical
sensation is mediated by the parietal lobes and involves the integration of primary
sensory modalities.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l56 level1 lfo90;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Testing Significance:</span></strong>
Testing cortical sensation is meaningful only when primary sensation is intact.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l56 level1 lfo90;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Double Simultaneous Stimulation:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l56 level2 lfo90;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Purpose:</span></strong> Useful as a
screening test for cortical function.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l56 level2 lfo90;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Procedure:</span></strong> With the
patient's eyes closed, the examiner lightly touches one or both hands and asks
the patient to identify the stimuli.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l56 level2 lfo90;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Implication of Parietal Lobe Lesion:</span></strong>
In the presence of a parietal lobe lesion, the patient may be unable to
identify the stimulus on the contralateral side when both hands are touched.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l56 level1 lfo90;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Other Modalities Involving Parietal
Cortex:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l56 level2 lfo90;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Two-Point Discrimination:</span></strong>
Discrimination of two closely placed stimuli as separate.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l56 level2 lfo90;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Stereognosis:</span></strong>
Identification of an object by touch and manipulation alone.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l56 level2 lfo90;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Graphesthesia:</span></strong>
Identification of numbers or letters written on the skin surface.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Ref: Harrisons principles of
INTERNAL MEDICINE 21<sup>th</sup> edition pg3281</span></strong></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>53[Q] A blast victim is brought to the emergency. Victim is
unconscious. BP is 80/50 mm Hg. Pulse is 110 per minute and thready and SpO, is
70%. Victim has rapid shallow breathing and signs of external blood loss are
present. JVP is raised and heart sounds are absent on auscultation. Which one
of the following is the next single most immediate step in the management,
after securing airway, breathing and circulation ? </p>

<p class=MsoNormal>(a) Chest X-ray PA and lateral view </p>

<p class=MsoNormal>(b) Urgent needle throacostomy </p>

<p class=MsoNormal>(c) Urgent pericardiocentesis </p>

<p class=MsoNormal>(d) Blood for cross match followed by blood transfusion </p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[ANS] c</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[SOL] </p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Cardiac Tamponade: Key Points</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l95 level1 lfo91;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Definition:</span></strong>
Accumulation of fluid in the pericardial space causing serious obstruction to
blood inflow into the ventricles, potentially fatal if not promptly treated.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l95 level1 lfo91;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Common Causes:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l95 level2 lfo91;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Idiopathic pericarditis</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l95 level2 lfo91;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Pericarditis secondary to neoplastic disease,
tuberculosis, bleeding from aortic dissection, cardiac operation, trauma, or
anticoagulant therapy.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l95 level1 lfo91;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Beck's Triad (Principal Features):</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l95 level2 lfo91;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Hypotension</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l95 level2 lfo91;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Soft or absent heart sounds</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l95 level2 lfo91;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Jugular venous distention with prominent x
(early systolic) descent but absent y (early diastolic) descent.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l95 level1 lfo91;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Fluid Quantity for Tamponade:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l95 level2 lfo91;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Can be as small as 200 mL (rapid development) or
&gt;2000 mL (slowly developing effusions).</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l95 level1 lfo91;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Diagnosis:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l95 level2 lfo91;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Echocardiography is crucial for prompt
diagnosis.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l95 level2 lfo91;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Doppler ultrasound shows increased tricuspid and
pulmonic valve flow velocities during inspiration, with decreased pulmonic
vein, mitral, and aortic flow velocities.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l95 level2 lfo91;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Late diastolic inward motion (collapse) of the
right ventricular free wall and right atrium.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l95 level2 lfo91;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Transesophageal echocardiography, CT, or cardiac
MRI may be needed for a detailed diagnosis.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l95 level1 lfo91;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Paradoxical Pulse:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l95 level2 lfo91;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>10 mmHg inspiratory decline in systolic arterial
pressure.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l95 level2 lfo91;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Result of inspiratory enlargement of the right
ventricle causing leftward bulging of the interventricular septum.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l95 level1 lfo91;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Management (Pericardiocentesis):</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l95 level2 lfo91;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Lifesaving procedure if tamponade is suspected.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l95 level2 lfo91;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Should be carried out promptly, preferably under
echocardiographic guidance.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l95 level2 lfo91;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Intrapericardial pressure may be measured before
fluid withdrawal.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l95 level2 lfo91;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Small catheter left in place for continued
drainage if needed.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l95 level1 lfo91;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Caution:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l95 level2 lfo91;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Immediate treatment is crucial as untreated
tamponade can be rapidly fatal.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l95 level2 lfo91;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>High index of suspicion needed, especially when
sudden cardiac silhouette enlargement, hypotension, and elevated jugular venous
pressure are observed.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l95 level1 lfo91;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Pericardial Fluid Analysis:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l95 level2 lfo91;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Exudative and/or bloody fluid may indicate
neoplasm, renal failure, cardiac injury, or tuberculosis.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l95 level2 lfo91;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Analyze for red and white blood cells, cytology
for neoplastic cells, and obtain cultures.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l95 level2 lfo91;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Polymerase chain reaction for Mycobacterium
tuberculosis DNA may support the diagnosis of tuberculous pericarditis.</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Ref: Harrisons principles of
INTERNAL MEDICINE 21<sup>th</sup> edition pg2021</span></strong><b><o:p></o:p></b></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>54[Q] A 21 year young female was brought to Emergency
Department with history of unknown substance ingestion. She was having
vomiting, profuse diarrhoea, bronchorrhoea and excessive sweating. On
examination miosis and muscular fasciculations were present. What is the most
likely diagnosis? </p>

<p class=MsoNormal>(a) Corrosive substance poisoning </p>

<p class=MsoNormal>(b) Aluminium phosphide poisoning </p>

<p class=MsoNormal>(c) Zinc phosphide poisoning </p>

<p class=MsoNormal>(d) Organophosphorus poisoning </p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[ANS] d</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[SOL] </p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Organophosphate Poisoning: Mechanism
and Clinical Management</span></strong></p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Mechanism of Toxicity:</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l158 level1 lfo92;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Acetylcholinesterase (AChE)
Inactivation:</span></strong> OP compounds lead to the inactivation of
acetylcholinesterase.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l158 level1 lfo92;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Accumulation of Acetylcholine (ACh):</span></strong>
Results in the accumulation of acetylcholine in cholinergic synapses.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l158 level1 lfo92;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Reactivation and Ageing:</span></strong>
Spontaneous hydrolysis allows enzyme reactivation initially, but
&quot;ageing&quot; process occurs, preventing further enzyme reactivation.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l158 level1 lfo92;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Rate of Ageing:</span></strong>
Determines toxicity; more rapid with dimethyl compounds than diethyl compounds,
especially rapid with nerve agents like soman.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Clinical Features and Management:</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l132 level1 lfo93;tab-stops:list 35.45pt'><![if !supportLists]><span
style='mso-fareast-font-family:"Liberation Serif";mso-bidi-font-family:"Liberation Serif"'><span
style='mso-list:Ignore'>1.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Acute Cholinergic Syndrome:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l132 level2 lfo93;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Onset:</span></strong> Within a few
minutes of exposure.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l132 level2 lfo93;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Features:</span></strong> Nicotinic
or muscarinic manifestations, vomiting, diarrhea, bronchoconstriction,
bronchorrhoea, salivation, sweating, miosis, muscular fasciculations, flaccid
paralysis.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l132 level2 lfo93;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Complications:</span></strong>
Respiratory failure, ataxia, coma, convulsions, cardiac abnormalities.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l132 level2 lfo93;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Management:</span></strong></p>

<p class=MsoNormal style='margin-left:106.35pt;text-indent:-14.15pt;mso-list:
l132 level3 lfo93;tab-stops:list 106.35pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Clear airway, assess breathing and circulation.</p>

<p class=MsoNormal style='margin-left:106.35pt;text-indent:-14.15pt;mso-list:
l132 level3 lfo93;tab-stops:list 106.35pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Administer high-flow oxygen and obtain
intravenous access.</p>

<p class=MsoNormal style='margin-left:106.35pt;text-indent:-14.15pt;mso-list:
l132 level3 lfo93;tab-stops:list 106.35pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>External decontamination, gastric lavage, or
activated charcoal if early presentation.</p>

<p class=MsoNormal style='margin-left:106.35pt;text-indent:-14.15pt;mso-list:
l132 level3 lfo93;tab-stops:list 106.35pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Atropine administration to reverse cholinergic
effects.</p>

<p class=MsoNormal style='margin-left:106.35pt;text-indent:-14.15pt;mso-list:
l132 level3 lfo93;tab-stops:list 106.35pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Oxime (pralidoxime chloride or obidoxime)
recommended if available.</p>

<p class=MsoNormal style='margin-left:106.35pt;text-indent:-14.15pt;mso-list:
l132 level3 lfo93;tab-stops:list 106.35pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Magnesium sulfate and ventilatory support may be
considered.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l132 level1 lfo93;tab-stops:list 35.45pt'><![if !supportLists]><span
style='mso-fareast-font-family:"Liberation Serif";mso-bidi-font-family:"Liberation Serif"'><span
style='mso-list:Ignore'>2.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Intermediate Syndrome:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l132 level2 lfo93;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Onset:</span></strong> 14 days after
exposure.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l132 level2 lfo93;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Features:</span></strong> Weakness
spreading from ocular muscles to head, neck, proximal limbs, and respiratory
muscles.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l132 level2 lfo93;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Complications:</span></strong>
Ventilatory failure.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l132 level2 lfo93;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Management:</span></strong>
Supportive care, including airway and ventilation maintenance.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l132 level1 lfo93;tab-stops:list 35.45pt'><![if !supportLists]><span
style='mso-fareast-font-family:"Liberation Serif";mso-bidi-font-family:"Liberation Serif"'><span
style='mso-list:Ignore'>3.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Organophosphate-induced Delayed
Polyneuropathy (OPIDN):</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l132 level2 lfo93;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Onset:</span></strong> 23 weeks
after exposure.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l132 level2 lfo93;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Features:</span></strong> Mixed
sensory/motor polyneuropathy, muscle cramps, numbness, paraesthesiae, flaccid
paralysis of lower and upper limbs, foot and wrist drop, high-stepping gait,
paraplegia.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l132 level2 lfo93;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Complications:</span></strong>
Incomplete recovery, limited functional recovery.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l132 level2 lfo93;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Management:</span></strong> No
specific therapy; physiotherapy for limiting deformity caused by muscle
wasting.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Diagnostic Confirmation:</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l29 level1 lfo94;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Measurement of plasma or red blood cell
cholinesterase activity.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l29 level1 lfo94;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Plasma cholinesterase is reduced more rapidly
but less specific than red cell cholinesterase.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Important Note:</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l134 level1 lfo95;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Antidote use should not be delayed pending
diagnostic results.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l134 level1 lfo95;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Monitoring and supportive care are essential
during the acute cholinergic phase.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l134 level1 lfo95;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Recovery may take weeks, and substantial
functional recovery can occur after 12 years.</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Ref: Davidson principles and practice
of medicine 24<sup>th</sup> edition pg232</span></strong></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>55[Q] A young female of 22 year old presented to the medical
emergency with complaints of nausea, vomiting, abdominal pain, diarrhea, and
convulsions along with methemoglobinemia. What is the likely diagnosis?</p>

<p class=MsoNormal>(a) Aluminum phosphide poisoning </p>

<p class=MsoNormal>(b) Zinc phosphide poisoning </p>

<p class=MsoNormal>(c) Copper sulfate poisoning</p>

<p class=MsoNormal>(d) Lead poisoning</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[ANS] c</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[SOL] </p>

<p class=MsoNormal>Copper sulfate, also known as cupric sulfate or copper(II)
sulfate, is indeed used as a fungicide. However, it is important to note that
it can be toxic if ingested. The clinical features of copper sulfate toxicity
include a range of symptoms and complications:</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Gastrointestinal Effects:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l118 level2 lfo96;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Nausea</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l118 level2 lfo96;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Vomiting</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l118 level2 lfo96;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Abdominal pain</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l118 level2 lfo96;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Diarrhea</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l118 level2 lfo96;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Corrosive effects on the gastrointestinal tract</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Systemic Effects:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l118 level2 lfo96;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Renal failure</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l118 level2 lfo96;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Liver failure</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l118 level2 lfo96;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Methemoglobinemia (a condition where an abnormal
amount of methemoglobin, a form of hemoglobin, is produced)</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l118 level2 lfo96;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Hemolysis (destruction of red blood cells)</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l118 level2 lfo96;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Rhabdomyolysis (breakdown of muscle tissue)</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l118 level2 lfo96;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Convulsions</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l118 level2 lfo96;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Coma</p>

<p class=MsoNormal>The discoloration of secretions to a blue or green color is
characteristic of copper poisoning.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Treatment:</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l135 level1 lfo97;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Gastrointestinal Decontamination</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l135 level1 lfo97;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Supportive Care</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l135 level1 lfo97;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Methylthioninium Chloride (Methylene
Blue)</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l135 level1 lfo97;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Chelation Therapy</span></strong></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Ref: Davidson principles and practice
of medicine 24<sup>th</sup> edition pg235</span></strong></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>56[Q] Which of the following are the components of the SOFA
(Sequential Organ Failure Assessment) ? </p>

<p class=MsoNormal>1. Serum bilirubin </p>

<p class=MsoNormal>2. Platelet count </p>

<p class=MsoNormal>3. Leuococyte count </p>

<p class=MsoNormal>4. Serum Creatinine</p>

<p class=MsoNormal>Select the correct answer using the code given below :</p>

<p class=MsoNormal>(a) 1, 2 and 3 </p>

<p class=MsoNormal>(b) 1, 2 and 4 </p>

<p class=MsoNormal>(c) 1, 3 and 4 </p>

<p class=MsoNormal>(d) 2, 3 and 4</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[ANS] b</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[SOL] Components of the SOFA</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Respiration (PaO2/FiO2)</span></strong></p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Coagulation (Platelets)</span></strong></p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Liver (Bilirubin):</span></strong></p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Cardiovascular (MAP - Mean Arterial
Pressure):</span></strong></p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Central Nervous System (Glasgow Coma
Scale):</span></strong></p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Renal (Creatinine or Urine Output):</span></strong></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Ref: Harrisons principles of
INTERNAL MEDICINE 21<sup>th</sup> edition pg2217</span></strong><b><o:p></o:p></b></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>57[Q] Purtschers retinopathy may be associated with</p>

<p class=MsoNormal>(a) Acute fulminant hepatic failure </p>

<p class=MsoNormal>(b) Acute pancreatitis </p>

<p class=MsoNormal>(c) Acute peritonitis </p>

<p class=MsoNormal>(d) Acute cholecystitis </p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[ANS] b</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[SOL]<b>C</b><b><span style='font-family:"S hne;ui-sans-serif;system-ui;a","serif";
color:#374151'>omplications associated with acute pancreatitis:</span> </b></p>

<p class=MsoNormal><span style='mso-spacerun:yes'> </span>Local Complications</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l88 level1 lfo98;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Pancreatic/Peripancreatic Fluid Collections:</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l88 level2 lfo98;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Acute Necrotic Collection (sterile or infected)</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l88 level2 lfo98;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Walled-off Necrosis (sterile or infected)</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l88 level2 lfo98;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Pancreatic Pseudocyst</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l88 level1 lfo98;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Disruption of Pancreatic Duct:</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l88 level2 lfo98;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Involves the main pancreatic duct or secondary
branches</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l88 level1 lfo98;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Pancreatic Ascites:</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l88 level2 lfo98;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Accumulation of fluid in the peritoneal cavity
due to pancreatic leakage</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l88 level1 lfo98;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Chylous Ascites:</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l88 level2 lfo98;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Resulting from the disruption of lymphatic ducts</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l88 level1 lfo98;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Involvement of Contiguous Organs:</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l88 level2 lfo98;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Necrotizing pancreatitis may extend to adjacent
organs, such as colon perforation</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l88 level1 lfo98;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Splanchnic Thromboses:</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l88 level2 lfo98;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Involves splenic vein, superior mesenteric vein,
and/or portal vein</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l88 level1 lfo98;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Bowel Infarction/Perforation:</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l88 level2 lfo98;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Resulting from vascular complications</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l88 level1 lfo98;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Gastric Outlet Obstruction:</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l88 level2 lfo98;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Due to inflammation affecting the stomach</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l88 level1 lfo98;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Biliary Obstruction:</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l88 level2 lfo98;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Jaundice may occur due to compression or
inflammation around the bile ducts</p>

<p class=MsoNormal>Systemic Complications</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l46 level1 lfo99;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Pulmonary:</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l46 level2 lfo99;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Pleural Effusion</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l46 level2 lfo99;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Atelectasis</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l46 level2 lfo99;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Mediastinal Fluid</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l46 level2 lfo99;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Pneumonitis</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l46 level2 lfo99;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Acute Respiratory Distress Syndrome (ARDS)</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l46 level2 lfo99;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Hypoxemia (may go unrecognized)</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l46 level1 lfo99;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Cardiovascular:</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l46 level2 lfo99;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Hypotension</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l46 level2 lfo99;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Hypovolemia</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l46 level2 lfo99;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Nonspecific ST-T changes in the
electrocardiogram mimicking myocardial infarction</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l46 level2 lfo99;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Pericardial Effusion</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l46 level1 lfo99;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Hematologic:</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l46 level2 lfo99;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Disseminated Intravascular Coagulation (DIC)</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l46 level2 lfo99;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Gastrointestinal Hemorrhage (peptic ulcer
disease, erosive gastritis, hemorrhagic pancreatic necrosis)</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l46 level2 lfo99;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Variceal Hemorrhage secondary to splanchnic
thrombosis</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l46 level1 lfo99;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Renal:</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l46 level2 lfo99;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Oliguria (&lt;300 mL/day)</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l46 level2 lfo99;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Azotemia</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l46 level2 lfo99;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Renal Artery and/or Renal Vein Thrombosis</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l46 level2 lfo99;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Acute Tubular Necrosis</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l46 level1 lfo99;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Metabolic:</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l46 level2 lfo99;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Hyperglycemia</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l46 level2 lfo99;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Hypertriglyceridemia</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l46 level2 lfo99;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Hypocalcemia</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l46 level2 lfo99;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Encephalopathy</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l46 level2 lfo99;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Sudden blindness (Purtschers retinopathy)</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l46 level1 lfo99;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Central Nervous System:</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l46 level2 lfo99;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Psychosis</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l46 level2 lfo99;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Fat Emboli</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l46 level2 lfo99;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Fat Necrosis</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l46 level1 lfo99;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Subcutaneous Tissues:</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l46 level2 lfo99;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Erythematous Nodules</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Ref: Harrisons principles of
INTERNAL MEDICINE 21<sup>th</sup> edition pg2664</span></strong><b><o:p></o:p></b></p>

<p class=MsoNormal>58[Q] Which of the following may constitute the
characteristic triad of Zollinger-Ellison syndrome ? </p>

<p class=MsoNormal>1. Severe peptic ulceration</p>

<p class=MsoNormal>2. Gastric acid hyposecretion </p>

<p class=MsoNormal>3. Gastrinoma</p>

<p class=MsoNormal>4. Pancreatic Neuro-endocrine tumor</p>

<p class=MsoNormal>Select the correct answer using the code given below :</p>

<p class=MsoNormal>(a) 1 and 3 only </p>

<p class=MsoNormal>(b) 2, 3 and 4</p>

<p class=MsoNormal>(c) 1,3 and 4 </p>

<p class=MsoNormal>(d) 1, 2 and 4</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[ANS] c</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[SOL] <br>
ZollingerEllison Syndrome</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l128 level1 lfo100;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Rare disorder characterized by gastric acid
hypersecretion and severe peptic ulceration.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l128 level1 lfo100;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Caused by a gastrin-secreting neuroendocrine
tumor (gastrinoma).</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Epidemiology:</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l4 level1 lfo101;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Accounts for about 0.1% of all cases of duodenal
ulceration.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l4 level1 lfo101;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Occurs in either sex at any age, most common
between 30 and 50 years.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Pathophysiology:</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l65 level1 lfo102;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Elevated gastrin stimulates acid secretion,
increasing parietal cell mass three- to sixfold.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l65 level1 lfo102;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Excessive acid output may reach upper small
intestine, reducing luminal pH to 2 or less.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l65 level1 lfo102;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Pancreatic lipase inactivated, bile acids
precipitated, leading to diarrhea and steatorrhea.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l65 level1 lfo102;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Around 90% of tumors occur in pancreatic head or
proximal duodenal wall.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l65 level1 lfo102;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>20-60% of patients have multiple endocrine
neoplasia (MEN) type 1.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Clinical Features:</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l17 level1 lfo103;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Severe and multiple peptic ulcers in unusual
sites (post-bulbar duodenum, jejunum, or esophagus).</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l17 level1 lfo103;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Poor response to standard ulcer therapy.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l17 level1 lfo103;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Short history, common bleeding, and
perforations.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l17 level1 lfo103;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Diarrhea in one-third or more of patients,
sometimes a presenting feature.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Investigations:</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l37 level1 lfo104;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Serum gastrin levels grossly elevated (10- to
1000-fold).</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l37 level1 lfo104;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Secretin injection causes paradoxical increase
in gastrin in ZollingerEllison syndrome.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l37 level1 lfo104;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Tumor localization and staging with CT, EUS,
somatostatin receptor scintigraphy, and gallium DOTATATE PET scanning.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Management:</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l16 level1 lfo105;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Resection for unifocal tumors; surgery not
always suitable for multifocal or metastatic disease.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l16 level1 lfo105;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>High-dose PPI therapy for healing ulcers and
alleviating diarrhea.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l16 level1 lfo105;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Somatostatin analog therapy may reduce gastrin
secretion and have an anti-tumor effect.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l16 level1 lfo105;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Genetic screening for MEN 1 recommended for all
patients.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l16 level1 lfo105;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Overall 5-year survival is 60%-75%.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Ref: Davidson principles and practice
of medicine 24<sup>th</sup> edition pg817</span></strong></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>59[Q] In a healthy young adult, what proportion of sleep
time is comprised Rapid Eye Movement (REM) sleep? </p>

<p class=MsoNormal>(a) 5-10%</p>

<p class=MsoNormal>(b) 20-25%</p>

<p class=MsoNormal>(c) 45-50%</p>

<p class=MsoNormal>(d) 70-75%</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[ANS] b</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[SOL] </p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Normal Nocturnal Sleep in Adults:</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l150 level1 lfo106;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Sleep typically progresses through NREM stages
N1N3 within 4560 minutes after sleep onset.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l150 level1 lfo106;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>NREM stage N3 (slow-wave sleep) predominates in
the first third of the night, constituting 1525% of total sleep time in young
adults.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l150 level1 lfo106;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>The first REM sleep episode usually occurs in
the second hour of sleep.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l150 level1 lfo106;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>NREM and REM sleep alternate through the night
in an ultradian sleep cycle with an average period of 90110 minutes.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Sleep in Healthy Young Adults:</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l82 level1 lfo107;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>REM sleep constitutes 2025% of total sleep.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l82 level1 lfo107;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>NREM stages N1 and N2 constitute 5060% of total
sleep.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Impact of Age on Sleep State
Organization:</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l8 level1 lfo108;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>N3 sleep is most intense during childhood,
decreasing with puberty and across the second and third decades of life.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l8 level1 lfo108;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>In older adults, N3 sleep may be absent, and the
remaining NREM sleep becomes more fragmented with frequent awakenings.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l8 level1 lfo108;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Age affects the proportion of REM sleep, with a
sharp decline after infancy.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Effects of Sleep Deprivation:</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l104 level1 lfo109;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Sleep deprivation increases the rapidity of
sleep onset and the intensity and amount of slow-wave sleep.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l104 level1 lfo109;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>REM sleep pressure may increase after sleep
deprivation, leading to earlier occurrences of REM sleep.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Cognitive Performance and Sleep
Deprivation:</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l155 level1 lfo110;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Sleep deprivation degrades cognitive
performance, especially in tasks requiring continual vigilance.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l155 level1 lfo110;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Older people are less vulnerable to
neurobehavioral performance impairment induced by acute sleep deprivation but
find it more challenging to obtain recovery sleep after staying awake all
night.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Sleep Disorders and Sleep
Fragmentation:</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l147 level1 lfo111;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Several disorders can cause sleep fragmentation,
emphasizing the importance of having sufficient sleep opportunity before
diagnostic polysomnograms.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Health Consequences of Inadequate
Sleep:</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l47 level1 lfo112;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Inadequate sleep in humans is associated with
various health issues, including glucose intolerance contributing to diabetes,
obesity, metabolic syndrome, impaired immune responses, accelerated
atherosclerosis, increased risk of cardiac disease, cognitive impairment,
Alzheimer's disease, and stroke.</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Ref: Harrisons principles of INTERNAL
MEDICINE 20<sup>th</sup> edition pg205</span></strong><b><o:p></o:p></b></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>60[Q] Which of the following drugs can cause Idiopathic
Intra cranial Hypertension?</p>

<p class=MsoNormal>1. Tetracycline</p>

<p class=MsoNormal>2. Retinoid </p>

<p class=MsoNormal>3. Vitamin A </p>

<p class=MsoNormal>4. Sulfonamides</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>Select the correct answer using the code given below:</p>

<p class=MsoNormal>(a) 1, 2 and 3 </p>

<p class=MsoNormal>(b) 2, 3 and 4 </p>

<p class=MsoNormal>(c) 1, 3 and 4 </p>

<p class=MsoNormal>(d) 1, 2 and 4</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[ANS] a</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[SOL] <strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Idiopathic Intracranial Hypertension
(IIH):</span></strong></p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Epidemiology:</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l66 level1 lfo113;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Typically occurs in young women with high BMI
(Body Mass Index).</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l66 level1 lfo113;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Annual incidence is around 3 per 100,000.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Etiology:</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l122 level1 lfo114;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Occurs in the absence of a structural lesion,
hydrocephalus, or other identifiable cause.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l122 level1 lfo114;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>The exact cause is uncertain, but there is an
association with obesity in females, possibly leading to a defect in
cerebrospinal fluid (CSF) reabsorption by the arachnoid villi.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l122 level1 lfo114;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Certain drugs may be associated with IIH,
including tetracycline, vitamin A, and retinoid derivatives.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Clinical Features:</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l136 level1 lfo115;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Usual presentation is with headaches, sometimes
accompanied by diplopia and visual disturbances.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l136 level1 lfo115;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Visual disturbances often involve transient
obscurations of vision associated with changes in posture.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l136 level1 lfo115;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Clinical examination typically reveals
papilledema but may show little else.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l136 level1 lfo115;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>False localizing cranial nerve palsies, usually
affecting the 6th nerve, may be present.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l136 level1 lfo115;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Accurate recording of visual fields is important
for future monitoring.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Investigations:</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l12 level1 lfo116;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Brain imaging is necessary to exclude structural
or other causes (e.g., cerebral venous sinus thrombosis).</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l12 level1 lfo116;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Ventricles are typically normal in size or small
(slit ventricles).</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l12 level1 lfo116;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Lumbar puncture can confirm the diagnosis by
showing raised normal CSF constituents at increased pressure (usually &gt; 30
cmH2O).</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Management:</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l87 level1 lfo117;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Management can be challenging, and there is no
specific evidence-based treatment.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l87 level1 lfo117;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Weight loss in overweight patients may be
beneficial if achievable.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l87 level1 lfo117;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Acetazolamide or topiramate may help lower
intracranial pressure, with the latter potentially aiding weight loss in some
patients.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l87 level1 lfo117;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Repeated lumbar puncture is an effective
treatment for headaches but may be technically difficult in obese individuals
and poorly tolerated.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l87 level1 lfo117;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Patients failing to respond, especially when
chronic papilledema threatens vision, may require optic nerve sheath
fenestration or a lumbo-peritoneal shunt.</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Ref: Davidson principles and practice
of medicine 24<sup>th</sup> edition pg1186</span></strong></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>61[Q] As per the Gell and Coombs classification, Farmers
lung is which type of hypersensitivity disease ?</p>

<p class=MsoNormal>(a) Type-I </p>

<p class=MsoNormal>(b) Type-II </p>

<p class=MsoNormal>(c) Type-III </p>

<p class=MsoNormal>(d) Type-IV</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[ANS] c</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[SOL] </p>

<p class=MsoNormal>Type I Immediate hypersensitivity</p>

<p class=MsoNormal>Type II Antibodymediated</p>

<p class=MsoNormal>Type III Immune complexmediated</p>

<p class=MsoNormal>Type IV Delayed type</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Ref: Davidson principles and practice
of medicine 24<sup>th</sup> edition pg78</span></strong></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>62[Q] Hormonal regulation of salt and water balance in a
nephron occurs at </p>

<p class=MsoNormal>(a) Proximal Convoluted Tubule (PCT) </p>

<p class=MsoNormal>(b) Loop of Henle </p>

<p class=MsoNormal>(c) Distal Convoluted Tubule (DCT) </p>

<p class=MsoNormal>(d) Collecting Ducts </p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[ANS] d</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[SOL] </p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Collecting Duct:</span></strong></p>

<p class=MsoNormal>The collecting duct plays a crucial role in modulating the
final composition of urine, contributing to reabsorption of approximately 45%
of filtered sodium (Na+). It is divided into two major segments: the cortical
collecting duct and the inner medullary collecting duct.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Cortical Collecting Duct:</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l152 level1 lfo118;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Reabsorbs filtered Na+.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l152 level1 lfo118;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Important for hormonal regulation of salt and
water balance.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l152 level1 lfo118;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Contains high-resistance epithelia with
principal cells (main water-reabsorbing, Na+-reabsorbing, and K+-secreting
cells) and type A and B intercalated cells.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l152 level1 lfo118;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Principal cells express aldosterone-sensitive
epithelial Na+ channels (ENaC), regulated by aldosterone.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l152 level1 lfo118;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Aldosterone stimulates Na+ reabsorption and K+ secretion
in principal cells.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l152 level1 lfo118;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Mutations in ENaC can lead to conditions like
Liddle's syndrome with hypokalemia, hypertension, and metabolic alkalosis.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l152 level1 lfo118;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Potassium-sparing diuretics like amiloride and
triamterene block ENaC.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l152 level1 lfo118;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Principal cells secrete K+ through an apical
membrane potassium channel.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Inner Medullary Collecting Duct:</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l14 level1 lfo119;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Similar to principal cells of the cortical
collecting duct.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l14 level1 lfo119;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Reabsorbs Na+ and secretes K+.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l14 level1 lfo119;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Inhibited by natriuretic peptides (atrial
natriuretic peptide or renal natriuretic peptide) in response to volume
expansion, leading to natriuresis.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l14 level1 lfo119;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Transports urea out of the lumen, contributing
to the hypertonicity of the medullary interstitium.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l14 level1 lfo119;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Urea is recycled by diffusing into the
descending and ascending limbs of the loop of Henle.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Vasopressin Regulation:</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l5 level1 lfo120;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Cells in both collecting duct segments express
vasopressin-regulated water channels (aquaporin-2 on apical membrane).</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l5 level1 lfo120;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Vasopressin binds to the V2 receptor on
basolateral membrane, triggering a signaling cascade that promotes water
permeability, water reabsorption, and concentrated urine production.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l5 level1 lfo120;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>In the absence of vasopressin, collecting duct
cells are water impermeable, and urine remains dilute.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Intercalated Cells:</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l25 level1 lfo121;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Type A intercalated cells mediate acid secretion
and bicarbonate reabsorption.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l25 level1 lfo121;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Type B intercalated cells mediate bicarbonate
secretion and acid reabsorption.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l25 level1 lfo121;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Active H+ transport and Cl&#8722;/HCO3 &#8722;
exchange are involved in acid-base balance.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l25 level1 lfo121;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Aldosterone influences the number of H+-ATPase
pumps, contributing to metabolic alkalosis in some cases.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Adaptations in Acid-Base Balance:</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l10 level1 lfo122;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Type A intercalated cells secrete excess H+ in
acidemia.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l10 level1 lfo122;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Type B intercalated cells predominate in states
of bicarbonate excess with alkalemia.</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Ref: Harrisons principles of
INTERNAL MEDICINE 21<sup>th</sup> edition pg2293</span></strong><b><o:p></o:p></b></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>63[Q] Which one of the following parameters suggests
pre-renal azotemia ?</p>

<p class=MsoNormal>(a) Renal tubular epithelial cell casts</p>

<p class=MsoNormal>(b) Glomerular casts in urine sediment</p>

<p class=MsoNormal>(c) Hyaline casts in urine sediment</p>

<p class=MsoNormal>(d) Fractional excretion of sodium &gt;1%</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[ANS] c</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[SOL] </p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Prerenal Azotemia:</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l70 level1 lfo123;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Tubules:</span></strong> Intact.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l70 level1 lfo123;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Urine Characteristics:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l70 level2 lfo123;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Concentrated (&gt;500 mosmol).</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l70 level2 lfo123;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Avid Na retention (urine Na concentration &lt;20
mmol/L).</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l70 level2 lfo123;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Low FENa (&lt;1%).</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l70 level2 lfo123;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Elevated UCr/PCr (&gt;40%).</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l70 level1 lfo123;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Contrast with ATN:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l70 level2 lfo123;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>FENa typically &gt;1% in ATN, or &lt;1% in
milder cases.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l70 level2 lfo123;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>UCr/PCr &lt;1% in milder ATN, differentiating
from prerenal.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l70 level1 lfo123;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Urine Sediment:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l70 level2 lfo123;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Prerenal: Usually normal or hyaline/granular
casts.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l70 level2 lfo123;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>ATN: Presence of cellular debris, tubular
epithelial casts, dark (muddy brown) granular casts.</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Ref: Harrisons principles of INTERNAL
MEDICINE 21<sup>th</sup> edition pg334</span></strong><b><o:p></o:p></b></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>64[Q] Most common cause Chronic Kidney Disease (CKD) is </p>

<p class=MsoNormal>(a) Hypertension associated CKD </p>

<p class=MsoNormal>(b) Autosomal Dominant Polycystic Kidney Disease(ADPKD) </p>

<p class=MsoNormal>(c) Diabetic nephropathy </p>

<p class=MsoNormal>(d) Glomerulonephritis </p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[ANS] c</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[SOL] </p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Chronic Kidney Disease (CKD):</span></strong></p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Prevalence:</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l120 level1 lfo124;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Stages 1 and 2 CKD:</span></strong>
Estimated in at least 6% of the adult population in the United States.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l120 level1 lfo124;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Stages 3 and 4 CKD:</span></strong>
Additional 4.5% of the U.S. population is estimated to have these stages.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Leading Cause:</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l107 level1 lfo125;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Diabetic Nephropathy:</span></strong>
Most frequent cause of CKD , often associated with type 2 diabetes mellitus.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Association with Hypertension:</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l110 level1 lfo126;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Hypertension:</span></strong>
Commonly observed in patients with newly diagnosed CKD, and it is often
attributed as a contributing factor.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Underlying Glomerulopathy:</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l26 level1 lfo127;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Subclinical Glomerulopathy:</span></strong>
Some CKD cases, initially attributed to hypertension, may have a subclinical
primary glomerulopathy, like focal segmental or global glomerulosclerosis.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Systemic Vascular Disease:</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l149 level1 lfo128;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Nephrosclerosis and Hypertension:</span></strong>
In some cases, progressive nephrosclerosis and hypertension are linked to a
systemic vascular disease affecting large and small vessels in other organs
such as the heart and brain.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l149 level1 lfo128;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Common in Older Patients:</span></strong>
Especially prevalent in older patients, and chronic kidney ischemia may be
underdiagnosed as a cause of CKD in this population.</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Ref: Harrisons principles of
INTERNAL MEDICINE 21<sup>th</sup> edition pg2312</span></strong><b><o:p></o:p></b></p>

<p class=MsoNormal><b><o:p>&nbsp;</o:p></b></p>

<p class=MsoNormal>65[Q] Which of the following statements regarding contrast
induced nephrotoxicity are correct?</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>1. Diabetes Mellitus is a risk factor.</p>

<p class=MsoNormal>2. N-acetylcysteine can fully reverse the renal injury.</p>

<p class=MsoNormal>3. Hydration is necessary.</p>

<p class=MsoNormal>4. Omit Metformin if nephrotoxicity occurs.</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>Select the correct answer using the code given below:</p>

<p class=MsoNormal>(a) 1, 2 and 3 </p>

<p class=MsoNormal>(b) 1, 2 and 4 </p>

<p class=MsoNormal>(c) 2, 3 and 4 </p>

<p class=MsoNormal>(d) 1, 3 and 4</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[ANS] d</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[SOL] </p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Contrast Nephrotoxicity:</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l106 level1 lfo129;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Definition:</span></strong> Acute
deterioration in renal function within 48 hours of IV radiographic contrast
media administration.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l106 level1 lfo129;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Risk Factors:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l106 level2 lfo129;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Pre-existing renal impairment (eGFR &lt;45
mL/min/1.73m).</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l106 level2 lfo129;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Use of ionic contrast media and repetitive
dosing in short time periods.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l106 level2 lfo129;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Conditions such as diabetes mellitus and
myeloma.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l106 level1 lfo129;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Prevention:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l106 level2 lfo129;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Hydration with free oral fluids and IV isotonic
saline (500 mL, then 250 mL/hr during the procedure).</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l106 level2 lfo129;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Withholding NSAIDs.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l106 level2 lfo129;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Omitting metformin for 48 hrs post-procedure in
moderate or high-risk patients.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l106 level2 lfo129;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Consideration of alternative imaging methods if
risks are high (eGFR &lt;30 mL/min/1.73m), but proceed if benefits outweigh
the risk.</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Ref: Davidson principles and practice
of medicine 24<sup>th</sup> edition pg565</span></strong></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>66[Q] Which component of auto-regulation of glomerular
filtration acts on efferent arteriole? </p>

<p class=MsoNormal>(a) Autonomous myogenic reflex </p>

<p class=MsoNormal>(b) Tubuloglomerular feedback </p>

<p class=MsoNormal>(c) Angiotensin II mediated vasoconstriction </p>

<p class=MsoNormal>(d) None of the above </p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[ANS] c</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[SOL] </p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Autoregulation of Glomerular
Filtration:</span></strong></p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Non-linear Relationship with Renal
Artery Pressure:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l3 level2 lfo130;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Glomerular filtration is influenced by renal
artery pressure, but the relationship is not linear across the physiological
blood pressure range.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Autoregulation Mechanisms:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l3 level2 lfo130;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Autoregulation of glomerular filtration involves
three major factors that modulate afferent or efferent arteriolar tone.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Factors Modulating Arteriolar Tone:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l3 level2 lfo130;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Autonomous Vasoreactive (Myogenic)
Reflex:</span></strong></p>

<p class=MsoNormal style='margin-left:106.35pt;text-indent:-14.15pt;mso-list:
l3 level3 lfo130;tab-stops:list 106.35pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>A first line of defense against fluctuations in
renal blood flow.</p>

<p class=MsoNormal style='margin-left:106.35pt;text-indent:-14.15pt;mso-list:
l3 level3 lfo130;tab-stops:list 106.35pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Acute changes in renal perfusion pressure
trigger reflex constriction or dilatation of the afferent arteriole in response
to rising or falling pressure.</p>

<p class=MsoNormal style='margin-left:106.35pt;text-indent:-14.15pt;mso-list:
l3 level3 lfo130;tab-stops:list 106.35pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Protects the glomerular capillary from sudden
changes in systolic pressure.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l3 level2 lfo130;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Tubuloglomerular Feedback (TGF):</span></strong></p>

<p class=MsoNormal style='margin-left:106.35pt;text-indent:-14.15pt;mso-list:
l3 level3 lfo130;tab-stops:list 106.35pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Involved in autoregulation by modulating
afferent arteriolar tone based on feedback from the tubular fluid.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l3 level2 lfo130;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Angiotensin IIMediated
Vasoconstriction:</span></strong></p>

<p class=MsoNormal style='margin-left:106.35pt;text-indent:-14.15pt;mso-list:
l3 level3 lfo130;tab-stops:list 106.35pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Affects efferent arteriolar tone.</p>

<p class=MsoNormal style='margin-left:106.35pt;text-indent:-14.15pt;mso-list:
l3 level3 lfo130;tab-stops:list 106.35pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Plays a role in maintaining glomerular
filtration pressure.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Purpose of Autoregulation:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l3 level2 lfo130;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>To maintain a relatively stable glomerular
filtration rate (GFR) despite changes in systemic blood pressure.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Protective Mechanism:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l3 level2 lfo130;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>The myogenic reflex acts as a protective
mechanism to prevent sudden and potentially damaging changes in the glomerular
capillary pressure.</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Ref: Harrisons principles of
INTERNAL MEDICINE 21<sup>th</sup> edition pg2288</span></strong><b><o:p></o:p></b></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>67[Q] Which of the following are consequences of nephrotic
syndrome ? </p>

<p class=MsoNormal>1. Increased lipoprotein synthesis </p>

<p class=MsoNormal>2. Low serum globulin levels </p>

<p class=MsoNormal>3.<span style='mso-spacerun:yes'> </span>Increased serum
aldosterone levels </p>

<p class=MsoNormal>4.<span style='mso-spacerun:yes'> </span>Increased serum
Antithrombin III levels </p>

<p class=MsoNormal>Select the correct answer using the code given below : </p>

<p class=MsoNormal>(a)1, 2 and 3 </p>

<p class=MsoNormal>(b) 1, 2 and 4 </p>

<p class=MsoNormal>(c) 1,3 and 4 </p>

<p class=MsoNormal>(d)2 and 3 only</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[ANS] a</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[SOL] </p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Consequences of the nephrotic
syndrome</span></strong></p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Mechanisms:</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l6 level1 lfo131;tab-stops:list 35.45pt'><![if !supportLists]><span
style='mso-fareast-font-family:"Liberation Serif";mso-bidi-font-family:"Liberation Serif"'><span
style='mso-list:Ignore'>1.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Hypoalbuminemia:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l6 level2 lfo131;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Cause:</span></strong> Urinary
protein losses exceeding liver synthetic capacity.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l6 level2 lfo131;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Consequence:</span></strong> Reduced
oncotic pressure.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l6 level1 lfo131;tab-stops:list 35.45pt'><![if !supportLists]><span
style='mso-fareast-font-family:"Liberation Serif";mso-bidi-font-family:"Liberation Serif"'><span
style='mso-list:Ignore'>2.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Avid Sodium Retention:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l6 level2 lfo131;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Cause:</span></strong> Secondary
hyperaldosteronism and poorly characterized intrarenal mechanisms.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l6 level2 lfo131;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Consequence:</span></strong> Edema.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l6 level1 lfo131;tab-stops:list 35.45pt'><![if !supportLists]><span
style='mso-fareast-font-family:"Liberation Serif";mso-bidi-font-family:"Liberation Serif"'><span
style='mso-list:Ignore'>3.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Hypercholesterolemia:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l6 level2 lfo131;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Cause:</span></strong> Non-specific
increase in liver lipoprotein synthesis due to low oncotic pressure.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l6 level2 lfo131;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Consequence:</span></strong>
Increased risk of atherosclerosis.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l6 level1 lfo131;tab-stops:list 35.45pt'><![if !supportLists]><span
style='mso-fareast-font-family:"Liberation Serif";mso-bidi-font-family:"Liberation Serif"'><span
style='mso-list:Ignore'>4.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Hypercoagulability:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l6 level2 lfo131;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Cause:</span></strong> Loss of
coagulation inhibitors, elevated procoagulant factors.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l6 level2 lfo131;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Consequence:</span></strong> Elevated
risk of venous thromboembolism.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l6 level1 lfo131;tab-stops:list 35.45pt'><![if !supportLists]><span
style='mso-fareast-font-family:"Liberation Serif";mso-bidi-font-family:"Liberation Serif"'><span
style='mso-list:Ignore'>5.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Infection Susceptibility:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l6 level2 lfo131;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Cause:</span></strong>
Hypogammaglobulinemia from urinary immunoglobulin loss.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l6 level2 lfo131;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Consequence:</span></strong>
Increased vulnerability to pneumococcal and meningococcal infections.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Ref: Davidson principles and practice
of medicine 24<sup>th</sup> edition pg572</span></strong></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>68[Q] Sickle cell syndromes are caused by a mutation in the
B-globin gene. Which one of the following correctly describes the change? </p>

<p class=MsoNormal>(a) Sixth amino acid-glutamic acid is replaced by valine. </p>

<p class=MsoNormal>(b) Twenty-sixth amino acid-glutamic acid is replaced by
lysine. </p>

<p class=MsoNormal>(c) Sixth amino acid-glutamic acid is replaced by lysine </p>

<p class=MsoNormal>(d) Ninety eighth amino acid-valine is replaced by
methionine.</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[ANS] a</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[SOL] </p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Sickle-Cell Anaemia: Overview</span></strong></p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Genetic Basis:</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l23 level1 lfo132;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Mutation:</span></strong> Single
glutamic acid to valine substitution at position 6 of the beta globin
polypeptide chain.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l23 level1 lfo132;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Inheritance:</span></strong>
Autosomal recessive trait.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Clinical Manifestations:</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l145 level1 lfo133;tab-stops:list 35.45pt'><![if !supportLists]><span
style='mso-fareast-font-family:"Liberation Serif";mso-bidi-font-family:"Liberation Serif"'><span
style='mso-list:Ignore'>1.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Sickle-Cell Disease (SS):</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l145 level2 lfo133;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Genotype:</span></strong> Homozygotes
(SS).</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l145 level2 lfo133;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Hemoglobin Produced:</span></strong>
Abnormal beta chains resulting in Hemoglobin S (HbS).</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l145 level2 lfo133;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Clinical Syndrome:</span></strong>
Sickle-cell disease.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l145 level1 lfo133;tab-stops:list 35.45pt'><![if !supportLists]><span
style='mso-fareast-font-family:"Liberation Serif";mso-bidi-font-family:"Liberation Serif"'><span
style='mso-list:Ignore'>2.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Sickle-Cell Trait (AS):</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l145 level2 lfo133;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Genotype:</span></strong>
Heterozygotes (AS).</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l145 level2 lfo133;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Hemoglobin Produced:</span></strong>
Mixture of normal and abnormal beta chains producing normal HbA and HbS.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l145 level2 lfo133;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Clinical Condition:</span></strong>
Sickle-cell trait.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l145 level2 lfo133;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Previous Belief:</span></strong>
Considered asymptomatic, but associated with an increased risk of sudden and
cardiovascular death in young adults.</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Ref: Davidson principles and practice
of medicine 24<sup>th</sup> edition pg960</span></strong></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>69[Q] In which of the following a high reticulocyte
production index is seen?</p>

<p class=MsoNormal>1. Sickle cell disease</p>

<p class=MsoNormal>2. Vitamin B-12 deficiency</p>

<p class=MsoNormal>3. Glucose 6 phosphate dehydrogenase deficiency</p>

<p class=MsoNormal>4. Blood loss</p>

<p class=MsoNormal>Select the correct answer using the code given below:</p>

<p class=MsoNormal>(a) 1, 2 and 3 </p>

<p class=MsoNormal>(b) 1, 2 and 4 </p>

<p class=MsoNormal>(c) 1, 3 and 4 </p>

<p class=MsoNormal>(d) 2, 3 and 4</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[ANS] c</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[SOL] Reticulocytes are immature red blood cells that still
contain some ribosomal RNA.<span style='mso-spacerun:yes'> </span>A high RPI
indicates an increased production of red blood cells, which can occur in
response to blood loss, hemolysis, or ineffective erythropoiesis. Glucose 6
phosphate dehydrogenase deficiency post hemolysis can have high RPI. In Sickle
cell disease due to<span style='mso-spacerun:yes'> </span>ineffective
erythropoiesis can have high RPI.</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>70[Q] Which one of the following combinations of drugs can
be used for treatment of relapsed myeloma ?</p>

<p class=MsoNormal>(a) Infliximab, Methotrexate, Dexamethasone </p>

<p class=MsoNormal>(b) Lenalidomide, Bortezomib, Dexamethasone </p>

<p class=MsoNormal>(c) Rituximab, Vincristine, Cytarabine </p>

<p class=MsoNormal>(d) Methotrexate, Doxorubicin, Prednisone </p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[ANS] b</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[SOL] <strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Treatment Landscape for
Relapsed/Refractory Multiple Myeloma:</span></strong></p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>1. Second-Generation Proteasome
Inhibitors:</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l102 level1 lfo134;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Agents:</span></strong> Carfilzomib,
ixazomib.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l102 level1 lfo134;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Use:</span></strong> Effective in
relapsed myeloma, even in cases refractory to lenalidomide and bortezomib.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l102 level1 lfo134;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Administration:</span></strong>
Ixazomib is an oral proteasome inhibitor.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>2. Immunomodulatory Agents:</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l123 level1 lfo135;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Agents:</span></strong> Lenalidomide,
pomalidomide.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l123 level1 lfo135;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Use:</span></strong> Lenalidomide and
pomalidomide are employed in relapsed myeloma treatment.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>3. Monoclonal Antibodies:</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l160 level1 lfo136;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Daratumumab:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l160 level2 lfo136;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Target:</span></strong> CD38.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l160 level2 lfo136;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Use:</span></strong> Achieves high
response rates; effective as a single agent and in combination with bortezomib,
dexamethasone, or lenalidomide and dexamethasone.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l160 level1 lfo136;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Isatuximab:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l160 level2 lfo136;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Target:</span></strong> CD38.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l160 level2 lfo136;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Use:</span></strong> Effective in
combination with pomalidomide or carfilzomib and dexamethasone.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l160 level1 lfo136;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Elotuzumab:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l160 level2 lfo136;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Target:</span></strong> SLAMF7.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l160 level2 lfo136;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Use:</span></strong> Shows
significant activity in combination with lenalidomide and dexamethasone.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>4. Histone Deacetylase Inhibitor:</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l124 level1 lfo137;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Agent:</span></strong> Panobinostat.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l124 level1 lfo137;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Use:</span></strong> Approved in
combination with bortezomib and dexamethasone for relapsed refractory myeloma.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>5. Novel Agents:</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l99 level1 lfo138;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Selinexor:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l99 level2 lfo138;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Mechanism:</span></strong> Exportin
inhibitor.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l99 level2 lfo138;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Use:</span></strong> Effective in
relapsed/refractory myeloma.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l99 level1 lfo138;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Melflufen:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l99 level2 lfo138;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Mechanism:</span></strong> Alkylating
agent conjugated to a peptide.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l99 level2 lfo138;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Use:</span></strong> Approved for
relapsed/refractory myeloma.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>6. BCMA-Targeted Therapies:</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l32 level1 lfo139;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Belantamab:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l32 level2 lfo139;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Type:</span></strong> Anti-BCMA
antibody-drug conjugate.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l32 level2 lfo139;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Use:</span></strong> Achieves
responses in relapsed/refractory myeloma; notable for ophthalmologic toxicity.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l32 level1 lfo139;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Ide-cel (Idecabtagene Vicleucel):</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l32 level2 lfo139;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Type:</span></strong> Anti-BCMA CAR
T-cell therapy.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l32 level2 lfo139;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Use:</span></strong> Approved beyond
fourth-line therapy; shows high response rates.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l32 level2 lfo139;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Ref: Harrisons principles of
INTERNAL MEDICINE 21<sup>th</sup> edition pg875</span></strong><b><o:p></o:p></b></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>71[Q] Which of the following can be used in the initial
management of heparin induced thrombocytopenia ?</p>

<p class=MsoNormal>1. Fondaparinux</p>

<p class=MsoNormal>2. Rivaroxaban</p>

<p class=MsoNormal>3. Lepirudin</p>

<p class=MsoNormal>4. Warfarin</p>

<p class=MsoNormal>Select the correct answer using the code given below : </p>

<p class=MsoNormal>(a) 1, 2 and 3 </p>

<p class=MsoNormal>(b) 1, 2 and 4 </p>

<p class=MsoNormal>(c) 1,3 and 4</p>

<p class=MsoNormal>(d) 2, 3 and 4 </p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[ANS] a</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[SOL] </p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Heparin-Induced Thrombocytopenia
(HIT): Overview and Management</span></strong></p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Pathophysiology:</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l53 level1 lfo140;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Trigger:</span></strong> Antibodies
against neoantigens on PF4 exposed when heparin binds.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l53 level1 lfo140;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Antibody Type:</span></strong>
Usually IgG isotype.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l53 level1 lfo140;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Mechanism:</span></strong> Antibodies
bind to heparin-PF4 complex and platelet Fc receptors, activating platelets and
generating prothrombotic platelet microparticles.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l53 level1 lfo140;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Prothrombotic Effect:</span></strong>
Microparticles express anionic phospholipids, bind clotting factors, and
promote thrombin generation.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Clinical Features:</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l59 level1 lfo141;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Onset:</span></strong> Typically 514
days after heparin initiation (can be earlier if heparin received in the past 3
months).</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l59 level1 lfo141;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Platelet Count Criteria:</span></strong>
Platelet count &lt;100,000/&#956;L or 50% decrease from pretreatment value.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l59 level1 lfo141;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Prevalence:</span></strong> More
common in surgical patients, females, and associated with thrombosis (venous
more common than arterial).</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Diagnosis:</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l11 level1 lfo142;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Enzyme-Linked Assays:</span></strong>
Detect antibodies against heparin-PF4 complexes (sensitive but not specific).</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l11 level1 lfo142;tab-stops:list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Serotonin Release Assay:</span></strong>
Most specific diagnostic test; measures serotonin release induced by patient
serum with added heparin.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Management:</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l57 level1 lfo143;tab-stops:list 35.45pt'><![if !supportLists]><span
style='mso-fareast-font-family:"Liberation Serif";mso-bidi-font-family:"Liberation Serif"'><span
style='mso-list:Ignore'>1.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Stop Heparin:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l57 level2 lfo143;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>In suspected or documented HIT.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l57 level1 lfo143;tab-stops:list 35.45pt'><![if !supportLists]><span
style='mso-fareast-font-family:"Liberation Serif";mso-bidi-font-family:"Liberation Serif"'><span
style='mso-list:Ignore'>2.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Alternative Anticoagulant:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l57 level2 lfo143;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Parenteral Direct Thrombin
Inhibitors:</span></strong> Argatroban, bivalirudin.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l57 level2 lfo143;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Factor Xa Inhibitors:</span></strong>
Fondaparinux, rivaroxaban.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l57 level1 lfo143;tab-stops:list 35.45pt'><![if !supportLists]><span
style='mso-fareast-font-family:"Liberation Serif";mso-bidi-font-family:"Liberation Serif"'><span
style='mso-list:Ignore'>3.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Monitoring and Transition:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l57 level2 lfo143;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Monitoring:</span></strong> Assess
platelet count and monitor for thrombosis.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l57 level2 lfo143;tab-stops:list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Transition to Oral Anticoagulant:</span></strong>
When platelet count normalizes, consider low-dose warfarin or direct oral
anticoagulant.</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Ref: Harrisons principles of
INTERNAL MEDICINE 21<sup>th</sup> edition pg930</span></strong><b><o:p></o:p></b></p>

<p class=MsoNormal><b><o:p>&nbsp;</o:p></b></p>

<p class=MsoNormal>72[Q] Red cell protoporphyrin levels will be raised in which
of the following conditions ?</p>

<p class=MsoNormal>1. Absolute iron deficiency</p>

<p class=MsoNormal>2. Relative iron deficiency </p>

<p class=MsoNormal>3. Lead poisoning</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>Select the correct answer using the code given below : </p>

<p class=MsoNormal>(a) 1 and 3 only </p>

<p class=MsoNormal>(b) 1 and 2 only </p>

<p class=MsoNormal>(c) 2 and 3 only </p>

<p class=MsoNormal>(d) 1, 2 and 3</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[ANS] a</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[SOL] <strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Red Cell Protoporphyrin</span></strong></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l93 level1 lfo144;tab-stops:0cm list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Overview:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l93 level2 lfo144;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Protoporphyrin is a critical intermediate in
heme synthesis.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l93 level2 lfo144;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Impaired heme synthesis leads to protoporphyrin
accumulation within red cells.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l93 level1 lfo144;tab-stops:0cm list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Significance:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l93 level2 lfo144;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Reflects inadequate iron supply to erythroid
precursors for hemoglobin synthesis.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l93 level1 lfo144;tab-stops:0cm list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Normal Values:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l93 level2 lfo144;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Normal: &lt;30 &#956;g/dL of red cells.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l93 level1 lfo144;tab-stops:0cm list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Iron Deficiency:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l93 level2 lfo144;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Elevated levels: &gt;100 &#956;g/dL.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l93 level2 lfo144;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Indicates insufficient iron support for
erythropoiesis.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l93 level1 lfo144;tab-stops:0cm list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Common Causes of Increased Levels:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l93 level2 lfo144;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Absolute or relative iron deficiency.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l93 level2 lfo144;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Lead poisoning.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l93 level1 lfo144;tab-stops:0cm list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Clinical Implications:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l93 level2 lfo144;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Monitoring red cell protoporphyrin aids in
diagnosing conditions affecting heme synthesis and iron availability.</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Ref: Harrisons principles of
INTERNAL MEDICINE 21<sup>th</sup> edition pg751</span></strong><b><o:p></o:p></b></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>73[Q] Negative Iron Balance is the first stage in the
progression to Iron Deficiency Anaemia. Which of the following laboratory
investigations will be found deranged in this stage, thereby pointing to early
iron-store depletion?</p>

<p class=MsoNormal>1. Bone Marrow Iron Stores</p>

<p class=MsoNormal>2. Percent transferrin saturation</p>

<p class=MsoNormal>3. Serum ferritin</p>

<p class=MsoNormal>4. Total Iron Binding Capacity</p>

<p class=MsoNormal>Select the correct answer using the code given below : </p>

<p class=MsoNormal>(a) 1, 2 and 3 </p>

<p class=MsoNormal>(b) 1, 2 and 4 </p>

<p class=MsoNormal>(c) 1,3 and 4</p>

<p class=MsoNormal>(d) 2, 3 and 4 </p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[ANS] c</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[SOL]</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Ref: Harrisons principles of
INTERNAL MEDICINE 21<sup>th</sup> edition pg749</span></strong><b><o:p></o:p></b></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>74[Q] Which of the following drugs carry a definite risk of
causing clinical haemolysis in persons suffering from Glucose-6 phosphate
dehydrogenase deficiency ?</p>

<p class=MsoNormal>1. Primaquine</p>

<p class=MsoNormal>2. Dapsone </p>

<p class=MsoNormal>3. Cotrimoxazole </p>

<p class=MsoNormal>4. Nitrofurantoin</p>

<p class=MsoNormal>Select the correct answer using the code given below :</p>

<p class=MsoNormal>(a) 1,3 and 4 </p>

<p class=MsoNormal>(b) 1 and 2 only</p>

<p class=MsoNormal>(c) 2, 3 and 4 only </p>

<p class=MsoNormal>(d) 1, 2, 3 and 4</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[ANS] d</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[SOL] </p>

<p class=MsoNormal>Glucose-6-phosphate dehydrogenase deficiency</p>

<p class=MsoNormal>Clinical features</p>

<p class=MsoNormal>Clinical Features:</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l127 level1 lfo145;tab-stops:0cm list 35.45pt'><![if !supportLists]><span
style='mso-fareast-font-family:"Liberation Serif";mso-bidi-font-family:"Liberation Serif"'><span
style='mso-list:Ignore'>1.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Acute Drug-Induced Hemolysis:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l127 level2 lfo145;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Triggered by certain drugs such as analgesics
(aspirin, phenacetin), antimalarials (primaquine, quinine, chloroquine,
pyrimethamine), antibiotics (sulphonamides, nitrofurantoin, ciprofloxacin), and
other medications (quinidine, probenecid, vitamin K, dapsone).</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l127 level1 lfo145;tab-stops:0cm list 35.45pt'><![if !supportLists]><span
style='mso-fareast-font-family:"Liberation Serif";mso-bidi-font-family:"Liberation Serif"'><span
style='mso-list:Ignore'>2.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Chronic Compensated Hemolysis:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l127 level2 lfo145;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>A long-term, ongoing destruction of red blood
cells without overt symptoms in between acute episodes.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l127 level1 lfo145;tab-stops:0cm list 35.45pt'><![if !supportLists]><span
style='mso-fareast-font-family:"Liberation Serif";mso-bidi-font-family:"Liberation Serif"'><span
style='mso-list:Ignore'>3.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Infection or Acute Illness:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l127 level2 lfo145;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Hemolysis may be triggered during times of
infection or acute illness.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l127 level1 lfo145;tab-stops:0cm list 35.45pt'><![if !supportLists]><span
style='mso-fareast-font-family:"Liberation Serif";mso-bidi-font-family:"Liberation Serif"'><span
style='mso-list:Ignore'>4.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Neonatal Jaundice:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l127 level2 lfo145;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Neonates with G6PD deficiency may exhibit
jaundice, particularly if they have the B enzyme variant.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l127 level1 lfo145;tab-stops:0cm list 35.45pt'><![if !supportLists]><span
style='mso-fareast-font-family:"Liberation Serif";mso-bidi-font-family:"Liberation Serif"'><span
style='mso-list:Ignore'>5.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Favism:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l127 level2 lfo145;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Acute hemolysis can occur after the ingestion of
broad beans (Vicia fava).</p>

<p class=MsoNormal>Laboratory Features:</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Non-Spherocytic Intravascular
Hemolysis:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l154 level2 lfo146;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Destruction of red blood cells within blood
vessels.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Blood Film Findings:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l154 level2 lfo146;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Bite Cells:</span></strong> Red cells
with a 'bite' of membrane missing.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l154 level2 lfo146;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Blister Cells:</span></strong> Red
cells with surface blistering of the membrane.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l154 level2 lfo146;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Irregularly Shaped Small Cells:</span></strong>
Abnormal shapes of red blood cells.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l154 level2 lfo146;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Polychromasia:</span></strong>
Reflecting increased reticulocyte count.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l154 level2 lfo146;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Denatured Hemoglobin:</span></strong>
Visible as Heinz bodies within the red cell cytoplasm with a supravital stain
like methyl violet.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>G6PD Level Assessment:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l154 level2 lfo146;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Indirect Assessment:</span></strong>
Screening methods that usually depend on the decreased ability to reduce dyes.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l154 level2 lfo146;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Direct Assessment:</span></strong> In
those with low screening values, direct assessment of G6PD is made.</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Ref: Davidson principles and practice
of medicine 24<sup>th</sup> edition pg958</span></strong></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>75[Q] A 40 year old male presented with complaints of
generalised weakness, weight loss, abdominal discomfort and decreased appetite.
On examination Splenomegaly (massive) was present. On investigation it was
found that haemoglobin was 7:0 g/dL, platelet count- 8 lakh per cubic mm, WBC
90000 per cubic mm. Most probably this is the case of</p>

<p class=MsoNormal>(a) Chronic lymphocytic leukemia </p>

<p class=MsoNormal>(b) Chronic myeloid leukemia </p>

<p class=MsoNormal>(c) Acute lymphoblastic leukemia </p>

<p class=MsoNormal>(d) Acute myeloid leukemia</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[ANS] b</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[SOL] </p>

<p class=MsoNormal>Chronic Myeloid Leukemia (CML)</p>

<p class=MsoNormal>Molecular Basis:</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l83 level1 lfo147;tab-stops:0cm list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Philadelphia Chromosome (Ph):</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l83 level2 lfo147;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Chromosome 22 is shortened due to a reciprocal
translocation with chromosome 9.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l83 level2 lfo147;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Break in the BCR (Breakpoint Cluster Region) on
chromosome 22.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l83 level2 lfo147;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>ABL oncogene from chromosome 9 fuses with the
BCR, forming the BCR-ABL fusion gene.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l83 level2 lfo147;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Codes for a 210 kDa protein with tyrosine kinase
activity, acting as an oncogene influencing cellular proliferation,
differentiation, and survival.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l83 level2 lfo147;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Target for effective tyrosine kinase inhibitor
(TKI) therapy.</p>

<p class=MsoNormal>Natural History:</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l111 level1 lfo148;tab-stops:0cm list 35.45pt'><![if !supportLists]><span
style='mso-fareast-font-family:"Liberation Serif";mso-bidi-font-family:"Liberation Serif"'><span
style='mso-list:Ignore'>1.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Chronic Phase:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l111 level2 lfo148;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Responsive to treatment, easily controlled.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l111 level2 lfo148;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Originally lasting 35 years, now prolonged with
TKI therapy, leading to a near-normal life expectancy.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l111 level1 lfo148;tab-stops:0cm list 35.45pt'><![if !supportLists]><span
style='mso-fareast-font-family:"Liberation Serif";mso-bidi-font-family:"Liberation Serif"'><span
style='mso-list:Ignore'>2.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Accelerated Phase:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l111 level2 lfo148;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Disease control becomes more difficult.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l111 level1 lfo148;tab-stops:0cm list 35.45pt'><![if !supportLists]><span
style='mso-fareast-font-family:"Liberation Serif";mso-bidi-font-family:"Liberation Serif"'><span
style='mso-list:Ignore'>3.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Blast Crisis:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l111 level2 lfo148;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Transformation into acute leukemia (myeloblastic
70%, lymphoblastic 30%).</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l111 level2 lfo148;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Relatively refractory to treatment, major cause
of death.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l111 level2 lfo148;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Survival depends on the timing of blast crisis.</p>

<p class=MsoNormal>Clinical Features:</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l86 level1 lfo149;tab-stops:0cm list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Symptoms at Presentation:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l86 level2 lfo149;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Lethargy, weight loss, abdominal discomfort,
gout, sweating.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l86 level2 lfo149;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>25% of patients are asymptomatic at diagnosis.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l86 level1 lfo149;tab-stops:0cm list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Physical Examination:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l86 level2 lfo149;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Splenomegaly in 90%, occasionally massive.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l86 level2 lfo149;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Hepatomegaly in about 50%.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l86 level2 lfo149;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Unusual lymphadenopathy.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l86 level1 lfo149;tab-stops:0cm list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Splenomegaly Complications:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l86 level2 lfo149;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Friction rub in splenic infarction cases.</p>

<p class=MsoNormal>Investigations:</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l30 level1 lfo150;tab-stops:0cm list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Blood Parameters:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l30 level2 lfo150;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Variable FBC results, normocytic normochromic
anemia common.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l30 level2 lfo150;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Leucocyte count varies (10 to 600  10^9/L).</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l30 level2 lfo150;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>High platelet count in about one-third of
patients.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l30 level2 lfo150;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Blood film shows granulocyte precursors, with
neutrophils and myelocytes predominant.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l30 level2 lfo150;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Eosinophils, basophils, and nucleated red cells
are common.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l30 level1 lfo150;tab-stops:0cm list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Disease Progression:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l30 level2 lfo150;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Accelerated phase shows an increase in primitive
cells.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l30 level2 lfo150;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Blast transformation characterized by a dramatic
increase in circulating blasts.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l30 level1 lfo150;tab-stops:0cm list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Bone Marrow Examination:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l30 level2 lfo150;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Confirms the diagnosis and phase.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l30 level2 lfo150;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Chromosome analysis shows the presence of the Ph
chromosome.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l30 level2 lfo150;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>RNA analysis demonstrates the presence of the
BCR-ABL gene product.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l30 level1 lfo150;tab-stops:0cm list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Biochemical Markers:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l30 level2 lfo150;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Elevated blood LDH.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l30 level2 lfo150;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>High uric acid due to increased cell breakdown.</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Ref: Davidson principles and practice
of medicine 24<sup>th</sup> edition pg967</span></strong></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>76[Q] Which of the following are risk factors for type 2 diabetes
mellitus? </p>

<p class=MsoNormal>1. Family history of diabetes </p>

<p class=MsoNormal>2. Underweight </p>

<p class=MsoNormal>3. Physical inactivity </p>

<p class=MsoNormal>4. Polycystic ovary syndrome </p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>Select the correct answer using the code given below: </p>

<p class=MsoNormal>(a) 1, 2 and 3 </p>

<p class=MsoNormal>(b) 1, 2 and 4 </p>

<p class=MsoNormal>(c) 1, 3 and 4 </p>

<p class=MsoNormal>(d) 2, 3 and 4 </p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[ANS] c</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[SOL] </p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Criteria for Screening Type 2
Diabetes Mellitus in Adults:</span></strong><b><o:p></o:p></b></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l50 level1 lfo151;tab-stops:0cm list 35.45pt'><![if !supportLists]><b><span
style='mso-fareast-font-family:"Liberation Serif";mso-bidi-font-family:"Liberation Serif"'><span
style='mso-list:Ignore'>1.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span></b><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Consider Testing in Overweight or
Obese Individuals:</span></strong><b><o:p></o:p></b></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l50 level2 lfo151;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol;mso-bidi-font-weight:bold'><span style='mso-list:Ignore'><span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><![endif]>BMI
&#8805;25 kg/m (&#8805;23 kg/m in Asian Americans or other ethnically
relevant definitions).<b><o:p></o:p></b></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l50 level2 lfo151;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol;mso-bidi-font-weight:bold'><span style='mso-list:Ignore'><span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><![endif]>Risk
Factors:<b><o:p></o:p></b></p>

<p class=MsoNormal style='margin-left:106.35pt;text-indent:-14.15pt;mso-list:
l50 level3 lfo151;tab-stops:0cm list 106.35pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol;mso-bidi-font-weight:bold'><span style='mso-list:Ignore'><span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><![endif]>Family
history of diabetes (parent or sibling with type 2 diabetes).<b><o:p></o:p></b></p>

<p class=MsoNormal style='margin-left:106.35pt;text-indent:-14.15pt;mso-list:
l50 level3 lfo151;tab-stops:0cm list 106.35pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol;mso-bidi-font-weight:bold'><span style='mso-list:Ignore'><span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><![endif]>Race/Ethnicity:
African American, Latino, Native American, Asian American, Pacific Islander.<b><o:p></o:p></b></p>

<p class=MsoNormal style='margin-left:106.35pt;text-indent:-14.15pt;mso-list:
l50 level3 lfo151;tab-stops:0cm list 106.35pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol;mso-bidi-font-weight:bold'><span style='mso-list:Ignore'><span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><![endif]>Hypertension
(blood pressure &#8805;140/90 mmHg).<b><o:p></o:p></b></p>

<p class=MsoNormal style='margin-left:106.35pt;text-indent:-14.15pt;mso-list:
l50 level3 lfo151;tab-stops:0cm list 106.35pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol;mso-bidi-font-weight:bold'><span style='mso-list:Ignore'><span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><![endif]>HDL
cholesterol level &lt;35 mg/dL (0.90 mmol/L) and/or triglyceride level &gt;250
mg/dL (2.82 mmol/L).<b><o:p></o:p></b></p>

<p class=MsoNormal style='margin-left:106.35pt;text-indent:-14.15pt;mso-list:
l50 level3 lfo151;tab-stops:0cm list 106.35pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol;mso-bidi-font-weight:bold'><span style='mso-list:Ignore'><span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><![endif]>Polycystic
ovary syndrome or acanthosis nigricans.<b><o:p></o:p></b></p>

<p class=MsoNormal style='margin-left:106.35pt;text-indent:-14.15pt;mso-list:
l50 level3 lfo151;tab-stops:0cm list 106.35pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol;mso-bidi-font-weight:bold'><span style='mso-list:Ignore'><span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><![endif]>History
of cardiovascular disease.<b><o:p></o:p></b></p>

<p class=MsoNormal style='margin-left:106.35pt;text-indent:-14.15pt;mso-list:
l50 level3 lfo151;tab-stops:0cm list 106.35pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol;mso-bidi-font-weight:bold'><span style='mso-list:Ignore'><span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><![endif]>Physical
inactivity.<b><o:p></o:p></b></p>

<p class=MsoNormal style='margin-left:106.35pt;text-indent:-14.15pt;mso-list:
l50 level3 lfo151;tab-stops:0cm list 106.35pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol;mso-bidi-font-weight:bold'><span style='mso-list:Ignore'><span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><![endif]>Other
conditions associated with insulin resistance (severe obesity, acanthosis
nigricans).<b><o:p></o:p></b></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l50 level1 lfo151;tab-stops:0cm list 35.45pt'><![if !supportLists]><b><span
style='mso-fareast-font-family:"Liberation Serif";mso-bidi-font-family:"Liberation Serif"'><span
style='mso-list:Ignore'>2.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span></b><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Annual Screening for Individuals with
Identified IFG, IGT, or Hemoglobin A1c of 5.76.4%:</span></strong><b><o:p></o:p></b></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l50 level2 lfo151;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol;mso-bidi-font-weight:bold'><span style='mso-list:Ignore'><span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><![endif]>Individuals
with previously identified impaired fasting glucose (IFG), impaired glucose
tolerance (IGT), or a hemoglobin A1c in the range of 5.76.4% should be
screened annually.<b><o:p></o:p></b></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l50 level1 lfo151;tab-stops:0cm list 35.45pt'><![if !supportLists]><b><span
style='mso-fareast-font-family:"Liberation Serif";mso-bidi-font-family:"Liberation Serif"'><span
style='mso-list:Ignore'>3.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span></b><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Screening Frequency for Women with
Gestational Diabetes Mellitus (GDM):</span></strong><b><o:p></o:p></b></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l50 level2 lfo151;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol;mso-bidi-font-weight:bold'><span style='mso-list:Ignore'><span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><![endif]>Women
who had gestational diabetes should be screened at least every 3 years.<b><o:p></o:p></b></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l50 level1 lfo151;tab-stops:0cm list 35.45pt'><![if !supportLists]><b><span
style='mso-fareast-font-family:"Liberation Serif";mso-bidi-font-family:"Liberation Serif"'><span
style='mso-list:Ignore'>4.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span></b><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Initiate Testing at 45 Years of Age
and Repeat Every 3 Years for Other Individuals</span></strong><b><o:p></o:p></b></p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l50 level1 lfo151;tab-stops:0cm list 35.45pt'><![if !supportLists]><b><span
style='mso-fareast-font-family:"Liberation Serif";mso-bidi-font-family:"Liberation Serif"'><span
style='mso-list:Ignore'>5.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span></span></b><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Screening for Individuals with HIV</span></strong><b><o:p></o:p></b></p>

<p class=MsoNormal><b><o:p>&nbsp;</o:p></b></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Ref: Harrisons principles of
INTERNAL MEDICINE 21<sup>th</sup> edition pg3097</span></strong><b><o:p></o:p></b></p>

<p class=MsoNormal><b><o:p>&nbsp;</o:p></b></p>

<p class=MsoNormal>77[Q] Which of the following with regard to gestational
diabetes mellitus (GDM) are correct?</p>

<p class=MsoNormal>1. Most women revert to normal glucose tolerance postpartum</p>

<p class=MsoNormal>2. Children born to a GDM mother have no increased risk of
diabetes mellitus later in life</p>

<p class=MsoNormal>3. Glucose intolerance develops during the second and third
trimesters</p>

<p class=MsoNormal>4. Insulin resistance is related to metabolic changes of
pregnancy</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>Select the correct answer using the code given below:</p>

<p class=MsoNormal>(a) 1, 2 and 3</p>

<p class=MsoNormal>(b) 1, 2 and 4</p>

<p class=MsoNormal>(c) 1, 3 and 4</p>

<p class=MsoNormal>(d) 2, 3 and 4</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[ANS] c</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[SOL] </p>

<p class=MsoNormal>Diabetes Mellitus (DM) and Reproductive Health:</p>

<p class=MsoNormal>Reproductive Capacity:</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l67 level1 lfo152;tab-stops:0cm list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Men and Women with DM:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l67 level2 lfo152;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Reproductive capacity appears to be normal in
both men and women with diabetes.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l67 level1 lfo152;tab-stops:0cm list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Menstrual Cycles in Women with DM:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l67 level2 lfo152;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Menstrual cycles may be associated with
alterations in glycemic control in women with diabetes.</p>

<p class=MsoNormal>Pregnancy and Gestational Diabetes Mellitus (GDM):</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l27 level1 lfo153;tab-stops:0cm list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Insulin Resistance in Pregnancy:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l27 level2 lfo153;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Pregnancy is associated with marked insulin
resistance, often leading to the diagnosis of gestational diabetes mellitus
(GDM).</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l27 level1 lfo153;tab-stops:0cm list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Effects of Hyperglycemia during
Pregnancy:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l27 level2 lfo153;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Hyperglycemia from the maternal circulation may
stimulate insulin secretion in the fetus.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l27 level2 lfo153;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Anabolic and growth effects of insulin may
result in macrosomia (large baby).</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l27 level2 lfo153;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Glucose, at high levels, is a teratogen to the
developing fetus.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l27 level1 lfo153;tab-stops:0cm list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Incidence of GDM:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l27 level2 lfo153;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>GDM complicates ~7% (range 114%) of
pregnancies.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l27 level2 lfo153;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Higher incidence in certain ethnic groups
(blacks, Latinas) with an increased risk of type 2 DM.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l27 level1 lfo153;tab-stops:0cm list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Screening Recommendations:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l27 level2 lfo153;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Screen for glucose intolerance between weeks 24
and 28 of pregnancy in women not known to have diabetes.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l27 level1 lfo153;tab-stops:0cm list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Therapy for GDM:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l27 level2 lfo153;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Involves Medical Nutrition Therapy (MNT) and
insulin if hyperglycemia persists.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l27 level2 lfo153;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Oral glucose-lowering agents not approved for
use during pregnancy, but metformin or glyburide have shown efficacy.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l27 level1 lfo153;tab-stops:0cm list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Postpartum Outcomes:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l27 level2 lfo153;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Morbidity and mortality rates for the mother and
fetus are not significantly different from the nondiabetic population.</p>

<p class=MsoNormal>Future Risks and Post-Delivery Outcomes:</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l105 level1 lfo154;tab-stops:0cm list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Increased Risk for Future Type 2 DM:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l105 level2 lfo154;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Individuals who develop GDM are at a marked
increased risk of developing type 2 DM in the future.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l105 level1 lfo154;tab-stops:0cm list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Post-Delivery Outcomes:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l105 level2 lfo154;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Most individuals with GDM revert to normal
glucose tolerance after delivery.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l105 level2 lfo154;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Some may continue to have overt diabetes or
impaired glucose tolerance post-delivery.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l105 level1 lfo154;tab-stops:0cm list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Risk for Offspring:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l105 level2 lfo154;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Children of women with GDM are at risk for
obesity, glucose intolerance, and increased risk of diabetes in adolescence.</p>

<p class=MsoNormal>Pregnancy Planning and Management in Individuals with Known
DM:</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l144 level1 lfo155;tab-stops:0cm list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Meticulous Planning and Treatment:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l144 level2 lfo155;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Individuals with known DM planning pregnancy
require meticulous planning and adherence to strict treatment regimens.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l144 level1 lfo155;tab-stops:0cm list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Intensive Insulin Therapy:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l144 level2 lfo155;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Intensive insulin therapy and near-normalization
of HbA1c (&lt;6.5%) are essential during pregnancy planning.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l144 level1 lfo155;tab-stops:0cm list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Preconception Glycemic Control:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l144 level2 lfo155;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Consideration for insulin infusion and
Continuous Glucose Monitoring (CGM) devices to improve glycemic control before
conception.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l144 level1 lfo155;tab-stops:0cm list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Risk Reduction during Preconception:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l144 level2 lfo155;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Normal blood glucose during preconception and
throughout fetal organ development is crucial.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l144 level2 lfo155;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Frequent monitoring of HbA1c every 2 months
throughout gestation.</p>

<p class=MsoNormal style='margin-left:35.45pt;text-indent:-14.15pt;mso-list:
l144 level1 lfo155;tab-stops:0cm list 35.45pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Maintenance of HbA1c &lt;6.06.5%:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l144 level2 lfo155;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Reduces the incidence and severity of fetal
macrosomia and neonatal hypoglycemia related to fetal hyperinsulinism driven by
elevated maternal glucose.</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Ref: Harrisons principles of
INTERNAL MEDICINE 21<sup>th</sup> edition pg3119</span></strong><b><o:p></o:p></b></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>78[Q] A Thyroid Function Test report shows the following
results: </p>

<p class=MsoNormal>TSH-Undetectable </p>

<p class=MsoNormal>T3-Raised </p>

<p class=MsoNormal>T4-Raised. </p>

<p class=MsoNormal>Which one of the following will be the most likely
interpretation on the basis of the above report? </p>

<p class=MsoNormal>(a) Hypothyroidism secondary pituitary disease<span
style='mso-spacerun:yes'> </span></p>

<p class=MsoNormal>(b) Transient thyroiditis in evolution </p>

<p class=MsoNormal>(c) Primary thyrotoxicosis </p>

<p class=MsoNormal>(d) Overtreatment of hypothyroidism with Liothyronine.</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[ANS] a</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[SOL] </p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Ref: Davidson principles and practice
of medicine 24<sup>th</sup> edition pg967</span></strong></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>79[Q] Which of the following biochemical abnormality is seen
in severe hypertriglyceridemia?</p>

<p class=MsoNormal><span style='mso-spacerun:yes'></span></p>

<p class=MsoNormal>(a) Psuedohyponatremia</p>

<p class=MsoNormal>(b) Metabolic alkalosis</p>

<p class=MsoNormal>(c) Hyperuricemia</p>

<p class=MsoNormal>(d) Hyperkalemia</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[ANS] a</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[SOL] </p>

<p class=MsoNormal><span style='color:#374151'>Pseudohyponatremia is a
condition in which the measured serum sodium appears low, but the actual sodium
content in the body is normal. This discrepancy is often due to changes in the
composition of the plasma, where water is diluted by substances other than
sodium. The two common causes of pseudohyponatremia are extreme
hyperlipidemia<span style='mso-spacerun:yes'> </span>and/or hyperproteinemia.</span></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic";color:#374151'>Ref: Harrisons
principles of INTERNAL MEDICINE 21<sup>th</sup> edition pg344</span></strong><b><o:p></o:p></b></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>80[Q] Which of the following statements are correct about
treatment with vit D supplement ? </p>

<p class=MsoNormal>1. Serum calcium levels improve earlier than serum PTH
levels</p>

<p class=MsoNormal>2. Patients should be closely observed with serial vitamin D
levels in blood as vitamin D toxicity occurs frequently</p>

<p class=MsoNormal>3. Vitamin D supplementation should always be in conjunction
with calcium supplementation.</p>

<p class=MsoNormal>4. Nephrolithiasis is a known complication</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>Select the correct answer using the code given below : </p>

<p class=MsoNormal>(a) 1, 2 and 3 </p>

<p class=MsoNormal>(b) 1, 2. and 4 </p>

<p class=MsoNormal>(c) 1,3 and 4 </p>

<p class=MsoNormal>(d) 2,3 and 4</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[ANS] c</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[SOL] </p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>81[Q] The first line investigation for diagnostic evaluation
of patients with hypercalcemia is</p>

<p class=MsoNormal>(a) 24 hour urinary calcium excretion</p>

<p class=MsoNormal>(b) Serum phosphate levels</p>

<p class=MsoNormal>(c) Serum iPTH levels</p>

<p class=MsoNormal>(d) Serum vitamin D levels</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[ANS] c</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[SOL] The first line investigation for diagnostic evaluation
of patients with hypercalcemia is to measure serum intact parathyroid hormone
(iPTH) levels. Elevated iPTH levels suggest primary hyperparathyroidism, while
low or undetectable iPTH levels suggest other causes of hypercalcemia such as
malignancy or granulomatous disease</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>82[Q] Consider the following conditions: </p>

<p class=MsoNormal>1. Kaposis sarcoma </p>

<p class=MsoNormal>2. Lymphoma </p>

<p class=MsoNormal>3. Tuberculosis</p>

<p class=MsoNormal>4. Persistent generalized lymphadenopathy</p>

<p class=MsoNormal>Which of the above are causes of lymphadenopathy in an HIV
positive patient? </p>

<p class=MsoNormal>(a) 1 and 3 only </p>

<p class=MsoNormal>(b) 2 and 3 only </p>

<p class=MsoNormal>(c) 1, 2, and 4 only </p>

<p class=MsoNormal>(d) 1, 2, 3, and 4 </p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[ANS] d</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[SOL] </p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Causes of Lymphadenopathy in HIV:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l112 level2 lfo156;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Malignancy: Kaposi's sarcoma </p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l112 level2 lfo156;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Infections: Tuberculosis</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Tuberculous Lymph Nodes:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l112 level2 lfo156;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Tuberculous lymph nodes can exhibit matted appearance
and may become fluctuant due to extensive caseous necrosis.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l112 level2 lfo156;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Inexperienced clinicians may mistakenly perform
incision and drainage when aspiration is sufficient.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Symmetrical Generalized
Lymphadenopathy:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l112 level2 lfo156;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Disseminated tuberculosis can lead to symmetrical
generalized lymphadenopathy.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Lymphoma Presentation:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l112 level2 lfo156;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Lymphoma typically presents with large, firm,
and asymmetric nodes.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l112 level2 lfo156;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Rapid enlargement, asymmetric enlargement, or
lymphadenopathy associated with constitutional symptoms warrants further
investigation.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Diagnostic Approach:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l112 level2 lfo156;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Lymph node needle aspiration is recommended.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l112 level2 lfo156;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>A portion of the sample should be sent for
Mycobacterium tuberculosis PCR (or AAFB microscopy if PCR is unavailable).</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l112 level2 lfo156;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Another portion should be fixed on a slide and
sent for cytology.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l112 level2 lfo156;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>In case caseous liquid is aspirated, it should
be sent for mycobacterial culture or PCR.</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Ref: Davidson principles and practice
of medicine 24<sup>th</sup> edition pg356</span></strong> </p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>83[Q] A patient receiving chemotherapy develops neutropenia.
He presents with fever, cough, expectoration, chest pain and hemoptysis. His CT
scan of chest reveals nodular infiltrates with halo sign and crescent sign. The
most useful drug for treating him is</p>

<p class=MsoNormal>(a) Colistin </p>

<p class=MsoNormal>(b) Granulocyte Macrophage Colony </p>

<p class=MsoNormal>(c) Voriconazole </p>

<p class=MsoNormal>(d) Piperacillin-tazobactam</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[ANS] c</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[SOL] </p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Criteria for the diagnosis of
probable invasive pulmonary aspergillosis<span
style='mso-spacerun:yes'> </span></span></strong></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'><span
style='mso-spacerun:yes'> </span>Host Factors:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l76 level2 lfo157;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Recent history of neutropenia (&lt;0.5  10^9/L
for &#8805;10 days) temporally related to the onset of fungal disease.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l76 level2 lfo157;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Recipient of allogeneic stem cell transplant.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l76 level2 lfo157;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Prolonged use of glucocorticoids (average
minimum 0.3 mg/kg daily prednisolone or equivalent) for &gt;3 weeks (excluding
allergic bronchopulmonary aspergillosis).</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l76 level2 lfo157;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Treatment with other recognized T-cell immune
suppressants, such as ciclosporin, tumor necrosis factor alpha-blockers,
specific monoclonal antibodies (e.g., alemtuzumab), or nucleoside analogs
during the last 90 days.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l76 level2 lfo157;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Inherited severe immune deficiency, e.g.,
chronic granulomatous disease or severe combined immune deficiency.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Clinical Criteria:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l76 level2 lfo157;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>The presence of one of the following on CT:</p>

<p class=MsoNormal style='margin-left:106.35pt;text-indent:-14.15pt;mso-list:
l76 level3 lfo157;tab-stops:0cm list 106.35pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Dense, well-circumscribed lesion(s) with or
without a halo sign.</p>

<p class=MsoNormal style='margin-left:106.35pt;text-indent:-14.15pt;mso-list:
l76 level3 lfo157;tab-stops:0cm list 106.35pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Air crescent sign.</p>

<p class=MsoNormal style='margin-left:106.35pt;text-indent:-14.15pt;mso-list:
l76 level3 lfo157;tab-stops:0cm list 106.35pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Cavity.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l76 level2 lfo157;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Tracheobronchitis: Tracheobronchial ulceration,
nodule, pseudomembrane, plaque, or eschar seen on bronchoscopy.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Mycological Criteria:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l76 level2 lfo157;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Mould in sputum, BAL (Bronchoalveolar Lavage)
fluid, or bronchial brush, indicated by one of the following:</p>

<p class=MsoNormal style='margin-left:106.35pt;text-indent:-14.15pt;mso-list:
l76 level3 lfo157;tab-stops:0cm list 106.35pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Recovery of fungal elements indicating a mould
of Aspergillus.</p>

<p class=MsoNormal style='margin-left:106.35pt;text-indent:-14.15pt;mso-list:
l76 level3 lfo157;tab-stops:0cm list 106.35pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Recovery by culture of a mould of Aspergillus.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l76 level2 lfo157;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Indirect tests (detection of antigen or cell
wall constituents):</p>

<p class=MsoNormal style='margin-left:106.35pt;text-indent:-14.15pt;mso-list:
l76 level3 lfo157;tab-stops:0cm list 106.35pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Galactomannan antigen in plasma, serum, or BAL
fluid.</p>

<p class=MsoNormal style='margin-left:106.35pt;text-indent:-14.15pt;mso-list:
l76 level3 lfo157;tab-stops:0cm list 106.35pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>&#946;-1,3-glucan detected in serum (detects
other species of fungi, as well as Aspergillus).</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Ref: Davidson principles and practice
of medicine 24<sup>th</sup> edition pg527</span></strong></p>

<p class=MsoNormal><span style='mso-spacerun:yes'></span></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>84[Q] A patient undergoes splenectomy after an accident. He
will require oral prophylaxis against which of the following organisms? </p>

<p class=MsoNormal>(a) Staphylococcus aureus </p>

<p class=MsoNormal>(b) Escherichia coli </p>

<p class=MsoNormal>(c) Streptococcus pneumoniae </p>

<p class=MsoNormal>(d) Pneumocystis jirovecii </p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[ANS] c</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[SOL] </p>

<p class=MsoNormal><b>Management of the splenectomised patient<o:p></o:p></b></p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'><span
style='mso-spacerun:yes'> </span>Pre-Surgery Vaccination:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l1 level2 lfo158;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Administer pneumococcal, Haemophilus influenzae
type B, meningococcal group C, and influenza vaccines at least 2-3 weeks before
elective splenectomy.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l1 level2 lfo158;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Vaccination should still be given after
emergency surgery, although it may be less effective.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Post-Surgery Vaccination:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l1 level2 lfo158;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Pneumococcal re-immunization should be given at
least every 5 years.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l1 level2 lfo158;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Annual influenza vaccination is recommended.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l1 level2 lfo158;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Document and maintain a record of the patient's
vaccination status.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Prophylactic Antibiotics:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l1 level2 lfo158;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Prescribe life-long prophylactic penicillin V
(500 mg twice daily).</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l1 level2 lfo158;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>In penicillin-allergic patients, consider using
a macrolide antibiotic.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Patient Education:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l1 level2 lfo158;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Educate patients about the risks of infection
and the importance of prophylactic measures.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l1 level2 lfo158;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Emphasize the need for adherence to prescribed
medications.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Medical Alert Identification:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l1 level2 lfo158;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Advise patients to carry a card or wear a
bracelet indicating their splenectomy status to alert healthcare professionals
about the increased risk of overwhelming sepsis.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Infection Management:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l1 level2 lfo158;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>In case of suspected sepsis, resuscitate the
patient and administer intravenous antibiotics.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l1 level2 lfo158;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Antibiotics should cover common pathogens like
pneumococcus, Haemophilus, and meningococcus, based on local resistance
patterns.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Specific Considerations:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l1 level2 lfo158;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Highlight the increased risk of cerebral malaria
in case of infection.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l1 level2 lfo158;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Promptly treat animal bites with local
disinfection and antibiotics to prevent serious soft tissue infection and
sepsis</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Ref: Davidson principles and practice
of medicine 24<sup>th</sup> edition pg957</span></strong></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>85[Q] A 30-year-old male recently diagnosed with HIV
presented with odynophagia. He was started on a proton-pump inhibitor, and an
upper GI endoscopy was done. There were serpiginous ulcers in normal
surrounding mucosa in the distal esophagus. The most likely diagnosis is</p>

<p class=MsoNormal>(a) Herpes simplex esophagitis </p>

<p class=MsoNormal>(b) Gastroesophageal reflux disease </p>

<p class=MsoNormal>(c) Cytomegalovirus esophagitis </p>

<p class=MsoNormal>(d) Candida esophagitis</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[ANS] c</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[SOL] </p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>86[Q] Which one of the following statements regarding post
gonococcal urethritis (PGU) is correct?</p>

<p class=MsoNormal>(a) Neisseria gonorrhoeae is the most frequent cause of PGU
in men</p>

<p class=MsoNormal>(b) PGU refers to non-gonococcal urethritis in men treated
earlier with a single dose of penicillin</p>

<p class=MsoNormal>(c) Combination therapy with azithromycin leads to resistant
and should be avoided.</p>

<p class=MsoNormal>(d) PGU usually occurs within one week after treatment of
non-gonococcal urethritis.</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[ANS] b</p>

<p class=MsoNormal>[SOL] </p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>87[Q] Which one of the following treatments is considered
the gold standard for brucellosis in adults?</p>

<p class=MsoNormal>(a) Streptomycin and Doxycycline</p>

<p class=MsoNormal>(b) Azithromycin and Rifampin</p>

<p class=MsoNormal>(c) Trimethoprim and Sulfamethoxazole</p>

<p class=MsoNormal>(d) Amikacin and Ciprofloxacin</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[ANS] a</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[SOL] </p>

<p class=MsoNormal><b>Treatment of brucellosis<o:p></o:p></b></p>

<p class=MsoNormal><b><o:p>&nbsp;</o:p></b></p>

<p class=MsoNormal style='mso-pagination:widow-orphan'><span style='color:#374151'>The
gold standard for the treatment of brucellosis in adults involves IM
streptomycin (0.751 g daily for 1421 days) along with doxycycline (100 mg
twice daily for 6 weeks). However, relapse rates of 5%10% have been observed
in both clinical trials and observational studies with this regimen. An
alternative treatment, and the current World Health Organization
recommendation, is rifampin (600900 mg/d) combined with doxycycline (100 mg
twice daily) for 6 weeks. The relapse/failure rate under trial conditions is
approximately 10%, but it can exceed 20% in many non-trial situations. This
discrepancy may be attributed to reduced doxycycline levels and increased
clearance rates when administered concomitantly with rifampin.</span> </p>

<p class=MsoNormal style='mso-pagination:widow-orphan'><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic";color:#374151'>Ref: Harrisons
principles of INTERNAL MEDICINE 21<sup>th</sup> edition pg1313</span></strong><b><o:p></o:p></b></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>88[Q] Which one of the following has the highest risk of
human immunodeficiency virus (HIV) transmission after a single exposure to an
HIV infected source?</p>

<p class=MsoNormal>(a) Vaginal delivery</p>

<p class=MsoNormal>(b) Vaginal intercourse</p>

<p class=MsoNormal>(c) Blood transfusion</p>

<p class=MsoNormal>(d) Percutaneous needle stick injury</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[ANS] c</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[SOL] </p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>89[Q] Consider the following statements with regard to
vitamin C: </p>

<p class=MsoNormal>1. It is heat stable.</p>

<p class=MsoNormal>2. Normal platelets are poor in ascorbate </p>

<p class=MsoNormal>3. Perifollicular hyperkeratosis is a clinical sign of
scurvy.</p>

<p class=MsoNormal>4. Infants fed exclusively on boiled milk are vitamin C
deficient.</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>Which of the above statements are correct?</p>

<p class=MsoNormal>(a) 1 and 2 </p>

<p class=MsoNormal>(b) 2 and 3 </p>

<p class=MsoNormal>(c) 1 and 4 </p>

<p class=MsoNormal>(d) 3 and 4</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[ANS] d</p>

<p class=MsoNormal>[SOL]</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>90[Q] Which of the following statements are correct in
respect of vitamin D?</p>

<p class=MsoNormal>1. Skin exposure to sunlight is the main source</p>

<p class=MsoNormal>2. Deficiency of vitamin D causes distal muscle weakness</p>

<p class=MsoNormal>3. Vitamin D synthesis decreases in winter, as one moves
away from equator</p>

<p class=MsoNormal>4. Body store accumulated during summer is consumed during
winter</p>

<p class=MsoNormal>Select the correct answer using the code given below:</p>

<p class=MsoNormal>(a) 1, 2 and 3 </p>

<p class=MsoNormal>(b) 1, 2 and 4 </p>

<p class=MsoNormal>(c) 1, 3 and 4</p>

<p class=MsoNormal>(d) 2, 3 and 4</p>

<p class=MsoNormal>[ANS] c</p>

<p class=MsoNormal>[SOL] </p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>91[Q] Which of the following are used in the treatment of
Acne vulgaris?</p>

<p class=MsoNormal>1. Topical benzoyl peroxide</p>

<p class=MsoNormal>2. Topical antibiotics clindamycin</p>

<p class=MsoNormal>3. Oral isotretinoin</p>

<p class=MsoNormal>4. Oral ivermectin</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>Select the correct answer using the code given below:</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>(a) 1, 2 and 3 </p>

<p class=MsoNormal>(b) 1, 2 and 4 </p>

<p class=MsoNormal>(c) 1, 3 and 4 </p>

<p class=MsoNormal>(d) 2, 3 and 4</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[ANS] a</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[SOL] </p>

<p class=MsoNormal><b>ACNE VULGARIS TREATMENT<o:p></o:p></b></p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Mild to Moderate Disease:</span></strong></p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Topical Therapy:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l157 level2 lfo162;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Comedones are treated with topical benzoyl
peroxide or retinoids.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l157 level2 lfo162;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Azelaic acid, with antimicrobial and
anticomedogenic action, may be used.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l157 level2 lfo162;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Topical retinoids like all-trans retinoic acid
and adapalene are employed for mild to moderate comedonal acne.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Inflammatory Acne:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l157 level2 lfo162;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Topical antibiotics such as erythromycin or
clindamycin are used for mild inflammatory acne.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l157 level2 lfo162;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Systemic tetracycline is prescribed for moderate
inflammatory acne for 36 months.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l157 level2 lfo162;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Oxytetracycline, lymecycline, doxycycline, or
erythromycin may be alternatives.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Hormonal Treatment:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l157 level2 lfo162;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Oestrogen-containing oral contraceptives can be
used in women, providing a small reduction in sebum production.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l157 level2 lfo162;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Combined oestrogen and anti-androgen
contraceptives are useful, especially in women with acne and hirsutism.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Referral for Isotretinoin:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l157 level2 lfo162;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>If there is inadequate response after 6 months
of combined systemic and topical approaches, referral for isotretinoin is
considered.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Moderate to Severe Disease:</span></strong></p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Isotretinoin (13-cis-retinoic acid):</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l81 level2 lfo163;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Used for moderate to severe acne not responding
adequately to other therapies.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l81 level2 lfo163;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Oral isotretinoin at 0.51 mg/kg over 4 months.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l81 level2 lfo163;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Has multifactorial mechanisms of action,
reducing sebum excretion, hypercornification, P. acnes colonization, and
inflammation.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l81 level2 lfo163;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Requires thorough screening and monitoring,
especially due to teratogenicity and possible mood disturbance.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Combination with Glucocorticoid:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l81 level2 lfo163;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Short-term combination with systemic
glucocorticoid may be needed to minimize the risk of acne flare in severe
cases.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Other Treatments for Scarring:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l81 level2 lfo163;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Intralesional injections, incision, and drainage
are used for inflamed acne nodules or cysts.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l81 level2 lfo163;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Preventative measures for scarring include
adequate treatment of active acne.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l81 level2 lfo163;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Treatments for scarring include intralesional
glucocorticoid, silicone dressings, carbon dioxide laser, microdermabrasion, chemical
peeling, and local excision.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Psychological Impact:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l81 level2 lfo163;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>The psychological impact of acne is significant
and should be considered in management decisions.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Dietary Association:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l81 level2 lfo163;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>No convincing evidence supports a causal
association between diet and acne.</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Ref: Davidson principles and practice
of medicine 24<sup>th</sup> edition pg1094</span></strong></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>92[Q] Which one of the following is a cause of scarring
alopecia?</p>

<p class=MsoNormal>(a) Androgenic alopecia</p>

<p class=MsoNormal>(b) Alopecia Areata</p>

<p class=MsoNormal>(c) Syphilis</p>

<p class=MsoNormal>(d) Radiotherapy</p>

<p class=MsoNormal>[ANS] d</p>

<p class=MsoNormal>[SOL] Scarring alopecia is a type of hair loss that occurs
when the hair follicles are replaced with scar tissue. Radiotherapy is a known
cause of scarring alopecia because it damages the hair follicles, which can
lead to permanent hair loss. </p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>93[Q] Which of the following are used as mood stabilizers
for the treatment of bipolar disorder? </p>

<p class=MsoNormal>1. Valproic acid </p>

<p class=MsoNormal>2. Lamotrigine </p>

<p class=MsoNormal>3. Carbamazepine </p>

<p class=MsoNormal>4. Propranolol </p>

<p class=MsoNormal>Select the correct answer using the code given below: </p>

<p class=MsoNormal>(a) 1, 2 and 3 </p>

<p class=MsoNormal>(b) 1, 2 and 4 </p>

<p class=MsoNormal>(c) 1, 3 and 4 </p>

<p class=MsoNormal>(d) 2, 3 and 4</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[ANS] a</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[SOL] </p>

<p class=MsoNormal><b>Bipolar disorder<o:p></o:p></b></p>

<p class=MsoNormal><b><o:p>&nbsp;</o:p></b></p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'><span
style='mso-spacerun:yes'> </span>Epidemiology:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l78 level2 lfo161;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Bipolar disorder is characterized by episodic
disturbances with periods of depressed and elevated mood.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l78 level2 lfo161;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Elevated mood is termed hypomania (mild or
short-lived) or mania (severe or chronic).</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l78 level2 lfo161;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Lifetime risk is approximately 1%2%, with onset
usually in the twenties and an equal prevalence in men and women.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Pathogenesis:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l78 level2 lfo161;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Bipolar disorder has a strong hereditary
component (approximately 70%).</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l78 level2 lfo161;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Relatives of patients have an increased
incidence of both bipolar and unipolar affective disorder.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l78 level2 lfo161;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Genome-wide association studies have identified
over a hundred genetic variants of small effect.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l78 level2 lfo161;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Life events such as physical illness, sleep
deprivation, and certain medications (e.g., steroids) may trigger episodes.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Diagnosis:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l78 level2 lfo161;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Diagnosis is based on clear evidence of episodes
of depression and mania.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l78 level2 lfo161;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Hypomanic or manic episodes are often preceded
or followed by an episode of depression.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l78 level2 lfo161;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Psychotic symptoms may occur in both depressive
and manic phases, termed affective psychosis.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l78 level2 lfo161;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Patients with symptoms of both bipolar disorder
and schizophrenia may be diagnosed with schizoaffective disorder.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Management:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l78 level2 lfo161;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Depression is treated similarly to unipolar
depression. If antidepressants are prescribed, they should be combined with a
mood-stabilizing drug to prevent inducing mania.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l78 level2 lfo161;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Manic episodes and psychotic symptoms often
respond well to antipsychotic drugs.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l78 level2 lfo161;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Prophylaxis to prevent recurrent episodes
involves mood-stabilizing agents like lithium, sodium valproate, lamotrigine,
olanzapine, quetiapine, and risperidone.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l78 level2 lfo161;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Lithium is the drug of first choice but requires
regular blood monitoring due to its narrow therapeutic range and potential
toxic effects.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l78 level2 lfo161;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Anticonvulsants and some antipsychotic drugs can
be used as second-line alternatives to lithium.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Prognosis:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l78 level2 lfo161;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>The relapse rate of bipolar disorder is high,
with patients potentially well between episodes.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l78 level2 lfo161;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>After one episode, the annual average risk of
relapse is about 10%15%, doubling after more than three episodes.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l78 level2 lfo161;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>There is an increased lifetime risk of suicide
(5%10%).</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Ref: Davidson principles and practice
of medicine 24<sup>th</sup> edition pg1254</span></strong></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>94[Q] An elderly alcoholic man who mainly eats a diet of
maize and maize products presents with complaints of chronic diarrhea, severe
sunburn-like lesions tension on exposed parts and acute delirium. He is
admitted. What is the likely diagnosis and its treatment? </p>

<p class=MsoNormal>(a) Celiac disease, Gluten-free diet </p>

<p class=MsoNormal>(b) Vitamin B12 deficiency, Parenteral B12 therapy </p>

<p class=MsoNormal>(c) Pellagra, Niacin therapy </p>

<p class=MsoNormal>(d) Whipples disease, Doxycycline + Trimethoprim </p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[ANS] c</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[SOL] </p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><b>Niacin (vitamin B3 ) Deficiency  pellagra<o:p></o:p></b></p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'><span
style='mso-spacerun:yes'> </span>Causes of Pellagra:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l130 level2 lfo160;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Pellagra was historically common among
individuals who relied heavily on maize, which contains niacytin, an unusable
form of niacin.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l130 level2 lfo160;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>It can develop in as little as 8 weeks in
individuals with severe niacin and tryptophan deficiency in their diets.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l130 level2 lfo160;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Pellagra persists in parts of Africa and is
observed in alcohol misusers and individuals with chronic small intestinal
diseases in developed countries.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Contributing Conditions:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l130 level2 lfo160;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Hartnup disease, a genetic disorder impairing
amino acid absorption, including tryptophan, can lead to pellagra.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l130 level2 lfo160;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Pellagra is occasionally seen in carcinoid
syndrome when there is excessive production of serotonin from tryptophan.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Three Ds of Pellagra:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l130 level2 lfo160;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Dermatitis: Characterized by erythema resembling
severe sunburn, particularly on sun-exposed parts like limbs. Casal's necklace
is a characteristic neck rash.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l130 level2 lfo160;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Diarrhea: Accompanied by anorexia, nausea,
glossitis, and dysphagia due to non-infective inflammation throughout the
gastrointestinal tract.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l130 level2 lfo160;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Dementia: Severe deficiency can lead to acute
delirium and, if untreated, progress to dementia.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Treatment:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l130 level2 lfo160;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Nicotinamide is used for treatment, with a
recommended dose of 100 mg three times daily orally or parenterally.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l130 level2 lfo160;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Rapid improvement is usually observed within 24
hours, including a reduction in erythema, cessation of diarrhea, and improved
mental state.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Toxicity of Niacin:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l130 level2 lfo160;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Excessive niacin intake may lead to reversible
hepatotoxicity.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l130 level2 lfo160;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Doses of nicotinic acid above 200 mg a day, used
as a lipid-lowering agent, can cause vasodilatory symptoms like flushing and/or
hypotension.</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Ref: Davidson principles and practice
of medicine 24<sup>th</sup> edition pg776</span></strong></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>95[Q] Which one of the following is an indication for
self-injectable adrenaline (epinephrine)? </p>

<p class=MsoNormal>(a) Anaphylaxis to allergens that are difficult to avoid </p>

<p class=MsoNormal>(b) Cardiogenic shock </p>

<p class=MsoNormal>(c) Pheochromocytoma </p>

<p class=MsoNormal>(d) Complete heart block </p>

<p class=MsoNormal>[ANS] a</p>

<p class=MsoNormal>[SOL] Self-injectable adrenaline (epinephrine) is indicated
for the emergency treatment of anaphylaxis, particularly when caused by
allergens that are difficult to avoid. </p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>96[Q] Which of the following statements with regard to
arterio-venous fistula in a dialysis patient is correct?</p>

<p class=MsoNormal>1. Distension and thickening of the vessel wall occur</p>

<p class=MsoNormal>2. Formed up to a year before dialysis is contemplated</p>

<p class=MsoNormal>3. Leg veins are usually preferred</p>

<p class=MsoNormal>4. Synthetic graft may be used if fistula formation is not
possible</p>

<p class=MsoNormal>Select the correct answer using the code given below:</p>

<p class=MsoNormal>(a) 1, 2 and 3 </p>

<p class=MsoNormal>(b) 1, 2 and 4</p>

<p class=MsoNormal>(c) 1, 3 and 4</p>

<p class=MsoNormal>(d) 2, 3 and 4</p>

<p class=MsoNormal>[ANS] b</p>

<p class=MsoNormal>[SOL] </p>

<p class=MsoNormal><b>Haemodialysis in ESRD<o:p></o:p></b></p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'><span
style='mso-spacerun:yes'> </span>Vascular Access for Hemodialysis:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l97 level2 lfo159;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Arteriovenous fistula (AVF) is the preferred
method for vascular access, usually created in the forearm up to a year before
dialysis is needed.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l97 level2 lfo159;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>After 46 weeks, arterialization occurs,
allowing the insertion of large-bore needles for hemodialysis.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Preservation of Arm Veins:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l97 level2 lfo159;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Preservation of arm veins is crucial in patients
with progressive renal disease for future hemodialysis needs.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l97 level2 lfo159;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>If AVF creation is not possible, synthetic
polytetrafluoroethylene (PTFE) grafts or central venous catheters may be used
for short-term access.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Screening and Vaccination:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l97 level2 lfo159;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Patients starting dialysis are screened for
hepatitis B, hepatitis C, and HIV.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l97 level2 lfo159;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Vaccination against hepatitis B is administered
if the patient is not immune.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Dialysis Procedure:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l97 level2 lfo159;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Hemodialysis is typically performed for 35
hours three times weekly, either at home or in an outpatient dialysis unit.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l97 level2 lfo159;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>The frequency and intensity of dialysis are
adjusted to achieve a urea reduction ratio of over 65%, as lower levels are
associated with increased mortality.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Improvement in Symptoms:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l97 level2 lfo159;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Most patients experience an improvement in
symptoms during the first 6 weeks of treatment.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Options to Increase Dialysis Intensity:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l97 level2 lfo159;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Escalating the number of standard sessions to
four or more per week.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l97 level2 lfo159;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Performing short, frequent dialysis sessions of
23 hours 57 times per week.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l97 level2 lfo159;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Nocturnal hemodialysis, using low blood-pump
speeds for approximately 8 hours overnight 56 times per week.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l97 level2 lfo159;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Including a filtration component
(hemodiafiltration) to achieve greater clearance of larger molecules.</p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Benefits of More Frequent and
Nocturnal Dialysis:</span></strong></p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l97 level2 lfo159;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Improved fluid balance and phosphate control.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l97 level2 lfo159;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Improvement in left ventricular mass.</p>

<p class=MsoNormal style='margin-left:70.9pt;text-indent:-14.15pt;mso-list:
l97 level2 lfo159;tab-stops:0cm list 70.9pt'><![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Potential improvement in mortality, although
this has not been robustly demonstrated.</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><strong><span style='font-family:"Liberation Serif","serif";
mso-bidi-font-family:"Noto Naskh Arabic"'>Ref: Davidson principles and practice
of medicine 24<sup>th</sup> edition pg595</span></strong></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[Q] An infant was born at 30 weeks of gestation and weighs
1-2 kg at birth. Which of the following is the recommended initial feeding
method?</p>

<p class=MsoNormal>(a) Intravenous fluids only </p>

<p class=MsoNormal>(b) Feeding by spoon and katori </p>

<p class=MsoNormal>(c) Breastfeeding </p>

<p class=MsoNormal>(d) Orogastric feeding</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[ANS] d</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[SOL] <span style='color:#374151'>For an infant born at 30
weeks of gestation and weighing 1-2 kg at birth, the recommended initial feeding
method is (d) Orogastric feeding. This involves passing a small feeding tube
through the baby's mouth or nose into the stomach to provide milk or formula.</span>
</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>97[Q] A newborn delivered at 32 weeks gestation is started
on spoon feeds after birth. On feeding with a spoon, the baby demonstrates some
spilling and coughing. What is the next step in management?</p>

<p class=MsoNormal>(a) Oragastric or nasogastric tube feeding </p>

<p class=MsoNormal>(b) Intravenous fluid therapy </p>

<p class=MsoNormal>(c) Gastrostomy tube feeding </p>

<p class=MsoNormal>(d) Breastfeeding </p>

<p class=MsoNormal>[ANS] a</p>

<p class=MsoNormal>[SOL] A newborn delivered at 32 weeks gestation is premature
and may have difficulty with feeding and coordination of sucking and
swallowing. Spilling and coughing while feeding are signs of feeding
difficulties and can lead to aspiration pneumonia. Therefore, the next step in
management should be orogastric or nasogastric tube feeding, which is a safe
and effective way to provide nutrition while reducing the risk of aspiration.
Once the baby's feeding and coordination improve, the baby can transition to
spoon feeding or breastfeeding.</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[Q] ByA child speaks bisyllables like Ma-Ma and Ba-Ba. He is
able to sit without support and looks at the source of sound diagonally. His
likely age is</p>

<p class=MsoNormal>(a) 4 months </p>

<p class=MsoNormal>(b) 6 months </p>

<p class=MsoNormal>(c) 8 months </p>

<p class=MsoNormal>(d) 10 months</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[ANS] d</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[SOL] At around 6 months of age, infants begin to babble,
producing repeated sounds such as &quot;ma-ma&quot; and &quot;ba-ba&quot; by 9
months. By 9 months of age, most infants are able to sit without support and
can localize the source of a sound by looking at it diagonally by 10 month.</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[Q] After sustaining a head injury, an 18 month old child
displays eye opening only to pain, moans on painful stimuli and withdraws to
painful stimuli. What is the modified Glasgow Coma Scale Score in this child?</p>

<p class=MsoNormal>(a) 6 </p>

<p class=MsoNormal>(b) 8</p>

<p class=MsoNormal>(c) 10 </p>

<p class=MsoNormal>(d) 12</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[ANS] b</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[SOL] The modified Glasgow Coma Scale (GCS) is used in
infants and young children. It evaluates eye opening, best motor response, and
verbal response. In this case, the child has eye opening only to pain (score of
2), moans on painful stimuli (score of 2), and withdraws to painful stimuli
(score of 4) for a total GCS score of 8. </p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[Q] Which of the following are reversible causes of
electromechanical ciation seen in pulseless activity?</p>

<p class=MsoNormal>1. Pericardial tamponade</p>

<p class=MsoNormal>2. Pulmonary thrombo-embolism </p>

<p class=MsoNormal>3. Hyperthermia </p>

<p class=MsoNormal>4. Hypokalemia </p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>Select the correct answer using the code given below:</p>

<p class=MsoNormal>(a) 1,2 and 3 </p>

<p class=MsoNormal>(b) 1,2 and 4 </p>

<p class=MsoNormal>(c) 1,3 and 4 </p>

<p class=MsoNormal>(d) 2,3 and 4</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[ANS] b</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[SOL] The mnemonic for reversible causes of pulseless
electrical activity (PEA) is &quot;H's and T's&quot;. The &quot;H's&quot;
include hypoxia, hypovolemia, hydrogen ion (acidosis), hypokalemia or
hyperkalemia, and hypothermia. The &quot;T's&quot; include tension
pneumothorax, tamponade (cardiac), thrombosis (pulmonary), thrombosis
(coronary), and toxins. </p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[Q] A 3-day old newborn presents with jaundice since birth.
Examination reveals pallor and hepatosplenomegaly. The newborn also has a
cephalhematoma. Which one of the following is the most important indicator to
the diagnosis of pathologic jaundice ? </p>

<p class=MsoNormal>(a) Pallor </p>

<p class=MsoNormal>(b) Hepatosplenomegaly </p>

<p class=MsoNormal>(c) Clinical jaundice since birth </p>

<p class=MsoNormal>(d) Cephalhematoma</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[ANS] c</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[SOL] Pathological jaundice is the type of jaundice which
occurs within the first 24 hours of life or persists beyond 14 days of life. In
this case, the newborn presents with jaundice since birth, which is the most
important indicator to the diagnosis of pathological jaundice. Pallor,
hepatosplenomegaly, and cephalhematoma are not specific for pathological
jaundice.</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[Q] What is the diagnosis of autistic spectrum disorder
primarily based on?</p>

<p class=MsoNormal>(a) Clinical criteria only</p>

<p class=MsoNormal>(b) Clinical criteria and genetic studies only</p>

<p class=MsoNormal>(c) Clinical criteria and MRI brain only</p>

<p class=MsoNormal>(d) Clinical criteria genetic studies and MRI brain</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[ANS] a</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[SOL] The diagnosis of autism spectrum disorder (ASD) is
primarily based on clinical criteria, including observation of the child's
behavior and developmental history. Although genetic studies and brain imaging,
such as MRI, may provide additional information, they are not used as the
primary method for diagnosis.</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[Q] According to the National AIDS Control Program, which
one of the following drugs is given to newborns born to HIV-positive mothers to
prevent mother to child transmission of HIV infection? </p>

<p class=MsoNormal>(a) Nevirapine</p>

<p class=MsoNormal>(b) Stavudine </p>

<p class=MsoNormal>(c)Indinavir </p>

<p class=MsoNormal>(d) Ritonavir</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[ANS] a</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[SOL] According to the National AIDS Control Program,
nevirapine is given to newborns born to HIV-positive mothers within 72 hours of
birth to prevent mother-to-child transmission of HIV infection. It is given as
a single dose of 2 mg/kg body weight. This strategy has been shown to
significantly reduce the risk of transmission from mother to child. Stavudine,
indinavir, and ritonavir are antiretroviral drugs used in the treatment of HIV
infection but are not used for prophylaxis in newborns.</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[Q] Which one of the following statements is correct in
context of human breast milk ?</p>

<p class=MsoNormal>(a) The concentration of lactose is 5g/dL</p>

<p class=MsoNormal>(b) The protein content is higher than that in animal milk</p>

<p class=MsoNormal>(c) Human milk does not contain taurine and cysteine like
animal milk and formula milk</p>

<p class=MsoNormal>(d) Human milk contains omega 2 and omega 6 (very long
chain) fatty acids</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[ANS] d</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[SOL] The concentration of lactose in human breast milk is
around 7 g/dL. This is higher than the concentration of lactose in cow's milk
(around 4.8 g/dL). The protein content in human milk is lower than in animal
milk, with the exception of whey protein, which is higher in human milk.
Taurine and cysteine are present in human milk, but in lower concentrations
compared to animal milk and formula milk. Human milk contains both omega-3 and
omega-6 fatty acids, including some very long chain fatty acids, which are
important for brain development.</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[Q] Which of the following are age appropriate language
milestones in a normally developing 2 year old child ?</p>

<p class=MsoNormal>1. Vocabulary of 50-100 words</p>

<p class=MsoNormal>2. Uses pronouns</p>

<p class=MsoNormal>3. Occasional repeating of words</p>

<p class=MsoNormal>4. Stating his name when asked</p>

<p class=MsoNormal>Select the correct answer using the code given below :</p>

<p class=MsoNormal>(a) 1, 2 and 3 </p>

<p class=MsoNormal>(b) 1, 2 and 4</p>

<p class=MsoNormal>(c) 1 and 3 only </p>

<p class=MsoNormal>(d) 2, 3 and 4</p>

<p class=MsoNormal>[ANS] a</p>

<p class=MsoNormal>[SOL] By 2 years of age, a child should have a vocabulary of
50-100 words and be able to use simple phrases and pronouns. Repeating words
and naming objects and body parts should be common. The child should be able to
state his or her name when asked by around 3 years. </p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[Q] Which of the following tools are used for developmental
screening ? </p>

<p class=MsoNormal>1. Denver-II</p>

<p class=MsoNormal>2. Ages and Stages Questionnaire</p>

<p class=MsoNormal>3. Parents Evaluation of Developmental Status</p>

<p class=MsoNormal>4. Bayley Scale for Infant and Toddler Development</p>

<p class=MsoNormal>Select the correct answer using the code given below :</p>

<p class=MsoNormal>(a) 1, 2, 3 and 4 </p>

<p class=MsoNormal>(b) 1, 2 and 4 </p>

<p class=MsoNormal>(c) 1, 3 and 4</p>

<p class=MsoNormal>(d) 2, 3 and 4 </p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[ANS] a</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[SOL] <span style='color:#111111'>The Denver-II, Ages and
Stages Questionnaire, Parents Evaluation of Developmental Status, and Bayley
Scale for Infant and Toddler Development are all tools used to assess a childs
development</span> </p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[Q] According to Kings College criteria, which of the
following are the indicators for referring to liver transplantation following
acetaminophen toxicity?</p>

<p class=MsoNormal>1. Transaminase levels &gt; 4000 IU/L</p>

<p class=MsoNormal>2. Acidemia (Serum pH &lt; 7.3) after adequate fluid
resuscitation</p>

<p class=MsoNormal>3. Coagulopathy (INR &gt; 6)</p>

<p class=MsoNormal>4. Renal dysfunction (creatinine &gt; 3-4 mg/dL)</p>

<p class=MsoNormal>Select the correct answer using the code given below:</p>

<p class=MsoNormal>(a) 1, 2 and 3</p>

<p class=MsoNormal>(b) 1, 2 and 4</p>

<p class=MsoNormal>(c) 1, 3 and 4</p>

<p class=MsoNormal>(d) 2, 3 and 4</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[ANS] d</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[SOL] According to King's College Criteria, patients with
acetaminophen toxicity and the following criteria should be referred for liver
transplantation: (1) arterial pH &lt; 7.3 or (2) prothrombin time &gt; 100
seconds or international normalized ratio (INR) &gt; 6.5 or (3) serum
creatinine &gt; 3.4 mg/dL despite adequate fluid resuscitation or (4) grade III
or IV hepatic encephalopathy. </p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[Q] Which one of the following statements is correct about
intra-dermal fractional Inactivated Polio Vaccine (fIPV) with respect to
intramuscular (I/M)IPV ?</p>

<p class=MsoNormal>(a) fIPV is one-tenth of the I/M dose of IPV</p>

<p class=MsoNormal>(b) fIPV is one-fifth of the I/M dose of IPV</p>

<p class=MsoNormal>(c) fIPV is half of the I/M dose of IPV</p>

<p class=MsoNormal>(d) fIPV is three-fourth of the I/M dose of IPV</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[ANS] b</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[SOL] The statement &quot;fIPV is one-fifth of the I/M dose
of IPV&quot; is correct. Intra-dermal fractional Inactivated Polio Vaccine
(fIPV) is a dose-sparing strategy that can be used to increase coverage in mass
vaccination campaigns. It involves administering one-fifth of the intramuscular
(I/M) dose of IPV into the dermis of the skin, which is a more immunogenic
site. This allows for more efficient use of IPV and helps to extend global IPV
supplies.</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[Q] Which one of the following statement is correct
regarding the Government of India program Home-based care of the young child?
</p>

<p class=MsoNormal>(a) It was started in 2014</p>

<p class=MsoNormal>(b) The grassroots health worker is the Anganwadi worker</p>

<p class=MsoNormal>(c) The grassroots health makes 6 home visits </p>

<p class=MsoNormal>(d) The infant is monitored from 3 months to 15 months of
age</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[ANS] d</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[SOL] The correct statement regarding the Government of
India program Home-based care of the young child is that the grassroots
health worker is the ASHA (Accredited Social Health Activist) worker (b). The
program was launched in 2018 as part of National Health Mission and POSHAN
Abhiyan for promotion of health and nutrition of young children (3-15 months),
for reducing child morbidity and mortality and for promotion of growth and
Early Childhood Development. Under HBYC, ASHA provides incentivized five home
visits on 3rd, 6th, 9th, 12th and 15th months.</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[Q] In a child with high anion gap metabolic acidosis,
poisoning with which of the following may be suspected?</p>

<p class=MsoNormal>(a) Iron</p>

<p class=MsoNormal>(b) Digoxin </p>

<p class=MsoNormal>(c) Rifampicin </p>

<p class=MsoNormal>(d) Beta blockers</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[ANS] a</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[SOL] MUDPILERS is a mnemonic that is often used to remember
the common causes of high anion gap metabolic acidosis. It stands for:</p>

<p class=MsoNormal>- M: Methanol</p>

<p class=MsoNormal>- U: Uremia (due to renal failure)</p>

<p class=MsoNormal>- D: Diabetic ketoacidosis</p>

<p class=MsoNormal>- P: Paraldehyde or Phenformin</p>

<p class=MsoNormal>- I: Iron tablets or Isoniazid</p>

<p class=MsoNormal>- L: Lactic acidosis</p>

<p class=MsoNormal>- E: Ethylene glycol (found in antifreeze)</p>

<p class=MsoNormal>- R: Rhabdomyolysis</p>

<p class=MsoNormal>- S: Salicylates (aspirin)</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[Q] Which one of the following is a &quot;Danger Sign&quot;
for a newborn baby?</p>

<p class=MsoNormal>(a) Temperature between 36.0C and 36.5C </p>

<p class=MsoNormal>(b) Respiratory rate more than 60/min </p>

<p class=MsoNormal>(c) Heart rate of 120/min </p>

<p class=MsoNormal>(d) Weight loss of 8% within the first week of life</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[ANS] b</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[SOL] <span style='color:#111111'>A respiratory rate of more
than 60 breaths per minute is considered a Danger Sign for a newborn baby </span></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[Q] The codes given below represent specific types of
permanent teeth: </p>

<p class=MsoNormal>1. Central and lateral incisors </p>

<p class=MsoNormal>2. Canines </p>

<p class=MsoNormal>3. Premolars </p>

<p class=MsoNormal>4. Molars </p>

<p class=MsoNormal>The eruption of which of the following combinations will
indicate menarche in girls?</p>

<p class=MsoNormal>(a) 1 and 2 </p>

<p class=MsoNormal>(b) 2 and 3 </p>

<p class=MsoNormal>(c) 3 and 4 </p>

<p class=MsoNormal>(d) none</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[ANS] d</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[SOL] According to a study conducted on 470 female students
aged 10-13 years, no correlation could be found between attainment of menarche
and eruption status of the permanent second molars. So, none of the given
options (a), (b), (c),would indicate menarche in girls.</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[Q] Urinary alkalinisation is used for enhancing excretion
of which of the following poisonings?</p>

<p class=MsoNormal>(a) Phenobarbitone </p>

<p class=MsoNormal>(b) Alprazolam </p>

<p class=MsoNormal>(c) Phenytoin </p>

<p class=MsoNormal>(d) Lithium </p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[ANS] d</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[SOL] Urinary alkalinisation is a technique used to enhance
the elimination of weak acids, such as salicylates and lithium, from the body
by increasing their solubility in alkaline urine. Lithium is an alkali metal
that is used to treat bipolar disorder. In cases of lithium poisoning, urinary
alkalinisation can be used to increase the excretion of lithium and prevent its
accumulation in the body. Phenobarbitone, alprazolam, and phenytoin are not
weak acids and are not eliminated by urinary alkalinisation.</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[Q] A 4-year-old child is brought with a history of
ingestion of 1g of paracetamol two hours back. What should be the initial
management?</p>

<p class=MsoNormal>(a) Induced vomiting </p>

<p class=MsoNormal>(b) Gastric lavage </p>

<p class=MsoNormal>(c) Oral N-acetylcysteine </p>

<p class=MsoNormal>(d) Alkaline diuresis</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[ANS] c</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[SOL] In the case of paracetamol poisoning, the initial
management should be oral N-acetylcysteine (NAC) administration. NAC is an
antidote that can prevent liver damage caused by paracetamol toxicity if given
within 8-10 hours of ingestion. Induced vomiting and gastric lavage are not
recommended as they may increase the risk of aspiration and are not effective
in removing the paracetamol already absorbed. Alkaline diuresis is not indicated
in paracetamol poisoning.</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[Q] Which of the following is the antidote to reverse the
muscarinic effects of organophosphate toxicity?</p>

<p class=MsoNormal>(a) Pralidoxime aldoxime methiodide (PAM)</p>

<p class=MsoNormal>(b) Atropine</p>

<p class=MsoNormal>(c) Adrenaline</p>

<p class=MsoNormal>(d) N-acetylcysteine</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[ANS] b</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[SOL] Atropine is the antidote used to reverse the
muscarinic effects of organophosphate toxicity. Organophosphates inhibit the
enzyme acetylcholinesterase, leading to an accumulation of acetylcholine and
overstimulation of muscarinic receptors. Atropine is a muscarinic antagonist
that competitively blocks the effects of acetylcholine at the muscarinic
receptors, thereby reducing the symptoms of organophosphate toxicity.
Pralidoxime (option a) is another antidote used to reactivate
acetylcholinesterase but does not directly reverse the muscarinic effects.
Adrenaline (option c) and N-acetylcysteine (option d) are not effective in
reversing muscarinic effects of organophosphate toxicity.</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><span style='color:#343541'>[Q]<span
style='mso-spacerun:yes'> </span>A 7 year old child is brought to the
emergency with seizures and drowsiness. The child had been receiving some drugs
for fever for the past two days. Child is found to be cyanosed with an oxygen
saturation of 40% and unresponsive to oxygen therapy. Blood gas analysis
reveals a normal PaQ,. Which drug intake may have caused the above condition ?</span>
</p>

<p class=MsoNormal>(a) Chloroquine<span style='mso-spacerun:yes'> </span></p>

<p class=MsoNormal>(b) Amoxycillin-Clavulanic acid </p>

<p class=MsoNormal>(c) Paracetamol</p>

<p class=MsoNormal>(d) Mefenamic acid</p>

<p class=MsoNormal>[ANS] a</p>

<p class=MsoNormal>[SOL] The symptoms described in the scenario, including
seizures, drowsiness, cyanosis, and unresponsiveness to oxygen therapy, are
suggestive of methemoglobinemia. Methemoglobinemia is a condition where the
iron in hemoglobin is converted to the ferric state (Fe3+) instead of the
normal ferrous state (Fe2+), reducing the oxygen-carrying capacity of blood.
Among the given options, chloroquine (option a) is known to cause
methemoglobinemia as a side effect. Chloroquine is an antimalarial drug that
can induce the formation of methemoglobin. </p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[Q] Autism Spectrum Disorder is characterized by which of
the following?</p>

<p class=MsoNormal>1. Onset before 3 years of age </p>

<p class=MsoNormal>2. Impaired verbal communication </p>

<p class=MsoNormal>3. Stereotypic and behavioral patterns </p>

<p class=MsoNormal>4. Tangential speech </p>

<p class=MsoNormal>Select the correct answer using the code given below:</p>

<p class=MsoNormal>(a) 1, 2 and 3 </p>

<p class=MsoNormal>(b) 1, 2 and 4 </p>

<p class=MsoNormal>(c) 1, 3 and 4 </p>

<p class=MsoNormal>(d) 2, 3 and 4 </p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[ANS] a</p>

<p class=MsoNormal>[SOL] Autism Spectrum Disorder (ASD) is a neurodevelopmental
disorder that is characterized by persistent deficits in social communication
and social interaction, as well as restricted, repetitive patterns of behavior,
interests, or activities. The Diagnostic and Statistical Manual of Mental
Disorders (DSM-5) criteria for ASD includes the following:</p>

<p class=MsoNormal>1. Persistent deficits in social communication and social
interaction across multiple contexts </p>

<p class=MsoNormal>2. Restricted, repetitive patterns of behavior, interests,
or activities </p>

<p class=MsoNormal>3. Symptoms present early in the developmental period </p>

<p class=MsoNormal>Therefore, options (a), (b), and (c) are partially correct,
but option (d) is incorrect because impaired verbal communication is one of the
core features of ASD.</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[Q] Which vaccines are stored in the top rack of the main
refrigerator compartment at a temperature of 410C?</p>

<p class=MsoNormal>(a) DPT, Hepatitis B, Measles, MMR vaccines </p>

<p class=MsoNormal>(b) DPT, TT, Hepatitis A vaccine </p>

<p class=MsoNormal>(c) BCG, DPT and Typhoid </p>

<p class=MsoNormal>(d) BCG, Measles and MMR vaccines </p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[ANS] d</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[SOL] </p>

<p class=MsoNormal style='margin-left:0cm;text-indent:-14.15pt;mso-list:l129 level1 lfo1;
tab-stops:list 0cm'><![if !supportLists]><span style='font-family:Symbol;
mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol'><span
style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>The cold chain is a system of storing and
transporting vaccines at recommended temperatures from the point of manufacture
to the point of use. </p>

<p class=MsoNormal style='margin-left:0cm;text-indent:-14.15pt;mso-list:l129 level1 lfo1;
tab-stops:list 0cm'><![if !supportLists]><span style='font-family:Symbol;
mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol'><span
style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Maintenance of appropriate temperature is
critical to the viability and potency of a vaccine. </p>

<p class=MsoNormal style='margin-left:0cm;text-indent:-14.15pt;mso-list:l129 level1 lfo1;
tab-stops:list 0cm'><![if !supportLists]><span style='font-family:Symbol;
mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol'><span
style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Vaccines must be stored at different
temperatures depending on their type. </p>

<p class=MsoNormal style='margin-left:0cm;text-indent:-14.15pt;mso-list:l129 level1 lfo1;
tab-stops:list 0cm'><![if !supportLists]><span style='font-family:Symbol;
mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol'><span
style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Vaccines that must not be frozen include: </p>

<p class=MsoNormal style='margin-left:0cm;text-indent:-14.15pt;mso-list:l129 level2 lfo1;
tab-stops:list 0cm'><![if !supportLists]><span style='font-family:Symbol;
mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol'><span
style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Hepatitis A </p>

<p class=MsoNormal style='margin-left:0cm;text-indent:-14.15pt;mso-list:l129 level2 lfo1;
tab-stops:list 0cm'><![if !supportLists]><span style='font-family:Symbol;
mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol'><span
style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Hib </p>

<p class=MsoNormal style='margin-left:0cm;text-indent:-14.15pt;mso-list:l129 level2 lfo1;
tab-stops:list 0cm'><![if !supportLists]><span style='font-family:Symbol;
mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol'><span
style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Whole cell killed typhoid vaccine </p>

<p class=MsoNormal style='margin-left:0cm;text-indent:-14.15pt;mso-list:l129 level1 lfo1;
tab-stops:list 0cm'><![if !supportLists]><span style='font-family:Symbol;
mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol'><span
style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Vaccines that can be frozen without harm
include: </p>

<p class=MsoNormal style='margin-left:0cm;text-indent:-14.15pt;mso-list:l129 level2 lfo1;
tab-stops:list 0cm'><![if !supportLists]><span style='font-family:Symbol;
mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol'><span
style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>BCG (especially after reconstitution) </p>

<p class=MsoNormal style='margin-left:0cm;text-indent:-14.15pt;mso-list:l129 level2 lfo1;
tab-stops:list 0cm'><![if !supportLists]><span style='font-family:Symbol;
mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol'><span
style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>OPV </p>

<p class=MsoNormal style='margin-left:0cm;text-indent:-14.15pt;mso-list:l129 level2 lfo1;
tab-stops:list 0cm'><![if !supportLists]><span style='font-family:Symbol;
mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol'><span
style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Measles </p>

<p class=MsoNormal style='margin-left:0cm;text-indent:-14.15pt;mso-list:l129 level1 lfo1;
tab-stops:list 0cm'><![if !supportLists]><span style='font-family:Symbol;
mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol'><span
style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Vaccines should be stored in the following
locations: </p>

<p class=MsoNormal style='margin-left:0cm;text-indent:-14.15pt;mso-list:l129 level2 lfo1;
tab-stops:list 0cm'><![if !supportLists]><span style='font-family:Symbol;
mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol'><span
style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>OPV vials in the freezer compartment (0 to -4C)
</p>

<p class=MsoNormal style='margin-left:0cm;text-indent:-14.15pt;mso-list:l129 level2 lfo1;
tab-stops:list 0cm'><![if !supportLists]><span style='font-family:Symbol;
mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol'><span
style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>BCG, measles, and MMR in the top rack of the
main compartment (4-10C) </p>

<p class=MsoNormal style='margin-left:0cm;text-indent:-14.15pt;mso-list:l129 level2 lfo1;
tab-stops:list 0cm'><![if !supportLists]><span style='font-family:Symbol;
mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol'><span
style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Other vaccines like DPT, DT, TT, hepatitis A,
and typhoid in the middle racks of the main compartment </p>

<p class=MsoNormal style='margin-left:0cm;text-indent:-14.15pt;mso-list:l129 level2 lfo1;
tab-stops:list 0cm'><![if !supportLists]><span style='font-family:Symbol;
mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol'><span
style='mso-list:Ignore'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Hepatitis B, varicella, and diluents in the
lower racks of the main compartment </p>

<p class=MsoNormal>I</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[Q] Identification of 4Ds is a key element of which
National Health Programme? </p>

<p class=MsoNormal>(a) IMNCI (Integrated Management of Childhood and Neonatal
illness)</p>

<p class=MsoNormal>(b) ICDS (Integrated Child Development Scheme)</p>

<p class=MsoNormal>(c) RBSK (Rashtriya Bal Swasthya Karyakram)</p>

<p class=MsoNormal>(d) JSSK (Janani Karyakram) Shishu Suraksha</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[ANS] c</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal>[SOL] The identification of '4Ds' (Defects at birth,
Deficiencies, Diseases, and Developmental delays) is a key element of the
Rashtriya Bal Swasthya Karyakram (RBSK). RBSK is a national health programme in
India that aims to provide comprehensive healthcare to children under the age
of 18, focusing on early detection and management of health issues. The
programme provides screening and early intervention services for the 4Ds,
including disabilities.</p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

</div>

</body>

</html>
